10-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

(Amendment No. 1)

☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended December 31, 2025

OR

☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________to ________.

Commission File Number 000-56565

ONEMETA INC.

(Exact name of registrant as specified in its charter)

Nevada	000-56565	20-5150818
(State or other jurisdiction of incorporation or organization)	(Commission File No.)	(IRS Employer Identification No.)

450 South 400 East, Suite 200, Bountiful, UT 84010

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (702) 550-0122

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of exchange on which registered
None.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-Accelerated Filer ☒ Smaller Reporting Company ☒ Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The aggregate market value of the registrant’s common stock held by non-affiliates of the registrant on June 30, 2025, based upon the closing price of the common stock as reported on the OTC Bulletin Board on such date, was approximately $12 million.

As of May 1, 2026, the registrant had 38,890,943 shares of common stock outstanding.

EXPLANATORY NOTE

OneMeta, Inc. is filing this Amendment No. 1 on Form 10-K/A, or this Amendment No. 1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, or the Original 10-K, originally filed with the U.S. Securities and Exchange Commission, or SEC, on April 15, 2026, or Original Filing Date, solely for the purpose of updating the patents and trademarks list of the Company. The information previously included patents that were not owned by Company as of December 31, 2025. This Amendment No. 1 amends and restates the list of intellectual properties of patents and trademarks that are owned by the Company as of December 31, 2025.

Except as described above, no other changes have been made to the Original 10-K. The Original 10-K continues to speak as of the date of the Original 10-K, and we have not updated the disclosures contained therein to reflect any events that have occurred as of a date subsequent to the date of the Original 10-K. Accordingly, this Amendment No. 1 should be read in conjunction with the Original 10-K. Defined terms used, but not defined, herein have the meanings ascribed to them in the Original 10-K.

TABLE OF CONTENTS

PART I
Item 1.	Business	4
Item 1A.	Risk Factors	10
Item 1B.	Unresolved Staff Comments	16
Item 2.	Properties	17
Item 3.	Legal Proceedings	17
Item 4.	Mine Safety Disclosures	17
PART II
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	18
Item 6.	Reserved	20
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	23
Item 8.	Financial Statements and Supplementary Data	24
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	25
Item 9A.	Controls and Procedures	25
Item 9B.	Other Information	26
PART III
Item 10.	Directors, Executive Officers and Corporate Governance	27
Item 11.	Executive Compensation	29
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	30
Item 13.	Certain Relationships and Related Transactions and Director Independence	34
Item 14.	Principal Accountant Fees and Services	36
PART IV
Item 15.	Exhibits and Financial Statement Schedules	37
Item 16.	Form 10-K Summary	37
SIGNATURES		38

2

PART I

Unless otherwise indicated in this report, “Company,” “OneMeta,” “we,” “us,” “our,” and similar terms refer to OneMeta Inc.

DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS

This report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements in this report, other than statements of historical fact, are “forward-looking statements” for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of our management for future operations, any statements concerning proposed new products or services, any statements regarding the integration, development or commercialization of the business or any assets acquired from other parties, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “seeks,” “believes,” “estimates,” “potential,” “forecasts,” “continue,” or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results will likely differ, and could differ materially, from those projected or assumed in the forward-looking statements. Investors are cautioned not to unduly rely on any such forward-looking statements.

All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Our actual results will likely differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. If we do update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections.

Our future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties. Please see Item 1A “Risk Factors” for a discussion of these risks and uncertainties.

DISCLOSURE REGARDING TRADEMARKS

This report includes trademarks, tradenames and service marks that are our property or the property of other third parties. Solely for convenience, such trademarks and tradenames sometimes appear without any “™” or “®” symbol. However, failure to include such symbols is not intended to suggest, in any way, that we will not assert our rights or the rights of any applicable licensor, to these trademarks and tradenames.

Risk Factor Summary

Our business is subject to significant risks and uncertainties that make an investment in us speculative and risky. Below we summarize what we believe are the principal risk factors but these risks are not the only ones we face, and you should carefully review and consider the full discussion of our risk factors in the section titled “Risk Factors”, together with the other information in this Annual Report on Form 10-K. If any of the following risks actually occurs (or if any of those listed elsewhere in this Annual Report on Form 10-K occur), our business, reputation, financial condition, results of operations, revenue, and future prospects could be seriously harmed. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that adversely affect our business.

Risks Related to Our Operating History, Capital Structure, Financial Position and Capital Needs

● The development of our technology, products, and services is highly competitive.

● We are an early-stage company and have incurred significant losses since our inception. We expect to incur losses for the foreseeable future and may never achieve or maintain profitability.

● Our audited financial statements for the year ended December 31, 2025 included a statement from our independent registered public accounting firm that there is a substantial doubt about our ability to continue as a going concern, and a continuation of negative financial trends could result in our inability to continue as a going concern.

● We have a limited operating history from which you can evaluate our performance, and accordingly, our prospects must be considered in light of the risks that any new company encounters.

Risks Related to Our Business

● We are dependent on our management team, and the loss of any key member of this team may prevent us from implementing our business plan in a timely manner, or at all.

● We face risks from artificial intelligence.

● We may not be able to successfully implement our growth strategy for our brand on a timely basis or at all.

Risks Related to our Common Stock

● Failure to maintain effective internal control over our financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act has caused and may cause in the future our financial reports to be inaccurate.

● Our current stockholders’ ownership may be diluted if additional capital stock is issued to raise capital, to finance acquisitions or in connection with strategic transactions.

● Our bylaws contain an exclusive forum provision, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents.

3

Item 1. Business.

Business Summary

We develop and market artificial intelligence products that eliminate language barriers in daily communications by providing high-quality, accurate, and efficient interpretation and translation services using natural language processing (NLP) technology. The Company’s focus is on developing a proprietary architecture that is faster and more accurate than any other company, with a commitment to providing superior quality services to its customers. The Company intends to serve a wide variety of markets and customers and is focused on becoming a leader in the creation of products for the interpretation and translation industry.

Our proprietary AI and machine learning architecture enable seamless translation and transcription of spoken and written words in seconds across multiple languages. Our VerbumSuite platform facilitates fluid and effective communication among individuals regardless of linguistic differences. With support for real-time conversations over-the-phone, virtual meetings, and online chats in over 140 languages and dialects, Verbum is reshaping how organizations, educational institutions, and customer service centers connect and collaborate. The Company develops and markets artificial intelligence products that eliminate language barriers in daily communications by providing high-quality, accurate, and efficient interpretation and translation services using natural language processing (NLP) technology. Our focus is on developing a proprietary architecture that is faster and more accurate than any other company, with a commitment to providing superior quality services to its customers. We intend to serve a wide variety of markets and customers and are focused on becoming a leader in the creation of products for the interpretation, translation, and transcription industries. Driven by a vision to create a more understanding world and revolutionize global communication, we are committed to solving complex problems with practical solutions. We recognize that artificial intelligence has the potential to turn good decisions into great ones, and we strive to harness this potential to drive positive change across industries.

The Company has observed increasing demand from enterprise customers for on-premise and private cloud deployments, driven by heightened requirements for data privacy, intellectual property protection, and cost predictability associated with artificial intelligence solutions. From inception, the Company’s architecture has been designed as a multi-tenant platform with the capability to provide isolated, private datasets for each client and sub-client, enabling secure and controlled deployments across industries with sensitive data requirements. This architectural approach has contributed to early customer traction, particularly in regulated and enterprise environments. In response to evolving market demand, the Company is expanding its focus on on-premise and private cloud solutions, aligning with broader industry trends toward sovereign AI and localized data processing. Additionally, NVIDIA has recognized the Company’s approach and technology, including references to OneMeta in NVIDIA’s public materials related to AI media and localization ecosystems.

Our Products

Our current VerbumSuite products described in detail below are built on our proprietary and patented systems and methods for substantially real-time speech, transcription, and translation technology. We are also developing additional proprietary products and features to expand the service capabilities built on our core technological foundation.

● Verbum. Verbum supports real time web-based conversations, discussions, meetings, and online chats in 140 languages, enabling fluent and effective communication among individuals that do not speak the same language. This product is distributed through our online platform, direct sales to businesses and organizations, and we are attempting to develop partnerships with existing video conferencing providers. The competitive position is against other video conferencing providers that also offer live interpretation services, such as Microsoft Teams, Zoom and Google Meet. We believe our main competitors are organizations that supply human interpreters which can be ten times more expensive than our Verbum product. The Verbum product is available to customers at a wholesale price of $0.30 to $0.36 per minute, as compared to human interpreters, which can range from $45.00 to $150.00 per hour, or $1.25 to $3.00 per minute.⁽¹⁾ The primary market for our Verbum product is for organizations or individuals that require real-time interpretation services.

(1) As reported in “Medical Interpreters in Outpatient Practice”, available at https://pmc.ncbi.nlm.nih.gov/articles/PMC5758324/.

VerbumOnSite^TM – Real Time Translation Powered by AI

● Multilingual Events - unlocks the power of seamless communication at live events through real-time translation and captioning services. Attendees can effortlessly scan a QR code to access real-time captions in over 140 languages directly on their phones.

● Ease of Integration - integrates into the event setup, ensuring a smooth and hassle-free experience for organizers and attendees. User-friendly, web-based design and compatibility incorporates powerful multilingual features without technical complexities.

● Inclusive Communication - committed to breaking language barriers and making events accessible to all such as for those with hearing disabilities. Our solution provides real-time, multilingual closed captions, ensuring full engagement in conversations and presentations and fostering an inclusive event experience.

● Currently available for use in live events requiring multilingual support.

4

VerbumOnsite™ has been adopted for pilot programs at major international conferences, supporting live audience captions and mobile access in over 140 languages.

VerbumCall^TM – AI-Powered Over-the-Phone Interpretation with No App or Internet Required

● Multilingual Calls - unlocks the power of seamless communication over the phone; similar to having a translator readily available in 140+ languages. VerbumCall transforms any mobile device into a personal translator without the need for internet connection or additional applications.

● Ease of Integration - integrates into the users current systems incorporating powerful multilingual calls without technical complexities.

● Scalable & Confidential - offers a scalable solution that adapts to the users business needs, whether making one call or thousands of calls. Our AI-powered conversations enable calls to be private and secure, ensuring business communications are confidential and protected.

● Currently available for integration with major Contract Center as a Service (CCaaS) providers.

Verbumcall™ has been deployed with early adopters in the bpo industry , proving its ability to lower costs and improve call handling time compared to human interpreters.

VerbumTM for Microstoft Teams – AI Translation for Multilingual Meetings

● Enhances the Microsoft Teams experience by facilitating multilingual groups to come together in meetings. Enables collaborators from all over the world to work together without language barriers. Each attendee chooses the language that they will be speaking in and the language in which they want to see captions and chat. As each person speaks in their preferred language from a list of 95+ languages, it is translated in near real-time for the rest of the group.

● When a user selects their preferred language, it does not impact the other users in the meeting. The system allows each user to understand and be understood using their preferred language.

● Translates chat messages into 3 selected languages in near real-time to allow flow of communication.

● Enables a transcript function allowing the user to upload documents that can be translated into 95+ languages and shared with the whole team.

● No formal legal or commercial agreement is required with Microsoft for the operation of this product within Microsoft Teams. The Company fully complies with Microsoft’s comprehensive development, publishing, and certification standards to ensure functionality, security and accessibility.

● Integration with Microsoft Teams is achieved through Microsoft Teams APIs and compliance with a detailed manifest that undergoes thorough third-party review. The manifest governs Verbum’s features and ensures secure, real-time multilingual translation capabilities, including captions and chat translations for over 120 languages. Verbum interacts with Microsoft Teams by processing real-time meeting audio and chat data (with user permission) to deliver high-accuracy, AI-powered translations directly within the Microsoft Teams interface.

● Fully operational and available to users.

● Verbum SDK. Verbum Software Developer Kit allows software programmers, potential channel partners, and corporate development teams to integrate our powerful multilingual communications platform Verbum™ — into new or existing Software-as-a-Service applications and/or client/server programs, helping them remove communications barriers for multinational organizations and/or those serving customers who speak/read different languages. This product may be distributed through partnerships with software developers or through direct sales to businesses and organizations that require interpretation services for their software. The competitive position would be against other software development kit providers that also offer interpretation services, such as Microsoft Azure or Amazon Translate. The expected market for this product is software developers and businesses that require interpretation services for their software applications.

5

Competition

The artificial intelligence language translation industry is nascent and characterized by rapidly advancing technologies and a strong emphasis on proprietary products. Our competition includes traditional language service providers such as human translators and transcription technology services developed by similar early-stage companies. While the traditional language service providers industry is large and mature, there are significant barriers to growth due to the lack of scalability of human-to-human interpretation and the ineffectiveness of providing a seamlessly fluid conversational experience. There are several early stage businesses who have developed technology for the purpose of voice-to-text closed captioning or generative text-to-voice capabilities, but we believe the practicality of these services diminishes their growth potential as it remains an unnatural form of communication, requires a minimum literacy adequacy for users, and presents challenges to productivity due to the additional cognitive load required to type or read language, major companies worldwide, such as Microsoft and Amazon have explored the development of similar technologies, but are unable to move at the speed and agility of growth-stage firms which will lead to a slow roll out, if developed.

We believe that the increasing shift toward on-premise and private cloud AI deployments introduces additional competitive dynamics, as enterprises prioritize solutions that offer data control, security, and predictable cost structures. Many competitors rely on centralized, cloud-based architectures or third-party APIs, which may limit their ability to address enterprise requirements for data residency and intellectual property protection. By contrast, the Company’s multi-tenant architecture, designed to support isolated client environments and flexible deployment models, including on-premise and private cloud configurations, positions the Company to address these evolving enterprise needs. While larger technology providers and emerging AI companies continue to invest in similar capabilities, the Company believes its early focus on secure, enterprise-grade deployments and proprietary datasets provides a competitive advantage in high-sensitivity and regulated use cases.

We believe that the principal competitive factors in our markets include the following:

● ease of adoption, use, and deployment;

● product functionality;

● platform capabilities;

● breadth and depth of platform integrations;

● scalability, availability and reliability;

● security and privacy;

● ability to support intercompany collaboration;

● brand awareness and reputation;

● customer support; and

● total cost of ownership.

Competition has intensified in recent periods, and we expect competition to continue to intensify as established and emerging companies continue to enter the markets we serve or attempt to address the translation problems.

6

Intellectual Property

The following chart provides information regarding the patents and trademarks of the Company:

Patents

Case No.	Title of Invention:	Country:	Status:	Application No.	Filing Date:	Patent No:	Date Issued:	Publication Number:	Published Date:
1META.055PR	SYSTEMS AND METHODS FOR RAPID MULTI-USER TEXT, SPEECH, AND TRANSLATION	US	Closed	63/374220	8/31/2022
1META.055PR2	SYSTEMS AND METHODS FOR RAPID MULTI USER TEXT, SPEECH, AND TRANSLATION	US	Closed	63/429505	12/1/2022
1META.055PR3	SYSTEMS AND METHODS FOR RAPID MULTI-USER TEXT, SPEECH, AND TRANSLATION	US	Closed	63/498261	4/25/2023
1META.055PR4	SYSTEMS AND METHODS FOR RAPID MULTI-USER TEXT, SPEECH, AND TRANSLATION	US	Closed	63/499696	5/2/2023

7

Trademarks

MARK	COUNTRY	FILING DATE APPLICATION NO.	REGISTRATION DATE REG. NO.	CLASSES	STATUS
ONEMETA	US	12/27/2022 97/732496		38 Int., 41 Int., 42 Int.	Published
ONEMETA	AU	6/23/2023 2366631		38 Int., 41 Int., 42 Int.	Published
ONEMETA	BR	6/27/2023 930935543		38 Int.	Published
ONEMETA	BR	6/27/2023 930935586		41 Int.	Published Opposed by Meta Serviços em Informática S/A
ONEMETA	BR	6/27/2023 930935780		42 Int.	Published
ONEMETA	CA	6/21/2023 2265023		38 Int., 41 Int., 42 Int.	Pending
ONEMETA	EM	23-Jun-2023 018892626	11/14/2023 018892626	Class: 38 Int., 41 Int., 42 Int.	Registered
ONEMETA	GB	23-Jun-2023 UK00003926115	09/29/2023 UK00003926115	Class: 38 Int., 41 Int., 42 Int.	Registered
ONEMETA	JP	2023-069779 06/23/2023	01/11/2024 6768808	38 Int., 41 Int., 42 Int.	Registered
ONEMETA	KR	6/23/2023 40-2023-0111479		38 Int., 41 Int., 42 Int.	Published
ONEMETA	MX	6/27/2023 2971922	11/15/2023 2625631	38 Int.	Registered
ONEMETA	MX	6/27/2023 2971924	11/15/2023 2625670	41 Int.	Registered
ONEMETA	MX	6/27/2023 2971926	09/25/2024 2759839	42 Int.	Registered
VERBUM	US	12/27/2022 97/732499		38 Int., 41 Int., 42 Int.	Pending
VERBUM	AU	6/23/2023 2366632	07/15/2024 2366632	38 Int., 41 Int., 42 Int.	Registered
VERBUM	BR	6/27/2023 930935950		38 Int.	Published
VERBUM	BR	6/27/2023 930936027		41 Int.	Published
VERBUM	BR	6/27/2023 930936078		42 Int.	Published
VERBUM	CA	6/21/2023 2265024		38 Int., 41 Int., 42 Int.	Pending
VERBUM	EU	6/23/2023 018892664	11/08/2023 018892664	38 Int., 41 Int., 42 Int.	Registered
VERBUM	UK	6/23/2023 UK00003926123	9/29/2023 UK00003926123	38 Int., 41 Int., 42 Int.	Registered
VERBUM	JP	6/23/2023 2023-069780	12/13/2023 2023-069780	38 Int., 41 Int., 42 Int.	Registered
VERBUM	KR	6/23/2023 40-2023-0111480		38 Int., 41 Int., 42 Int.	Registered
VERBUM	MX	6/27/2023 2971928		38 Int.	Pending
VERBUM	MX	6/27/2023 2971930	11/28/2023 2632270	41 Int.	Registered
VERBUM	MX	6/27/2023 2971933		42 Int.	Pending

8

Our business objective is to help organizations throughout the world to achieve their full potential via artificial intelligence by eliminating language barriers in daily communications by providing high-quality, accurate, and efficient translation and transcription services using natural language processing (NLP) technology. The Company’s focus is on developing a proprietary architecture that is faster and more accurate than any other technology with a commitment to providing superior quality services to their customers.

Human Resources

As of December 31, 2025, the Company had 1 employee. The number of employees will increase through time and natural sales growth.

Corporate Information

The Company was originally incorporated as Promotions on Wheels Holdings, Inc., a Nevada corporation, on July 3, 2006. On December 26, 2008, the name of the Company was changed to Blindspot Alert, Inc. On September 11, 2009, the Company’s name was changed to WebSafety, Inc. On March 23, 2021, the Company’s name was changed to VeriDetx Corp. On June 8, 2021, the Company’s name was changed to WebSafety, Inc. On August 1, 2022, the Company acquired Metalanguage Corp (the “Acquisition”). Metalanguage Corp. was solely owned by Saul Leal, who has become the Company’s CEO. Metalanguage Corp. owned certain intellectual property regarding the use of artificial intelligence for the translation and transcription of foreign languages. This intellectual property became the basis of the Company’s Verbum and Verbum SDK products. The Company issued shares of Series B-1 Convertible Preferred Stock and common stock to Mr. Leal in exchange for all of the stock of Metalanguage Corp (the “Acquisition”). Upon completion of the Acquisition, Mr. Leal became the CEO of the Company and became a director on the Company’s board of directors. On June 20, 2023, the Company’s name was changed to OneMeta Inc.

Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. On October 31, 2025, the Company entered into (i) a Confidential General Release and Settlement Agreement with Rowland W. Day II, the Company’s former President, Chief Financial Officer, Secretary, Chief Legal Officer, and a member of the Board of Directors (the “Settlement Agreement”), and (ii) a related Stock Repurchase Agreement with the Rowland W. Day II and Jaimie D. Day Family Trust under declaration dated April 13, 1990 (the “Stock Repurchase Agreement” and together with the Settlement Agreement, the “Agreements”). The Agreements were approved by the Company’s Board of Directors on November 3, 2025. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of 4,309,710 shares of the Company’s Series B-1 Preferred Stock and 307,647 shares of common stock, at per-share prices ranging from $0.605-$0.66 for the preferred shares and $0.055-$0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. As of April 10, 2026, the Company purchased 4,166,667 shares of the Company’s Series B-1 Preferred Stock held by Rowland at a price of $0.66 per Series B-1 Preferred share for a total cash consideration of $2,750,000.

9

Available Information

Our website address is https://www.onemeta.ai/. Information contained on or that can be accessed through our website does not constitute part of this Annual Report on Form 10-K and the inclusion of our website address in this Annual Report on Form 10-K is an inactive textual reference only.

The following filings are available through our investor relations website after we file them with the Securities and Exchange Commission, or the SEC: Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and our Proxy Statement for our annual meeting of stockholders. These filings are also available for download free of charge on our investor relations website. Our investor relations website is located at https://investors.onemeta.ai/sec-filings. The SEC also maintains an Internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.

Item 1A. Risk Factors.

Risk Factors

An investment in our securities involves a high degree of risk. You should consider carefully all of the material risks described below, together with the other information contained in this Form 10-K. If any of the following events occur, our business, financial condition, results of operations and cash flows may be materially adversely affected.

Risks Related to Our Operating History, Capital Structure, Financial Position and Capital Needs

The development of our technology, products, and services is highly competitive.

We will face intense competition with respect to any products that we may seek to develop or commercialize in the future. Our competitors include major companies worldwide. Many of our competitors have significantly greater financial, technical and human resources than we have and superior expertise in research and development and marketing approved products/services and thus may be better equipped than we are to develop and commercialize products/services. These competitors also compete with us in recruiting and retaining qualified personnel and acquiring technologies. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. Accordingly, our competitors may commercialize products more rapidly or effectively than we are able to, which would adversely affect our competitive position, the likelihood that our products/services will achieve initial market acceptance and our ability to generate meaningful additional revenues from our products.

We are an early-stage company and have incurred significant losses since our inception. We expect to incur losses for the foreseeable future and may never achieve or maintain profitability.

We are an early-stage company. We only recently acquired our principal language interpretation and translation business in June of 2022. We face all the risks faced by newer companies, including significant competition from existing and emerging competitors, many of which are established and have better access to capital. In addition, as a new business, we may encounter unforeseen expenses, difficulties, complications, delays, and other known and unknown factors. We will need to transition from an early-stage company to a company capable of supporting larger scale commercial activities. If we are not successful in such a transition, our business, results, and financial condition will be harmed.

We have not been profitable to date, and we expect operating losses for the near future. For the years ended December 31, 2025 and 2024, we had net revenue of $1,505,866 and $31,304, respectively, and incurred net losses of $3,839,617 and $5,607,358, respectively. While we have recently entered into certain contracts for the distribution and sale of our language translation solutions, there can be no assurance that these contracts will yield the expected results, generate any revenue or that we will not continue to incur net losses in the future. We may not succeed in expanding our customer base and service offerings and even if we do, may never generate revenue that is significant enough to achieve profitability. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Furthermore, we may not be able to control overhead expenses even where our operations successfully expand. Our failure to become and remain profitable would depress our value and could impair our ability to raise capital, expand our business, diversify our product offerings, or even continue our operations.

Our audited financial statements for the year ended December 31, 2025 includes a statement from our independent registered public accounting firm that there is substantial doubt about our ability to continue as a going concern, and a continuation of negative financial trends could result in our inability to continue as a going concern.

There is substantial doubt about our ability to continue as a going concern over the next twelve months and our independent registered public accounting firm has included a “going concern” explanatory paragraph in their report in our financial statements as of and for the year ended December 31, 2025.

We have a limited operating history from which you can evaluate our performance, and accordingly, our prospects must be considered in light of the risks that any new company encounters.

We acquired our language and interpretation business in June of 2022. Accordingly, we have no significant history upon which an evaluation of our prospects and future performance can be made. Our proposed operations are subject to all of the business risks associated with a new enterprise. The likelihood of our creation of a viable business must be considered in light of the problems, expenses, difficulties, complications, and delays frequently encountered in connection with the inception of a business, operation in a competitive industry, and the continued development of our technology and the results of our clinical data. We anticipate that our operating expenses will increase for the near future. There can be no assurances that we will ever operate profitably. You should consider our business, operations and prospects in light of the risks, expenses and challenges faced as an early-stage company.

10

New product development involves a lengthy, expensive and complex process.

There can be no assurance that we will be capable of developing and commercializing new products. New product development involves a lengthy, expensive and complex process. In addition, before we can commercialize any new product candidates, we will need to:

● conduct substantial research and development;

● test product viability; and

● expend significant funds.

This process involves a high degree of risk and takes several years. Our product development efforts may fail for many reasons, including failure of the product at the research or development stage. In addition, as we develop product candidates, we will have to make significant investments in product development, marketing and sales resources.

We may be unable to manage our future growth effectively, which could make it difficult to execute our business strategy.

Our growth has placed, and may continue to place, significant demands on our organizational, administrative, and operational infrastructure, including operations, quality control, technical support and customer service, sales force management and general and financial administration. As we continue to grow, we will need to make significant investments in multiple divisions of our company, including in sales, marketing, product development, information technology, equipment, facilities, and human resources. We will also need to improve our operational, financial and management controls as well as our reporting systems and procedures.

If we are unable to manage our growth effectively, we may be unable to execute our business plan, which could have a material adverse effect on our business and our results of operations. Managing our planned growth effectively will require us to:

● maintain a low cost of customer acquisition relative to customer lifetime value; and

● successfully hire, train, and motivate additional employees, including additional personnel for our technology, sales and marketing efforts.

The expansion of our products and services and customer base may result in increases in our overhead and selling expenses. Any increase in expenditures in anticipation of future sales that do not materialize would adversely affect our profitability. In addition, if we are unable to effectively manage the growth of our business, the quality of our products may suffer and we may be unable to address competitive challenges, which would adversely affect our overall business, operations, and financial condition.

Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.

We have only recently become subject to the periodic reporting requirements of the Exchange Act. We must design our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. For example, our directors or executive officers could inadvertently fail to disclose a new relationship or arrangement causing us to fail to make a required related party transaction disclosure. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected.

11

Risks Related to Our Business

We are dependent on our management team, and the loss of any key member of this team, or our failure to recruit and retain new personnel, may prevent us from implementing our business plan in a timely manner, or at all.

Our success depends largely upon the continued services of our executive officers and other key personnel, particularly our Chief Executive Officer, Saul Leal. Our executive officers or key personnel could terminate their employment with us at any time without penalty. In addition, we do not maintain key person life insurance policies on any of our employees. The loss of one or more of these executive officers or key personnel could seriously harm our business and may prevent us from implementing our business plan in a timely manner, or at all.

Additionally, our expansion plans are contingent on our ability to successfully recruit and retain new personnel to meet the needs of our expanded operations. Any failure to recruit new personnel could have a material adverse effect on our business, financial condition, results of operations and prospects.

We may be unable to adequately protect our brand and our other intellectual property rights.

We regard our patents, brand, customer lists, trademarks, domain names, trade secrets and similar intellectual property as critical to our success. We may rely on U.S. and international trademark, copyright and patent law, trade secret protection, agreements and other methods with our employees and others to protect our proprietary rights. We might not be able to obtain protection in the United States or other countries for all our intellectual property. The protection of our intellectual property rights may require the expenditure of significant financial, managerial and operational resources. Moreover, the steps we take to protect our intellectual property may not adequately protect our rights or prevent third parties from infringing or misappropriating our proprietary rights, and we may be unable to broadly enforce all our intellectual property rights. Any of our present or future patents, trademarks or other intellectual property rights may be challenged by others or invalidated through administrative process or litigation. Any of our presently pending or future patent and trademark applications may never be granted. To date, we have applied for patent protection with respect to our business and products (e.g., products, systems, and processes for automated translation and transcription). Even if we are granted one or more patents, there is no guarantee that others will not independently develop or otherwise acquire equivalent or superior technology or intellectual property rights. Even if they do, there is no guarantee that enforcement of our intellectual property will succeed in the courts, or that our intellectual property will be held valid if challenged during that process. Furthermore, our confidentiality agreements and other measures may not effectively prevent disclosure of our proprietary information, technologies and processes and may not provide an adequate remedy in the event of unauthorized disclosure of such information.

We might be required to spend significant resources to apply for, obtain, monitor and protect, and enforce our intellectual property rights. For example, we may initiate claims or litigation against others for infringement, misappropriation or violation of our intellectual property rights or other proprietary rights or to establish the validity of such rights. However, we may be unable to discover or determine or prove the extent of any infringement, misappropriation or other violation of our intellectual property rights and other proprietary rights. Despite our efforts, we may be unable to prevent third parties from infringing upon, misappropriating or otherwise violating our intellectual property rights and other proprietary rights. Any litigation, whether or not it is resolved in our favor, could result in significant expense to us and divert the efforts of our technical and management personnel, which may materially and adversely affect our business, financial condition, and results of operations.

In addition, our licensed technology platform may use open-source software. While we believe that our core AI translation and transcription datasets are proprietary and open-source models currently provide only supplementary functionality and verification, the use of such open-source software may subject us to certain conditions, including the obligation to offer, distribute, or disclose our licensed technology platform for no or reduced cost, make the proprietary source code subject to open-source software licenses available to the public, license our software and systems that use open-source software for the purpose of making derivative works, or allow reverse assembly, disassembly, or reverse engineering. We may periodically monitor our use of open-source software to avoid subjecting our technology platform to conditions we do not intend. However, if our licensed technology platform becomes subject to such unintended conditions, it could have a material adverse effect on our business, financial condition, and results of operations.

12

From time to time, third parties may claim that one or more of our products or services infringe their intellectual property rights.

We may in the future be subject to intellectual property rights claims, which are costly to defend, could require us to pay damages and could limit our ability to use certain technologies in the future. Companies in the technology industries own large numbers of patents, copyrights, trademarks and trade secrets and frequently enter into litigation based on allegations of infringement or other violations of intellectual property rights. As we face increasing competition, the possibility of intellectual property rights claims against us grows. Our technologies may not be able to withstand any third-party claims or rights against their use.

Any dispute or litigation regarding patents or other intellectual property could be costly and time consuming due to the uncertainty of intellectual property litigation and could divert our management and key personnel from our business operations. A claim of intellectual property infringement could force us to enter into a costly or restrictive license agreement, which might not be available under acceptable terms or at all, could require us to redesign our products, which would be costly and time-consuming, and/or could subject us to an injunction against development and sale of certain of our products or services. We may have to pay substantial damages, including damages for past infringement if it is ultimately determined that our products infringe on a third party’s proprietary rights. Even if these claims are without merit, defending a lawsuit takes significant time, may be expensive and may divert management’s attention from other business concerns. Any public announcements related to litigation or interference proceedings initiated or threatened against us could cause our business to be harmed. Our intellectual property portfolio may not be sufficiently relevant or effective in asserting a counterclaim, or negotiating a license, in response to a claim of intellectual property infringement. In certain of our businesses we may rely on third party intellectual property licenses and we cannot ensure that these licenses will be available to us in the future on favorable terms or at all.

We may not be able to enforce our intellectual property rights throughout the world.

The laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the United States. Many companies have encountered significant problems in obtaining, protecting and defending intellectual property rights in certain foreign jurisdictions. This could make it difficult for us to stop the infringement or the misappropriation of our intellectual property rights. The loss of our patents, trademarks (e.g., the OneMeta brand or logo or other registered or common law trade names) or other intellectual property rights or a diminution in the perceived quality of products or services associated with the Company would harm our business. Our efforts to obtain or protect our intellectual property rights in such countries may be inadequate. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our technology and the enforcement of intellectual property.

We face risks from artificial intelligence.

Our products and services use artificial intelligence-powered translation technology. The use of artificial intelligence in our business presents risks and challenges, including that artificial intelligence algorithms may be flawed, datasets may be insufficient, erroneous, stale, or contain biased information, or translations made by artificial intelligence systems may be discriminatory, offensive, illegal, or otherwise harmful. Artificial intelligence can be based on machine learning that uses inputs that give rise to claims of copyright infringement. These risks, deficiencies and other failures of artificial intelligence systems could subject us to competitive harm, regulatory action, legal liability, and brand or reputational harm. In addition, there is no guarantee that our artificial intelligence powered translation products will be competitive or provide sufficiently fast and accurate translation services, so we could lose market share or be subject to harmful market feedback and reputational risk.

Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated trade secrets.

Although we try to ensure that our employees and consultants do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third parties. Litigation may be necessary to defend these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs to us, including reputational harm, and be a distraction to management and other employees.

13

We may be subject to significant liability that is not covered by insurance.

Although we believe that the extent of our insurance coverage is consistent with industry practice, any claim under our insurance policies may be subject to certain exceptions, may not be honored fully, in a timely manner, or at all, and we may not have purchased sufficient insurance to cover all losses incurred. If we were to incur substantial liabilities or if our business operations were interrupted for a substantial period, we could incur costs and suffer losses. Inventory, equipment, and business interruption losses may not be covered by our insurance policies. Additionally, insurance coverage may not be available to us at commercially acceptable premiums in the future, or at all.

If the reputation of our brand erodes significantly, it could have a material impact on our results of operations.

Our financial success is directly dependent on the consumer perception of our brand. The success of our brand may suffer if our marketing plans or product initiatives do not have the desired impact on our brand’s image or its ability to attract consumers. Further, our results could be negatively affected if our brand suffers substantial damage to its reputation due to real or perceived quality issues or other actions by the Company or any of its executives. Our brand could also suffer if we fail to obtain the brand protection (e.g., trademarks) that we seek now or in the future. For example, if a competing company succeeds in opposing or canceling our trademarks, this could cause us to re-brand, which could cause significant costs and harm to the Company.

We may not be able to successfully implement our growth strategy for our brand on a timely basis or at all.

We believe that our future success depends, in part, on our ability to implement our growth strategy of leveraging our existing brand and products to drive increased sales. Our ability to implement this strategy depends, among other things, on our ability to:

● successfully register trademarks and obtain similar intellectual property protection for our brand;

● successfully compete in the product categories in which we choose to operate;

● introduce new and appealing products and successfully innovate on our existing products;

● develop and maintain consumer interest in our brand; and

● increase our brand recognition and loyalty.

We may not be able to implement this growth strategy successfully. Our planned marketing expenditures may not result in increased total sales or generate sufficient levels of consumer interest or brand awareness, and our high rates of sales and income growth may not be sustainable over time. Our sales and results of operations will be negatively affected if we fail to implement our growth strategy or if we invest resources in a growth strategy that ultimately proves unsuccessful.

Technology failures or security breaches could disrupt our operations and negatively impact our business.

In the normal course of business, we rely on information technology systems to process, transmit, and store electronic information as well as in the delivery of our services to customers Furthermore, a significant portion of the communications between, and storage of personal data of, our personnel and customers depend on information technology.

Our information technology systems may be vulnerable to a variety of interruptions, as a result of updating our enterprise platform or due to events beyond our control, including, but not limited to, natural disasters, terrorist attacks, telecommunications failures, computer viruses, hackers, and other security issues. These events could compromise our confidential information, impede, or interrupt our business operations, and may result in other negative consequences, including remediation costs, loss of revenue, litigation and reputational damage. Furthermore, if a breach or other breakdown results in disclosure of confidential or personal information, we may suffer reputational, competitive and/or business harm.

While we have implemented administrative and technical controls and taken other preventive actions to reduce the risk of cyber incidents and protect our information technology, they may be insufficient to prevent physical and electronic break-ins, cyber-attacks, or other security breaches to our computer systems, which could have a material adverse effect on our business, financial condition or results of operations.

14

RISKS RELATED TO OUR COMMON STOCK

Failure to maintain effective internal control over our financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act has caused and may cause in the future our financial reports to be inaccurate.

We are required pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, to maintain internal control over financial reporting and to assess and report on the effectiveness of those controls. This assessment includes disclosure of any material weaknesses identified by our management in our internal control over financial reporting. Our management concluded that our internal controls over financial reporting were, and continue to be, ineffective as of December 31, 2025, identified a material weakness in our internal controls due to the lack of sufficient personnel to allow for segregation of duties (resulting from the limited number of personnel available) and the lack of formal documentation of our control environment. While management is working to remediate the material weaknesses, there is no assurance that such changes, when economically feasible and sustainable, will remediate the identified material weaknesses or that the controls will prevent or detect future material weaknesses. If we are not able to maintain effective internal control over financial reporting, our financial statements, including related disclosures, may be inaccurate, which could have a material adverse effect on our business.

Failure to continue improving our accounting systems and controls could impair our ability to comply with the financial reporting and internal controls requirements for publicly traded companies.

As a public company, we operate in an increasingly demanding regulatory environment, which requires us to comply with the Sarbanes-Oxley Act of 2002, and the related rules and regulations of the SEC. Company responsibilities required by the Sarbanes-Oxley Act include establishing corporate oversight and adequate internal control over financial reporting and disclosure controls and procedures. Effective internal controls are necessary for us to produce reliable financial reports and are important to help prevent financial fraud.

Management performed an annual assessment as of December 31, 2025 of the effectiveness of our internal control over financial reporting for its annual report. Our management concluded that our internal control over financial reporting was, and continues to be, ineffective as of December 31, 2025, due to material weaknesses in our internal controls due to the lack of segregation of duties (resulting from the limited number of personnel available) and the lack of formal documentation of our control environment. For as long as we remain an “emerging growth company” as defined in the JOBS Act, we have and intend to consider to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act. We may continue to take advantage of these reporting exemptions until we are no longer an “emerging growth company.” To mitigate the lack of segregation of duties material weaknesses, we engaged an outside firm to assist management with such accounting and will continue to use outside firms as a resource to deal with other non-recurring or unusual transactions. However, notwithstanding our mitigation efforts, there is no assurance we will not encounter accounting errors in the future. If we cannot provide reliable financial reports or prevent fraud, our business and results of operations could be harmed, and investors could lose confidence in our reported financial information.

Our current stockholders’ ownership may be diluted if additional capital stock is issued to raise capital, to finance acquisitions or in connection with strategic transactions.

We intend to seek to raise additional funds, finance acquisitions or develop strategic relationships by issuing equity or convertible debt securities, which would reduce the percentage ownership of our existing stockholders. Our board of directors has the authority, without action or vote of the stockholders, to issue all or any part of our authorized but unissued shares of common or preferred stock. Our articles of incorporation authorize us to issue up to 500,000,000 shares of common stock and 50,000,000 shares of preferred stock. Future issuances of common or preferred stock would reduce your influence over matters on which stockholders vote and would be dilutive to earnings per share. In addition, any newly issued preferred stock could have rights, preferences, and privileges senior to those of the common stock. Those rights, preferences, and privileges could include, among other things, the establishment of dividends that must be paid prior to declaring or paying dividends or other distributions to holders of our common stock or providing for preferential liquidation rights. These rights, preferences and privileges could negatively affect the rights of holders of our common stock, and the right to convert such preferred stock into shares of our common stock at a rate or price that would have a dilutive effect on the outstanding shares of our common stock.

Our bylaws contain an exclusive forum provision, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents.

Our Bylaws provide that, unless we consent in writing to the selection of an alternative forum, the state and federal courts in the State of Nevada shall be the exclusive forum for any litigation relating to our internal affairs, including, without limitation: (a) any derivative action brought on behalf of us, (b) any action asserting a claim for breach of fiduciary duty to us or our stockholders by any current or former officer, director, employee, or agent of us, or (c) any action against us or any current or former officer, director, employee, or agent of us arising pursuant to any provision of the Nevada Revised Statutes, the Articles of Incorporation, or the Bylaws.

15

For the avoidance of doubt, the exclusive forum provision described above does not apply to any claims arising under the Securities Act or Exchange Act. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

The choice of forum provision in our bylaws may limit our stockholders’ ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers, employees or agents, which may discourage such lawsuits against us and our directors, officers, employees and agents even though an action, if successful, might benefit our stockholders. The applicable courts may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. With respect to the provision making the state and federal courts in the State of Nevada the sole and exclusive forum for certain types of actions, stockholders who do bring a claim in the state and federal courts in the State of Nevada could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near Nevada. Finally, if a court were to find this provision of our bylaws inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could have a material adverse effect on us.

We are an “emerging growth company” and our compliance with the reduced reporting and disclosure requirements applicable to “emerging growth companies” may make our common stock less attractive to investors.

We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act, or JOBS Act, and we have elected to take advantage of certain exemptions and relief from various reporting requirements that are applicable to other public companies that are not “emerging growth companies.” These provisions include, but are not limited to: being permitted to have only two years of audited financial statements and only two years of related management’s discussion and analysis of financial condition and plan of operation disclosures; being exempt from compliance with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act; being subject to reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and not being required to hold nonbinding advisory votes on executive compensation or on any golden parachute payments not previously approved.

In addition, while we are an “emerging growth company,” we will not be required to comply with any new financial accounting standard until such standard is generally applicable to private companies. As a result, our financial statements may not be comparable to companies that are not “emerging growth companies” or elect not to avail themselves of this provision.

We may remain an “emerging growth company” until the fiscal year-end following the fifth anniversary of the completion of our initial public offering, though we may cease to be an “emerging growth company” earlier under certain circumstances, including if (i) we have more than $1.235 billion in annual revenue in any fiscal year, (ii) we become a “large accelerated filer,” with at least $700 million of equity securities held by non-affiliates as of the end of the second quarter of that fiscal year, or (iii) we issue more than $1.0 billion of non-convertible debt over a three-year period.

The exact implications of the JOBS Act are still subject to interpretations and guidance by the SEC and other regulatory agencies, and we cannot assure you that we will be able to take advantage of all of the benefits of the JOBS Act. In addition, investors may find our common stock less attractive to the extent we rely on the exemptions and relief granted by the JOBS Act. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may decline or become more volatile.

Item 1B. Unresolved Staff Comments.

None.

16

Item 1C. Cybersecurity.

The Company’s Cybersecurity System includes administrative, technical, and physical safeguards and is designed to provide an appropriate level of protection to maintain the confidentiality, integrity and availability of the Company’s and its customers’ information. This includes protecting against known and evolving threats to the security of the Company’s systems and information, and against unauthorized access, compromise, or loss of data. The Cybersecurity System is managed centrally, so the same security controls, policies and procedures are implemented across the organization. The Company maintains cybersecurity policies including an Acceptable Use Policy that all system users sign to acknowledge that they understand their security responsibilities. All system users receive security awareness training which includes phishing attack simulation testing.

A key element of the Company’s Cybersecurity System is to mature the system to align with the CIS18 Critical Security Controls security framework. The CIS controls are designed based on real-world data about cyber-attacks, to ensure that the measures are effective against current threats. The framework provides a prioritized set of actions, which enables the Company to focus its efforts on the most effective defensive measures first. This prioritization helps in optimizing the use of resources for maximum impact on security. This strategy provides a structured and effective approach to cybersecurity, helping the Company to protect its assets, comply with regulations, manage risks, and improve its overall security posture.

Governance

The Company has established controls and procedures to escalate enterprise-level issues, including cybersecurity matters, to the appropriate management levels within its organization and to its Board of Directors, or members or committees thereof, as appropriate. The Company’s Board of Directors is responsible for enterprise risk management, including its approach to managing cybersecurity risk, and has delegated oversight responsibility of information security risks to its Audit Committee. Under the Company’s framework, cybersecurity issues are analyzed by subject matter experts for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact. Matters determined to present potential material impacts to the Company’s financial results, operations, and/or reputation are immediately reported by management to the Company’s Board of Directors or its Audit Committee, as appropriate, in accordance with its escalation framework.

In addition, the Company has established procedures to ensure that management responsible for overseeing the effectiveness of disclosure controls is informed in a timely manner of known cybersecurity risks and incidents that may materially impact the Company’s operations and that timely public disclosure is made as appropriate. The Company’s Cybersecurity System is led by the Chief Executive Officer (“CEO”) in collaboration with other third-party cybersecurity service providers which in turn assist in monitoring our exposure from significant information technology suppliers, significant software as a service providers and major vendors with access to our information technology systems. Further, team members who support our cybersecurity program have relevant educational and industry experience through various roles involving information technology, security, auditing, compliance, systems and programming. The Company does not maintain cyber insurance coverage at this time. During the last three years, the Company has not experienced a material security breach and, as a result, the Company has not incurred any material expenses from such a breach. Furthermore, during such time, the Company has not been penalized or paid any amount under any information security breach settlement.

Item 2. Properties.

Our executive offices are located at 450 South 400 East, Suite 200, Bountiful, Utah, 84010. We rent an executive office at the cost of $1,600 per month and it is rented on a month-to-month basis. The directors and officers of the company generally work from their home offices.

Item 3. Legal Proceedings.

We are not currently party to any pending legal proceedings that we believe would, individually or in the aggregate, have a material adverse effect on our financial condition, cash flows or results of operations.

Item 4. Mine Safety Disclosures.

The disclosure required by this item is not applicable.

17

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our common stock trades on the OTC Bulletin Board under the symbol ONEI. As of December 31, 2025, there were 258 shareholders of our common stock and the total shares outstanding of 38,890,943. The transfer agent for our common stock is Pacific Stock Transfer 6725 Via Austin Parkway Suite 300, Las Vegas, Nevada 98119.

Trades in our common stock may be subject to Rule 15g-9 under the Exchange Act, which imposes requirements on broker-dealers who sell securities subject to the rule to persons other than established customers and accredited investors. For transactions covered by the rule, broker-dealers must make a special suitability determination for purchasers of the securities and receive the purchaser’s written agreement to the transaction before the sale.

Our shares are subject to rules applicable to “penny stock” which pertain to any equity security with a market price less than $5.00 per share or an exercise price of less than $5.00 per share. Penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the SEC, which specifies information about penny stock and the nature and significance of risks of the penny stock market. A broker-dealer must also provide the customer with bid and offer quotations for the penny stock, the compensation of the broker-dealer, and sales person in the transaction, and monthly account statements indicating the market value of each penny stock held in the customer’s account. In addition, the penny stock rules require that, prior to a transaction in a penny stock not otherwise exempt from those rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction. These disclosure requirements may have the effect of reducing the trading activity in our shares.

Dividend Policy

We have not paid or declared any cash dividends on our common stock in the past and do not foresee doing so in the foreseeable future. We intend to retain any future earnings for the operation and expansion of our business. Any decision as to future payment of dividends will depend on the available earnings, the capital requirements of our Company, our general financial condition and other factors deemed pertinent by our Board of Directors.

18

Sales of Unregistered Securities

Date of Transaction	Transaction type (e.g. new issuance, cancellation, shares returned to treasury)	Number of Shares Issued (or cancelled)		Class of Securities	Value of shares issued ($/per share) at Issuance		Were the shares issued at a discount to market price at the time of issuance? (Yes/No)	Individual/ Entity Shares were issued to (entities must have individual with voting / investment control disclosed).	Reason for share issuance (e.g. for cash or debt conversion) -OR- Nature of Services Provided	Restricted or Unrestricted as of this filing.	Exemption or Registration Type.
4/1/2025	New Issue		1,000,000	Common	$	.50	No	Invictus General Partners	Cash	Restricted	Exempt
4/17/2025	New Issue		100,000	Common	$	.23	No	Dayanna Rojas	Services	Restricted	Exempt
2/4/2025	New Issue		-	$100,000 Convertible Note		-	No	Amorim Joint Trust	Cash	Restricted	Exempt
2/6/2025	New Issue		-	$50,000 Convertible Note		-	No	Roy Chestnutt	Cash	Restricted	Exempt
2/20/2025	New Issue		-	$50,000 Convertible Note		-	No	Glenn Harper	Cash	Restricted	Exempt
2/24/2025	New Issue		-	$25,000 Convertible Note		-	No	Eduardo Souza Amorim	Cash	Restricted	Exempt
2/25/2025	New Issue		-	$100,000 Convertible Note		-	No	Ignatius Living Trust	Cash	Restricted	Exempt
2/26/2025	New Issue		-	$250,000 Convertible Note		-	No	Felipe Amorim	Cash	Restricted	Exempt
3/20/2025	New Issue		-	$50,000 Convertible Note		-	No	Roy Chestnutt	Cash	Restricted	Exempt
3/21/2025	New Issue		-	$40,000 Convertible Note		-	No	Ivan Satori Filho	Cash	Restricted	Exempt
7/28/2025	New Issue		-	$100,000 Convertible Note		-	No	Atlantic Staffing, LLC	Cash	Restricted	Exempt
10/31/2025	New Issue		-	$1,000,000 Convertible Note		-	No	Jarman Family Holdings LLC	Cash	Restricted	Exempt
10/31/2025	New Issue		-	$1,000,000 Convertible Note		-	No	Jeffrey M. Canter	Cash	Restricted	Exempt

19

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

Holders of Record

As of December 31, 2025, there were 258 record holders, of the Company’s common stock.

Item 6. Selected Financial Data.

As a “smaller reporting company,” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read in conjunction with our financial statements, including the notes thereto, appearing in this Form 10-K and are hereby referenced. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this report. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this report. We believe it is important to communicate our expectations. However, our management disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

These forward-looking statements are based on our management’s current expectations and beliefs and involve numerous risks and uncertainties that could cause actual results to differ materially from expectations. You should not rely upon these forward-looking statements as predictions of future events because we cannot assure you that the events or circumstances reflected in these statements will be achieved or will occur. You can identify a forward-looking statement by the use of the forward-terminology, including words such as “may”, “will”, “believes”, “anticipates”, “estimates”, “expects”, “continues”, “should”, “seeks”, “intends”, “plans”, and/or words of similar import, or the negative of these words and phrases or other variations of these words and phrases or comparable terminology. These forward-looking statements relate to, among other things: our sales, results of operations and anticipated cash flows; capital expenditures; depreciation and amortization expenses; sales, general and administrative expenses; our ability to maintain and develop relationship with our existing and potential future customers, and, our ability to maintain a level of investment that is required to remain competitive. Many factors could cause our actual results to differ materially from those projected in these forward-looking statements, including, but not limited to: variability of our revenues and financial performance; risks associated with technological changes; the acceptance of our products in the marketplace by existing and potential customers; disruption of operations or increases in expenses due to our involvement with litigation or caused by civil or political unrest or other catastrophic events; general economic conditions, government mandates; and, the continued employment of our key personnel and other risks associated with competition.

Overview

The Company operates to develop artificial intelligence products that enable companies and individuals to reach their highest potential by eliminating language barriers in daily communications by providing high-quality, accurate, and efficient interpretation and translation services using natural language processing (NLP) technology. The Company’s focus is on developing a proprietary architecture that is faster and more accurate than any other company, with a commitment to providing superior quality services to its customers. The Company intends to serve a wide variety of markets and customers and will be focused on becoming a leader in the creation of pragmatic products for the interpretation and translation industry.

Basis of Presentation

Our financial statements are prepared in accordance with U.S. generally accepted accounting principles, which requires the use of estimates, assumptions, and the exercise of subjective judgment as to future uncertainties. Our financial statements have been prepared using the accounting and reporting guidance in Accounting Standards Codification Topic 946, Financial Services—Investment Companies, or ASC Topic 946.

20

Results of Operations

Revenues

The Company had revenue of $1,505,866 and $31,304 for the years ended December 31, 2025, and 2024, respectively.

The Company is in a product development stage and has generated very limited revenue in the past, primarily by providing its language translation services to a limited number of customers. The Company expects to commence generating revenue pursuant to certain contracts into which it has recently entered:

● On October 8, 2024, the Company entered into an “Original Equipment Manufacture” agreement with inContact, Inc. (“inContact”), a Delaware corporation. inContact is an affiliate of NICE Ltd., a company incorporated in Israel whose shares are traded on the Tel Aviv Stock Exchange and whose American Depositary Shares are traded on the Nasdaq Global Select Market. Nice is one of the largest customer service companies in the world. Pursuant to the Agreement, inContact will distribute and sell the Company’s OEM solutions, consisting of over-the-phone consecutive AI language transaction solutions to customers and inContact will pay fees to the Company based on usage of the Company’s OEM solutions. The Agreement has an exclusivity period of eighteen months and an initial term of three years.

● One August 22, 2024, the Company entered into a Genesys AppFoundery ISV Partner Agreement with Genesys Cloud Services, Inc. (“Genesys”), a California corporation. Genesys manages the Genesys AppFoundry, a marketplace of solutions that offers Genesys customers a curated selection of integrations and applications. The agreement governs the Company’s non-exclusive participation as an AppFoundry ISV Partner in the Genesys AppFoundry Program. The Company has agreed to pay a non-refundable revenue share to Genesys during the term of the Agreement based on a percentage of the revenue invoiced by the Company or Genesys in connection with the sale of the Company’s software through the AppFoundry marketplace. The agreement may be terminated by either party without cause upon ninety (90) days written notice to the other party.

● On July 22, 2024, the Company entered into an Independent Software Vendor Program Agreement with Five9, Inc. (“Five9”), a Delaware corporation. Five9 is a leading provider of intelligent cloud software and applications for contact centers. Pursuant to the Agreement, Five9 granted the Company a non-exclusive, worldwide, royalty-free, non-sublicensable and non-transferable license to access the Five9 developer account with the purpose of integrating the Company’s products and services and becoming an accredited vendor under Five9’s ISV program. The Company has agreed to pay a non-refundable ISV Program participation fee to Five9 for the initial one-year term of the agreement and for each one-year renewal term thereafter. Further, each party to the Agreement may receive referral fees from the other party for the referral of prospective customers.

The Company is currently in the “proof of concept” phase with respect to the inContact, Genesys and Five9 agreements and expects to begin generating revenue from these agreements in the near future; however, there can be no assurance that these contracts will yield the expected results or generate any revenue. In general, the Company intends to generate revenue through the following sources:

● Subscription Model: The Company may offer its interpretation and translation services to customers on a subscription basis, with customers paying a monthly or annual fee to access the service.

● Pay-Per-Use Model: The Company may generate revenue on a pay-per-use model, where customers pay for interpretation or translation services on a per-minute or per-word basis.

● Licensing: The Company may license its proprietary NLP technology and architecture to other companies for a fee.

● Training and Education: The Company generates revenue by offering training and education services related to interpretation and translation, such as online courses and in-person workshops.

● Consultancy Services: The Company may generate revenue by offering consultancy services related to interpretation and translation, such as advising clients on best practices or providing customized solutions to meet their specific needs.

● Partnerships and Collaborations: The Company may form both formal and informal relationships with other businesses or organizations to offer joint interpretation and translation services and generate revenue through a revenue-sharing agreement.

We currently have limited customer relationships and revenue. Although we currently have multiple discussions underway, there can be no assurance of us entering into additional service agreements and business relationships.

Expenses

Operating expenses consist primarily of research and development, salaries and benefits, infrastructure and equipment, professional services and distribution and delivery.

● Research and Development: Developing and maintaining the proprietary NLP technology and architecture will be a significant future expense for the Company. This will include expenses related to hiring and retaining top talent, conducting research and development, and investing in technology infrastructure and equipment.

● Salaries and Benefits: The Company will invest in hiring and retaining additional employees to perform various functions, such as software development, customer support, sales, and administration. This will include salaries, benefits, and other employee-related expenses.

● Infrastructure and Equipment: The Company will invest in technology infrastructure and equipment to support its software development and distribution operations. This will include expenses related to servers, software licenses, hardware, and office equipment.

● Professional Services: Depending on the Company’s needs, it may need to engage professional services such as legal, accounting, or consulting services, which would be an expense for the Company.

● Distribution and Delivery: The Company will need to invest in distribution and delivery methods for its products, such as software updates, shipping, or online delivery. This will include expenses related to logistics, software licensing, or server maintenance.

21

The Company will bear all expenses of its operations, including, without limitation: (a) fees, costs and expenses of outside counsel, accountants, auditors, consultants, administrators, depositaries and other similar outside advisors and service providers with respect to the Company and its business or operations; (b) any taxes, fees or other governmental charges levied against the Company or on its income or assets or in connection with its business or operations, and preparation expense in connection with such governmental charges or to otherwise comply with applicable tax reporting obligations or any legal implementation of such regimes, but excluding any amounts to the extent that the Company has been reimbursed therefore; (c) fees, costs and expenses incurred in connection with any audit, examination, investigation or other proceeding by any taxing authority or incurred in connection with any governmental inquiry, investigation or proceeding, in each case, involving or otherwise applicable to the Company, including the amount of any judgments, settlements, remediation or fines paid in connection therewith; (d) the portion fairly allocable to the Company of fees, costs and expenses incurred in connection with legal, regulatory and tax services provided on behalf of the Company and compliance with U.S. federal, state or local law or other non-U.S. law or other law and regulation relating to the Company’s activities, reports, filings, disclosures and notices prepared in connection with the laws and/or regulations of jurisdictions in which the Company engages in activities; (e) fees, costs and expense related to the offering of Shares (including expense associated with updating the offering materials, expenses associated with printing such materials, expenses associated with subscriptions and redemptions, and travel expenses relating to the ongoing offering of Shares) or a transfer of Shares or repurchase (but only to the extent not paid or otherwise borne by the transferring Shareholder and/or assignee of the transferring Shareholder, as appliable); (f) fees, costs and expenses related to procuring, developing, implementing or maintaining information technology, data subscriptions and license-based services, product development materials, equipment and services, computer software or hardware and electronic equipment used in connection with providing services to the Company in connection with obtaining and performing research related to potential or actual product development; (g) fees, costs and expenses incurred in connection with the dissolution and liquidation of the Company; and (h) all other costs and expenses of the Company and its affiliates in connection with the business or operation of the Company.

The Company will bear any extraordinary expenses it may incur, including any litigation expenses.

Results of Operations for the Years Ended December 31, 2025 and 2024

	December 31, 2025			December 31, 2024
Revenue	$	1,505,866		$	31,304
Cost of Revenue		208,590			-
Net profit		1,297,276			31,304
Operating expenses:
Research and development		1,178,595			869,899
General and administrative		2,888,343			2,937,425
Advertising and marketing		25,760			92,688
Legal and professional		687,066			625,957
Total operating expenses		4,779,764			4,525,969
Loss from operations		(3,482,488	)		(4,521,665	)
Other expense:
Interest expense		(357,129	)		(73,890	)
Total other expense		(357,129	)		(73,890	)
Net loss	$	(3,839,617	)	$	(4,595,555	)

22

Revenue and Cost of Revenue

Revenue for the year ended December 31, 2025 was $1,505,866 as compared to $31,304 as of December 31, 2024. Our cost of revenue for the year ended December 31, 2025 was $208,590 as compared to $0 as of December 31, 2024. The Company entered into several new sales and service contracts and began recognizing revenue from the new contracts during the year ended December 31, 2025.

Operating Expenses

Total operating expenses for the year ended December 31, 2025 were $4,779,764 as compared to $4,525,969 as of December 31, 2024. The increase in our operating expenses was primarily a result of (i) an increase in research and development expenses from $896,899 for the year ended December 31, 2024 to $1,178,595 for the year ended December 31, 2025, (ii) an increase in legal and professional expenses from $625,957 for the year ended December 31, 2024 to $687,066 for the year ended December 31, 2025, offset by (iii) decrease in general and administrative expenses from $2,937,425 for the year ended December 31, 2024 to $2,888,343 for the year ended December 31, 2025 and (iv) decrease in advertising and marketing expenses from $92,688 for the year ended December 31, 2024 to $25,760 for the year ended December 31, 2025, each of which were connected to management’s efforts to perform obligations related to new sales contracts, increased efforts to develop new products and improve new products and increased consulting fees related to the registration of the Company with the SEC.

Other Expense

Other expense was $357,129 for the year ended December 31, 2025, compared to $73,890 for the year ended December 31, 2024, an increase of $283,239. This increase was from increased interest expenses which, in turn, was attributable to increased borrowings from for the year ended December 31, 2024 to for the year ended December 31, 2025.

Net Loss

As a result of our increase in revenue and operating expenses, we had net loss of $3,839,617 for the year ended December 31, 2025 as compared to $4,595,555 for the year ended December 31, 2024.

Liquidity and Capital Resources

As of December 31, 2025, the Company had total assets of $123,780, of which $121,937 were current assets. We also had total liabilities of $4,431,863, of which $3,044,251 were current liabilities. We have incurred net losses since our inception and we anticipate net losses and negative operating cash flows for the near future and we may not be profitable or realize growth in the value of our assets. To date, our primary sources of capital have been cash generated from common stock sales and debt financing. While these sources of capital have primarily been from third party investors, they have also included loans from Mr. Rowland W. Day II, our former President and CFO.

As of December 31, 2025, the Company had not yet achieved profitable operations and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management is seeking to obtain additional funds by equity financing and or related party advances, however, there is no assurance of additional funding being available. If we fail to increase our revenue, raise capital or enter into such agreements as and when needed, we may have to significantly delay, scale back or discontinue our operations or the development and commercialization of one or more of our products. Where the anticipated offering is successful, we may decide to raise additional financing, in addition to the net proceeds from this offering, to support further growth of our operations. Where the anticipated offering is unsuccessful, we expect to use proceeds from the issuance of equity, debt financings, or other capital transactions to fund our operations and satisfy our liquidity requirements.

We believe our ability to achieve commercial success and continued growth will be dependent upon our ability to sell our products and our continued access to capital either through sales of our equity or cash generated from operations. We will attempt to obtain additional capital through private investors; however, we have no agreements or understandings with third parties at this time in regard to investing additional monies.

The Company doesn’t have any plans to repurchase any of its equity or debt.

Related Parties

See “Item 13. Certain Relationships and Related Transactions, and Director Independence” for a description of certain transactions and relationships with related parties.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

As a “smaller reporting company,” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.

23

Item 8. Financial Statements and Supplementary Data.

Our financial statements for the fiscal years ended December 31, 2025 and 2024 are attached hereto.

TABLE OF CONTENTS

Audited Financial Statements of OneMeta Inc.	Page Number
Report of Independent Registered Public Accounting Firm (PCAOB ID 2738)	F-1
Balance Sheets as of December 31, 2025 and 2024	F-2
Statements of Operations for the years ended December 31, 2025 and 2024	F-3
Statements of Stockholders’ Equity (Deficit) for the years ended December 31, 2025 and 2024	F-4
Statements of Cash Flows for the years ended December 31, 2025 and 2024	F-5
Notes to Financial Statements	F-6

24

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Shareholders of OneMeta, Inc.

Opinion on the Financial Statements

We have audited the accompanying balance sheets of OneMeta, Inc. (the Company) as of December 31, 2025 and 2024, and the related statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the years in the two-year period ended December 31, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the company has incurred recurring losses from operations and had not yet achieved profitable operations as of December 31, 2025 which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

Revenue Recognition

The company generates revenue from contracts with customers. As discussed in the notes to the financial statements, managements estimate of the consideration received and recognized from its contract agreements is considered variable.

Given the intricate considerations and complexities inherent in revenue transactions, the assessment of contract revenues requires a nuanced understanding of contract terms and performance obligations therein, transaction processes, verification procedures, and valuation methodologies. As such, Auditing management’s evaluation of the accounting for contract revenues recognized involved significant judgement and subjectivity due to technological considerations and complexity of the implementation of technology within those said contracts.

We evaluated the appropriateness and accuracy of management’s assessment in relation to our understanding of the revenue contracts, evaluation of transaction processes, verification of transactions, and assessment of valuation methods.

/s/ M&K CPAS, PLLC

PCAOB ID 2738

We have served as the Company’s auditor since 2022.

The Woodlands, TX

April 15, 2026

F-1

OneMeta Inc.

Balance Sheets

	December 31, 2025			December 31, 2024
ASSETS
Current assets:
Cash	$	4,584		$	215,816
Accounts receivable, net		22,508			5,000
Prepaid and other current assets		94,845			94,031
Total current assets		121,937			314,847
Noncurrent Assets:
Property and equipment, net		1,843			-
Total noncurrent assets		1,843			-
Total assets	$	123,780		$	314,847
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable	$	926,889		$	586,305
Accrued expenses		133,845			18,025
Accrued expenses, related party		97,000			501,822
Convertible notes payable		940,000			650,000
Convertible notes payable, related party		250,000			-
Promissory notes payable, net		380,321			-
Senior secured promissory notes, related party		-			543,515
Deferred revenue		316,196			700,000
Total current liabilities		3,044,251			2,999,667
Noncurrent Liabilities:
Convertible notes payable, net of current portion and discount		1,387,612			-
Total noncurrent liabilities		1,387,612			-
Total liabilities		4,431,863			2,999,667
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, $0.001 par value, 50,000,000 shares authorized,		-			-
Series A preferred stock, $0.001 par value, 5,000,000 shares authorized, 2,068 issued and outstanding		2			2
Series B-1 convertible preferred stock, $0.001 par value, 8,619,420 shares authorized, 8,619,420 shares issued and outstanding		862			862
Common stock, $0.001 par value, 500,000,000 shares authorized, 38,890,943 and 37,790,943 shares issued and outstanding, respectively		38,891			37,791
Common stock liability		527,889			-
Additional paid in capital		38,480,044			36,792,679
Accumulated deficit		(43,355,771	)		(39,516,154	)
Total stockholders’ equity (deficit)		(4,308,083	)		(2,684,820	)
Total liabilities and stockholders’ equity (deficit)	$	123,780		$	314,847

The accompanying notes are an integral part of these financial statements.

F-2

OneMeta Inc.

Statements of Operations

For the years ended December 31, 2025 and 2024

	December 31, 2025			December 31, 2024
Revenue	$	1,505,866		$	31,304
Cost of revenue		208,590			-
Gross profit		1,297,276			31,304
Operating expenses:
Research and development		1,178,595			896,899
General and administrative		2,888,343			2,937,425
Advertising and marketing		25,760			92,688
Legal and professional		687,066			625,957
Total operating expenses		4,779,764			4,552,969
Loss from operations		(3,482,488	)		(4,521,665	)
Other expense:
Interest expense		(357,129	)		(73,890	)
Total other expense		(357,129	)		(73,890	)
Net loss	$	(3,839,617	)	$	(4,595,555	)
Deemed dividend
Common stock dividend		-			(1,011,803	)
Net loss available to common shareholders	$	(3,839,617	)	$	(5,607,358	)
Net loss per common share:
Basic	$	(0.10	)	$	(0.17	)
Diluted	$	(0.10	)	$	(0.17	)
Weighted average common shares outstanding:
Basic		38,612,313			33,883,019
Diluted		38,612,313			33,883,019

The accompanying notes are an integral part of these financial statements.

F-3

OneMeta Inc.

Statements of Changes in Stockholders’ Equity (Deficit)

For the years ended December 31, 2025 and 2024

	Series A Preferred Stock				Series B-1 Convertible Preferred Stock				Common Stock				Common Stock		Additional paid-in		Accumulated
	Shares		Amount		Shares		Amount		Shares		Amount		liability		capital		Deficit			Total
Balance, December 31, 2023		2,068		2		8,619,420		862		32,995,460		32,996		-		33,992,707		(33,908,796	)		117,771
Common shares issued for cash		-		-		-		-		969,500		969		-		724,631		-			725,600
Stock based compensation		-		-		-		-		1,500,000		1,500		-		1,055,791		-			1,057,291
Deemed dividend		-		-		-		-		2,325,983		2,326		-		1,009,477		(1,011,803	)		-
Contributed capital		-		-		-		-		-		-		-		4,448		-			4,448
Imputed interest		-		-		-		-		-		-		-		5,625		-			5,625
Net loss		-		-		-		-		-		-		-		-		(4,595,555	)		(4,595,555	)
Balance, December 31, 2024		2,068	$	2		8,619,420	$	862		37,790,943	$	37,791		-	$	36,792,679	$	(39,516,154	)	$	(2,684,820	)
Common shares issued for cash		-		-		-		-		1,000,000		1,000		-		474,000		-			475,000
Common shares issued for service		-		-		-		-		100,000		100		-		22,900		-			23,000
Stock based compensation		-		-		-		-		-		-		-		392,585		-			392,585
Imputed interest		-		-		-		-		-		-		-		149,399		-			149,399
Relative fair value of warrants issued with convertible debt		-		-		-		-		-		-		-		648,481		-			648,481
Common shares liability		-		-		-		-		-		-		527,889		-					527,889
Net loss		-		-		-		-		-		-		-		-		(3,839,617	)		(3,839,617	)
Balance, December 31, 2025		2,068	$	2		8,619,420	$	862		38,890,943	$	38,891	$	527,889	$	38,480,044	$	(43,355,771	)	$	(4,308,083	)

The accompanying notes are an integral part of these financial statements.

F-4

OneMeta Inc.

Statements of Cash Flows

For the years ended December 31, 2025 and 2024

	December 31, 2025			December 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(3,839,617	)	$	(4,595,555	)
Adjustment to reconcile net loss to cash used in operating activities:
Imputed interest		149,399			5,625
Stock based compensation		415,585			1,057,291
Common stock liability		527,889			-
Amortization expense		108			-
Depreciation expense		58,414			-
Net change in:
Accounts receivable		(17,508	)		1,935
Prepaid and other current assets		(814	)		(87,211	)
Accounts payable		686,568			388,769
Accrued expenses		115,820			18,025
Accrued expenses, related party		(750,806	)		(100,123	)
Deferred revenue		(383,804	)		700,000
CASH FLOWS USED IN OPERATING ACTIVITIES		(3,038,766	)		(2,611,244	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment		(1,951	)		-
CASH FLOWS USED IN INVESTING ACTIVITIES		(1,951	)		-
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of related party note		-			(221,990	)
Proceeds from senior secured promissory notes, related party		266,935			643,000
Payments of senior secured notes payable, related party		(810,450	)		(99,485	)
Proceeds from convertible notes		2,250,000			650,000
Proceeds from convertible notes, related party		290,000			-
Proceeds from senior secured promissory notes		370,000			-
Repayment of senior secured promissory notes		(12,000	)		-
Proceeds from related party advances		-			72,000
Payment of related party advances		-			(72,000	)
Proceeds from issuance of common shares		475,000			725,600
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		2,829,485			1,697,125
NET CHANGE IN CASH		(211,232	)		(914,119	)
Cash, beginning of period		215,816			1,129,935
Cash, end of period	$	4,584		$	215,816
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid on interest expense	$	101,345		$	42,526
Cash paid for income taxes	$	-		$	-
NON-CASH TRANSACTIONS
Expenses paid on the Company’s behalf	$	345,984		$	325,381
Deemed dividend	$	-		$	1,011,803
Relative fair value of warrants issued with convertible debt	$	648,481		$	-
Contributed capital	$	-		$	4,448

The accompanying notes are an integral part of these financial statements.

F-5

OneMeta Inc.

Notes to the Financial Statements

Note 1. Basis of Presentation

The accompanying audited financial statements of OneMeta Inc. (“we”, “our”, “OneMeta” or the “Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America and the rules of the Securities and Exchange Commission (“SEC”). The Company’s fiscal year end is December 31.

OneMeta was originally incorporated as Promotions on Wheels Holdings, Inc., a Nevada corporation, on July 3, 2006. On December 26, 2008, the name of the Company was changed to Blindspot Alert, Inc. On September 11, 2009, the Company’s name was changed to WebSafety, Inc. On March 23, 2021, the Company’s name was changed to VeriDetx Corp. On June 8, 2021, the Company’s name was changed to WebSafety, Inc. On July 10, 2022, the Company’s name was changed to OneMeta AI. On June 20, 2023, the Company’s name was changed to OneMeta Inc.

Note 2. Summary of Significant Accounting Policies

Use of Estimates

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of stock-based compensation, fair value measurement and long-term customer contracts.

Cash and Cash Equivalents

Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable

Accounts receivables are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, past experience, review of customer profiles and the aging of receivable balances. As of December 31, 2025 and 2024, there was $1,160 and $1,160 of allowance for credit losses, respectively.

Property and Equipment

Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows:

	Estimated
Category	Useful Lives
Computer Equipment	3 years

Intangible Assets, and Long-Lived Assets

The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of a long-lived asset is measured by comparison of the carrying amount to the expected future undiscounted cash flows that the asset is expected to generate. Any impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value.

F-6

Related Parties

The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

Fair Value of Financial Instruments

The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates.

Revenue Recognition

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

● Identification of the contract with a customer

● Identification of the performance obligations in the contract

● Determination of the transaction price

● Allocation of the transaction price to the performance obligations in the contract

● Recognition of revenue when, or as, the Company satisfies a performance obligation

Subscription and license

We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software.

We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service.

Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient.

Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed.

F-7

OEM solution

The Company provides Over-the-phone, consecutive AI Translation Service (“VerbumCall SDK”) that uses WebSocket connections to provide an AI service designed to facilitate effortless communication across languages within the platforms. This product leverages advanced AI capabilities to provide consecutive audio translation, ensuring that both patrons and agents experience conversations without the need for additional steps or complicated setups.

The Company has multiple performance obligations in the customer contract with inContact. The Company is to generate revenue through the following sources: sale of OEM Solution software and professional services, which consist of implementation, configuration, custom development, optimization, training and technical support services of the OEM Solution.

VerbumAgentis

On March 31, 2025, the Company entered into a reseller and distribution agreement to provide software development kit (SDK) to the reseller to use and/or resell to their customers. The Company will provide the reseller with a VerbumAgentis communication platform and an encryption key to install on their computer system and servers. In return, the reseller is to pay an initial one-time paid-up fee of $500,000.

VerbumAgentis is a standalone communication platform with core capabilities such as chat-based interaction, transcription, and multilingual simultaneous interpretation for voice-to-voice customer interactions. It includes real-time bidirectional communication and integrations. While live translation leverages underlying language models (SDK), the core platform delivers independent value even without SDK execution for each interaction.

VerbumAgentis is installed on client’s servers that they control. The Company is to deliver and install the VerbumAgentis platform on the customers’ server and provide translation services on an as requested basis by the end customers. The customer benefits from the VerbumAgentis platform as a standalone system once installed on their infrastructure. Further, the translation services and other per usage items outlined in the contract are obligations that arise when those services are initiated by the customer.

Disaggregation of revenues

The Company disaggregates revenue between subscription and license revenue and training and education revenue.

	For the Years Ended
	December 31, 2025		December 31, 2024
Subscription, license and software revenue	$	617,430	$	27,804
Professional Services		868,881		3,500
OEM Solution		19,555		-
Total Revenue	$	1,505,866	$	31,304

Deferred Revenue

Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. On October 8, 2024, the Company entered into an OEM Agreement to provide OEM Solutions hosting consisting of over-the-phone consecutive AI language translation solutions. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. The Company identified three separate performance obligations within the contract. The performance obligations are OEM Solution service, professional services and technical support. The OEM Solution revenue is recognized based on a per-minute rate while the professional services and technical support revenue is recognized based on a per hour rate. The Company expects the $700,000 credit to be used mainly by OEM Solution and professional services. The Company recognized $448,804 of the credit during the year ended December 31, 2025. As of December 31, 2025, the Company expects to recognize all the unsatisfied performance obligations as revenue in the following five months.

F-8

During the year ended December 31, 2025, the Company recognized additional $65,000 of deferred revenue on new sales contracts. As of December 31, 2025 and 2024, the deferred revenue balance was $316,196 and $700,000, respectively.

Stock-Based Compensation

All stock-based awards to employees and non-employee contractors, including any grants of stock and stock options, are measured at fair value at the grant date and recognized over the relevant vesting period in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. Stock based awards to non-employees are recognized as a selling, general and administrative expense over the period of performance. Such awards are measured at fair value at the date of grant. In addition, for awards that vest immediately, the awards are measured at fair value and recognized in full at the grant date.

Basic and Diluted Loss Per Share

Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined by using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2025, the Company’s potentially dilutive shares, which were not included in the calculation of net loss per share, included warrants to purchase 6,350,000 common shares, options to purchase 5,465,000 common shares, conversion of Series B-1 shares to purchase 94,813,620 common shares, conversion of Series A shares to purchase 2,585 common shares, the conversion of the convertible notes to 31,838,135 common shares and common stock liability to issue 2,228,000 common shares. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations for the years ended December 31, 2025 and 2024, reflected in the accompanying statement of operations.

Segments Reporting

The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company using information about combined net income from operations. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.

Recent Accounting Pronouncements

Income Taxes

In December 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning January 1, 2025 on a prospective basis, with retrospective application permitted for all prior periods presented. We adopted ASU No. 2023-09 during the year ended December 31, 2025, which had no material impact on the Company’s financial statements.

F-9

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires specified information about certain costs and expenses be disclosed in the notes to the financial statements, including the expense caption on the face of the income statement in which they are disclosed, in addition to a qualitative description of remaining amounts not separately disaggregated. Entities will also be required to disclose their definition of “selling expenses” and the total amount in each annual period. The standard is effective for the Company for annual periods beginning January 1, 2027 and for interim periods beginning January 1, 2028, with updates applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures.

Credit Losses

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides updates related to CECL guidance for certain short-term receivables. The ASU is effective for fiscal years beginning after December 15, 2025. The Company is currently evaluating the impact of this guidance on its disclosures.

Note 3. Going Concern

These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of December 31, 2025, the Company had not yet achieved profitable operations and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The Company is actively seeking funding through debt and equity offerings. Management cannot be certain that such events or a combination thereof can be achieved.

Note 4. Related Party Transactions

Expense paid on the Company’s behalf

During the years ended December 31, 2025 and 2024, Mr. Day, a significant shareholder and former President and CFO, paid $345,984 and $341,108 of expenses on the Company’s behalf. The Company repaid $416,332 and $275,097 during the years ended December 31, 2025 and 2024, respectively. The advances accrued interest at the rate of 14%. As of December 31, 2025 and December 31, 2024, the balance owed to Mr. Day, with accrued interest, was $0 and $70,348, respectively.

Accrued salary and interest

As of December 31, 2025, the accrued related party salary and accrued interest expense was $97,000 and $12,307, respectively. As of December 31, 2024, the accrued related party salary and accrued interest expense was $364,500 and $23,121, respectively.

Senior secured notes payable

On May 10, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $225,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 10, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the remaining principal balance of $139,516 and the accrued interest of $27,171.

F-10

On June 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $216,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) December 12, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $216,000 and the accrued interest of $36,731.

On August 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) February 12, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $80,000 and the accrued interest of $13,409.

On August 27, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $5,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on October 31, 2024. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $5,000 and the accrued interest of $809.

On September 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $23,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) March 26, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $23,000 and the accrued interest of $3,458.

On October 14, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 13, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $80,000 and the accrued interest of $11,476.

F-11

On January 28, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $6,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on February 28, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $6,000 and the accrued interest of $71.

On March 21, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $3,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on April 21, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $3,000 and the accrued interest of $36.

On May 13, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $36,500 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on June 12, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $36,500 and the accrued interest of $420.

On June 25, 2025, Rowland Day paid $4,345 of debt origination fees related to loans made by Day on behalf of the Company. The balance due accrued interest at the rate of 14% per annum. The balance is payable on demand. During the year ended December 31, 2025, the Company repaid the balance of $4,345 and the accrued interest of $204.

On July 3, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $8,000 with Saul Leal (the “Lender”). The note will accrue interest at the rate of 14% per annum and matures on January 3, 2026. During the year ended December 31, 2025, the Company repaid the principal balance of $8,000 and the accrued interest of $120.

On July 10, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $104,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. In the event of a default, the Company will accrued interest at a rate of 16%. Under the July 10, 2025 secured promissory note agreement, on July 30, 2025 and August 30, 2025, the Company borrowed an additional $75,000 and $30,000, respectively. During the year ended December 31, 2025, the Company repaid the principal balance of $104,000 and the accrued interest of $7,439.

On November 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $14,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on January 31, 2025. During the year ended December 31, 2024, the Company repaid $14,000 of the secured promissory note principal.

For all of the secured promissory notes payable with the Lender, to secure the prompt and complete payment of all secured obligations, for value received and pursuant to the notes, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

As of December 31, 2025 and 2024, the related party senior secured promissory notes payable principal balance was $0 and $543,515, respectively, with accrued interest of $0 and $43,853, respectively.

F-12

Settlement Agreement

Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. In connection with his resignation, the Company made payments to Mr. Day in the amount of $917,966.43 in satisfaction of outstanding loans and reimbursable credit card balances owed to him and a payment in the amount of $408,486.01 for accrued salary. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of 4,309,710 shares of the Company’s Series B-1 Preferred Stock and 307,647 shares of common stock, at per-share prices ranging from $0.605-$0.66 for the preferred shares and $0.055-$0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. If the Company does not complete the stock repurchase by the stated deadline, the parties may pursue non-financial remedies available under the Stock Repurchase Agreement. As of December 31, 2025, the Company determined that the probability of the option to purchase the shares was improbable, as such, no accrual for the purchase of the shares was recognized as of December 31, 2025.

Convertible notes payable

During the year ended December 31, 2025, the Company issued 0% interest convertible notes payable to a director, a director nominee and two relative of a the director nominee in exchange for $250,000. The convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

The Company calculated imputed interest of $30,359 on these zero percent convertible notes using an interest rate of 14% and recorded to additional paid-in-capital. The Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates of the convertible notes. As of December 31, 2025, the convertible notes payable principal balance was $250,000.

The convertible notes matured and became convertible during the year ended December 31, 2025. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of December 31, 2025. As of December 31, 2025, the matured convertible notes would potentially be converted into 1,299,934 common shares.

	For the Years Ended
	December 25, 2025			December 25, 2024
Convertible notes payable, relate party	$	250,000		$	-
Total convertible notes payable, relate party		250,000			-
Less: current portion		(250,000	)		-
Long term convertible notes payable, relate party, net of current	$	-		$	-

Note 5. Convertible Notes Payable

In December 2024, the Company issued convertible notes payable to three investors in exchange for $650,000. During the year ended December 31, 2025, the Company issued 0% interest convertible notes payable to three investors in exchange for $190,000. The convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date. The Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates.

F-13

The Company calculated imputed interest of $119,040 on these zero percent convertible notes using an interest rate of 14% and recorded to additional paid-in-capital. As of December 31, 2025 and December 31, 2024, the convertible notes payable principal balance was $940,000 and $650,000, respectively.

All convertible notes matured and became convertible during the year ended December 31, 2025. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of December 31, 2025. As of December 31, 2025, the matured convertible notes would potentially be converted into 5,538,201 common shares.

On November 3, 2025, the Company entered into a Convertible Notes Agreement and a Warrant Purchase Agreements (the “Purchase Agreements”), dated as of October 31, 2025, with two investors (the “Holders”) for their purchase of (i) 14% convertible secured promissory notes of the Company in the aggregate original principal amount of $2,000,000 payable on October 31, 2028 (the “Notes”) with a fixed conversion price of $0.08 and (ii) 5-year warrants to purchase 6,000,000 shares of the Company’s common stock at an exercise price of $0.08. The proceeds are to used to repay all amounts outstanding under those certain 14% secured promissory notes and credit card balances to the former President of the Company in the amounts of $917,966 and $408,486, respectively. The remainder of the proceeds were used for working capital and general corporate purposes. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders.

The warrants had a relative fair value of $648,481, which was recorded as a discount on the note. The Company recognized amortization on the debt discount of $36,093 during the year ended December 31, 2025. As of December 31, 2025, the principal balance of the notes was $2,000,000 with an unamortized debt discount of $612,389.

	For the Years Ended
	December 25, 2025			December 25, 2024
Convertible notes payable	$	2,327,612		$	650,000
Total convertible notes payable		2,327,612			650,000
Less: current portion		(940,000	)		(650,000	)
Long term convertible notes payable, net of current	$	1,387,612		$	-

Note 6. Promissory Notes

On September 11, 2025, the Company entered into a Promissory Note for a principal amount of $353,050 with the Company receiving cash proceeds of $300,000. The Company recognized debt discount of $53,050 at the issuance of the notes. The note matures on August 30, 2026, and bears a one-time interest of 12% or $42,366. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date.

The Company recognized amortization on the debt discount of $17,683 during the year ended December 31, 2025. As of December 31, 2025, the principal balance of the note was $353,050 with an unamortized debt discount of $35,367.

On October 13, 2025, the Company entered into a Promissory Note for a principal amount of $88,550 with the Company receiving cash proceeds of $70,000. The Company recognized debt discount of $18,550 at the issuance of the notes. The note matures on August 15, 2026 and bears a one-time interest of 15% or $13,282. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date.

F-14

The Company repaid $12,000 of the principal balance and recognized amortization on the debt discount of $4,638 during the year ended December 31, 2025. As of December 31, 2025, the principal balance of the note was $76,550 with an unamortized debt discount of $13,913.

	For the Years Ended
	December 25, 2025			December 25, 2024
Promissory notes payable, net	$	380,321		$	-
Total Promissory notes payable, net		380,321			-
Less: current portion		(380,321	)		-
Long term Promissory notes payable, net of current	$	-		$	-

As of December 31, 2025, the Company had unamortized debt discount of $49,279.

Note 7. Equity

The Company is currently authorized to issue up to 500,000,000 shares of common stock with a par value of $0.001. In addition, The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors.

On May 1, 2023, the Company amended their articles of incorporation to increase the authorized B-1 preferred shares to 8,619,420 shares.

Common Stock

2025

On April 1, 2025, the Company issued 1,000,000 common shares at $0.50 per share for a net proceed of $475,000. The Company paid $25,000 as a finder fee to a consultant related to the issuance.

On April 17, 2025, the Company issued 100,000 common shares for service performed. The grant-date fair value of these shares was $23,000, calculated using the market price of $0.23 of the common stock on the date of grant. The awards are immediately vested, and the value of the issuance was recorded as stock-based compensation.

2024

During the year ended December 31, 2024, the Company issued 969,500 shares of common stock for cash and collected $725,600.

On November 25, 2024, the Company issued 1,500,000 shares of common stock to a consultant for service that were valued at $652,500.

On November 25, 2024, the Board approved the issuance of additional 2,325,983 shares of common stock to shareholders. The shares were issued to shareholders who previously entered into subscription agreements with the Company. This issuance was recorded as a deemed dividend and valued at $1,011,803.

Preferred Stock

Under our Articles of Incorporation, we are authorized to issue up to 2,068 shares of Series A Preferred Stock and up to 8,619,420 of Series B-1 Preferred Stock, each with par value of $0.001. The Series B-1 Preferred Stock is comprised solely of Series B-1 Preferred Stock.

Series A Preferred Stock

The Series A Preferred Stock has liquidation and dividend preferences. Each share of Series A has voting rights equal to the number of shares of common stock the Series A is convertible to and is convertible on a 1 to 1.25 common share basis. As of December 31, 2025 and December 31, 2024 there are 2,068 shares of Series A-1 issued and outstanding.

Series B-1 Preferred Stock

The Series B -1 Preferred Stock (“Series B-1”) has liquidation and dividend preferences. Each share of Series B-1 Preferred Stock has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock that the series of preferred shares are convertible into. Each share is convertible on a 1 to 11 common share basis. Our Articles of Incorporation include covenants requiring 51% of the outstanding votes of the series of stock to amend or repeal any incorporation documents that would alter the rights or preferences of the Series B-1 Preferred Stock, alter the authorized number of shares of the series, create or issue any classes of preferred stock senior to the Series B-1 Preferred Stock, amend the company’s bylaws, or enter into a transaction that would result in a change in control. On September 30, 2023, the Company amended its Articles of Incorporation to remove the redemption right of the Series B-1 Preferred Stock. As of December 31, 2025 and 2024, there are 8,619,420 shares of Series B-1 issued and outstanding.

F-15

Common Stock Liability

During the year ended December 31, 2025, the Company granted the issuance of 28,000 common shares to three consultants for services rendered in prior years. The shares had a fair value of $17,360, which was recorded as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On December 1, 2024, the Company granted the issuance of 300,000 restricted common shares to an advisor. The restricted common shares vest in twelve months equal instalments. The restricted common shares had a fair value of $141,000, of which was recognized as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the 300,000 restricted common shares were fully vested. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On August 1, 2025, the Company entered into a consultant agreement where the consultant will receive 7,000 common shares on a monthly basis beginning on the effective date of the agreement. On December 15,2025, the Company entered into an amendment to the consultant agreement to increase the number of monthly common shares to 14,000 common shares per month beginning on January 1, 2026. As of December 31, 2025, the Company granted the issuance of 35,000 common shares to the consultant. The shares had a fair value of $8,197, which was recorded as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On August 1, 2025, the Company entered into a consultant agreement where the consultant will receive 7,000 common shares on a monthly basis beginning on the effective date of the agreement. As of December 31, 2025, the Company granted the issuance of 35,000 common shares to the consultant. The shares had a fair value of $8,197, which was recorded as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On October 1, 2025, the Company granted the issuance of 120,000 restricted common shares to an advisor. The restricted common shares vest in twelve months equal instalments. The restricted common shares had a fair value of $32,280. The Company recognized $8,070 as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, 30,000 restricted common shares were vested. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On November 10, 2025, the Company entered into a service agreement where the Company will grant the issuance of 40,000 restricted common shares to the advisor on or before January 18, 2026. The Company granted the issuance of the restricted common shares on December 12, 2025. The restricted common shares were granted with a six month restriction period. The restricted common shares had a fair value of $9,196. The Company recognized $3,065 as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, 0 restricted common shares were vested.

On December 12, 2025, the Company granted the issuance of 1,800,000 common shares to two employees. The shares had a fair value of $342,000, which was recorded as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

As of December 31, 2025, the total common stock liability was 2,228,000 shares of common stock.

F-16

Stock Warrants

During the year ended December 31, 2025, the Company issued 6,000,000 common stock warrants in conjunction with convertible secured promissory notes agreements. The warrants had a relative fair value of $648,481, which was recorded as a discount on the note. The relative fair value of the warrants was estimated using a black-scholes model with the following assumptions:

	Year Ended
	December 31, 2025
Fair value of common stock on measurement date		$0.16 per share
Risk free interest rate (1)		3.71	%
Volatility (2)		307.04	%
Dividend yield (3)		0	%
Expected term (in years)		5 years

(1)	The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
(2)	The trading volatility was determined by calculating the volatility of the Company’s peer group.
(3)	The Company does not expect to pay a dividend in the foreseeable future.

The following table summarizes the stock warrant activity for the years ended December 31, 2025 and 2024:

	Warrants		Weighted-Average Exercise Price Per Share
Outstanding, December 31, 2023		350,000	$	1.29
Granted		–		–
Exercised		–		–
Forfeited		–		–
Expired		–		–
Outstanding, December 31, 2024		350,000		1.29
Granted		6,000,000		0.08
Exercised		–		–
Forfeited		–		–
Expired		–		–
Outstanding, December 31, 2025		6,350,000	$	0.15

As of December 31, 2025, the outstanding and exercisable warrants have a weighted average remaining term of 4.70 with intrinsic value of $966,000.

Stock Options

2025

On December 12, 2025, the board of directors approved the issuance of 1,050,000 option to employees, a director and an advisors. The options issued have a five-year term at an exercise price of $0.19. The options issued to the employees vest immediately on the date of issuance. The options issued to the director and the advisor vest in 12 months instalments beginning on the date of issuance. The total fair value of these option grants at issuance was $131,135. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.19, Exercise price $0.19, Term 2.5-3.0 years, Volatility 99.34%-117.91% and Discount rate 3.73%.

2024

On January 24, 2024, the board of directors approved the issuance of 750,000 options to a director. The options have a ten-year term at an exercise price of $0.51 and vest in 4 equal annual instalments beginning one year from the issuance date. The total fair value of these option grants at issuance was $368,386. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 6.25 years, Volatility 162.68% and Discount rate 4.14%.

F-17

On August 5, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The options vest as follows: (i) 50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options. Participant’s sales objectives for the following calendar year will be set by November 15 of the prior year. The total fair value of these option grants at issuance was $43,894. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 3.75 and 5 years, Volatility 120.76% and 167.38% and Discount rate 3.62%.

On August 19, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028. The total fair value of these option grants at issuance was $52,021. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.57, Exercise price $0.57, Term 3.75 years, Volatility 117.27% and Discount rate 3.75%.

On October 29, 2024, the board of directors approved the issuance of 1,200,000 options to an employee. The options expire on March 28, 2029 and have an exercise price of $0.75. 75,000 Options are fully vested and 525,000 Options will become vested and exercisable with respect to 37,500 shares on the last day of each calendar quarter beginning December 31, 2024, and ending on September 30, 2028, until 525,000 Option Shares are 100% vested. For a period of four years beginning October 1, 2024, ending September 30, 2025; October 1, 2025, ending September 30, 2026; October 1, 2026 ending September 30, 2027; and October 1, 2027 ending September 30, 2028, 150,000 Option Shares will vest (subject to meeting certain total new bookings) on September 30 of each year, beginning September 30, 2025. Vesting for each 12-month term is contingent upon Participant exceeding a minimum amount of total new bookings as determined by the Company’s board of directors or their designee. For the first term ending on September 30, 2025, Participant must exceed $5 million of total new bookings for the first vesting of 150,000 Option Shares. The total fair value of these option grants at issuance was $387,206. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.43, Exercise price $0.75, Term 4.21 and 4.41 years, Volatility 120.02% and 122.74 and Discount rate 4.38%.

On November 26, 2024, the Company amended the October 29, 2024 option issuance to change the exercise price to $0.41 per commons stock share and to extend the expiration of the options to October 1, 2029. The Company calculated the incremental fair value based on the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified. The total incremental fair value of the modified awards was $67,171.

The following table summarizes the stock option activity for the years ended December 31, 2025 and 2024:

	Options			Weighted-Average Exercise Price Per Share
Outstanding, December 31, 2023		3,645,000		$	0.43
Granted		2,170,000			0.46
Exercised		–			–
Forfeited		(1,400,000	)		0.33
Expired		–			–
Outstanding, December 31, 2024		4,415,000			0.46
Granted		1,050,000			0.19
Exercised		–			–
Forfeited		–			–
Expired		–			–
Outstanding, December 31, 2025		5,465,000		$	0.41
Exercisable, December 31, 2025		912,744		$	0.40

F-18

During the year ended December 31, 2025, the Company recognized $392,585 of expense related to outstanding stock options. During the year ended December 31, 2024, the Company recognized $404,791 of expense related to outstanding stock options. As of December 31, 2025, the un-recognized stock compensation was $665,593. As of December 31, 2025, the outstanding and exercisable options have a weighted average remaining term of 3.37.

Note 8: Commitments and Obligations

In December 2024, The Company entered into employment agreements with Mr. Leal and Mr. Day, each of which will become effective as of the effective date of the registration statement on Form S-1 in connection with the Company’s planned public offering of its shares. Pursuant to the employment agreements, Mr. Day has agreed to serve as President, Chief Financial Officer, Secretary, Chief Legal Officer and Chairman of the Board of the Company and Mr. Leal has agreed to serve as Chief Executive Officer and as a Director for five years from the effective date in consideration for an annualized salary of $300,000, payable in regular instalments in accordance with the usual payment practices of the Company. The employment agreements contemplate annual bonus awards based on the achievement of performance objectives and targets established annually by the Board of Directors and possible additional bonuses for services and results achieved by Mr. Day and Mr. Leal.

Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. On October 31, 2025, the Company entered into (i) a Confidential General Release and Settlement Agreement with Rowland W. Day II, the Company’s former President, Chief Financial Officer, Secretary, Chief Legal Officer, and a member of the Board of Directors (the “Settlement Agreement”), and (ii) a related Stock Repurchase Agreement with the Rowland W. Day II and Jaimie D. Day Family Trust under declaration dated April 13, 1990 (the “Stock Repurchase Agreement” and together with the Settlement Agreement, the “Agreements”). The Agreements were approved by the Company’s Board of Directors on November 3, 2025. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of 4,309,710 shares of the Company’s Series B-1 Preferred Stock and 307,647 shares of common stock, at per-share prices ranging from $0.605-$0.66 for the preferred shares and $0.055-$0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. If the Company does not complete the stock repurchase by the stated deadline, the parties may pursue remedies available under the Stock Repurchase Agreement.

On July 22, 2024, the Company entered into an Independent Software Vendor Program Agreement (the “Agreement”) with Five9, Inc. (“Five9”), a Delaware corporation. Five9 is a leading provider of intelligent cloud software and applications for contact centers. Pursuant to the Agreement, Five9 granted the Company a non-exclusive, worldwide, royalty-free, non-sublicensable and non-transferable license to access the Five9 developer account with the purpose of integrating the Company’s products and services and becoming an accredited vendor under Five9’s ISV program. The Company has agreed to pay a non-refundable ISV Program participation fee to Five9 for the initial one-year term of the Agreement and for each one-year renewal term thereafter. Further, each party to the Agreement may receive referral fees from the other party for the referral of prospective customers.

One August 22, 2024, the Company entered into a Genesys AppFoundery ISV Partner Agreement with Genesys Cloud Services, Inc. (“Genesys”), a California corporation. Genesys manages the Genesys AppFoundry, a marketplace of solutions that offers Genesys customers a curated selection of integrations and applications. The agreement governs the Company’s non-exclusive participation as an AppFoundry ISV Partner in the Genesys AppFoundry Program. The Company has agreed to pay a non-refundable revenue share to Genesys during the term of the Agreement based on a percentage of the revenue invoiced by the Company or Genesys in connection with the sale of the Company’s software through the AppFoundry marketplace. The agreement may be terminated by either party without cause upon ninety (90) days written notice to the other party.

F-19

On October 8, 2024, the Company entered into an OEM Agreement (the “Agreement”) with inContact, Inc. (“inContact”), a Delaware corporation. inContact is an affiliate of NICE Ltd., a company incorporated in Israel, whose shares are traded on the Tel Aviv Stock Exchange and whose American Depositary Shares are traded on the Nasdaq Global Select Market. NICE is one of the largest customer service companies in the world. Pursuant to the Agreement, inContact will distribute and sell the Company’s OEM solutions, consisting of over-the-phone consecutive AI language translation solutions to customers and inContact will pay fees to the Company based on usage of the Company’s OEM solutions. The agreement has an initial term of three years and will automatically renew for additional periods of one year. Additionally, the Company will continue to provide support to NICE for a period of five years following termination or expiration of the agreement. The agreement also has an exclusivity period of eighteen months. During the exclusivity period, NICE shall not develop or make its own native over-the-phone consecutive AI language translation solution, nor shall NICE OEM a competitive over-the-phone consecutive AI language translation solution, where such solution is embedded within the NICE Product. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. As of December 31, 2025, the Company recognized $448,804 of the credit balance as revenue and expects to recognize all the unsatisfied performance obligations as revenue in the next five months.

Note 9. Income Tax

The Company is subject to United States federal income taxes at an approximate rate of 21%. The reconciliation of the provision for income taxes at the United States federal statutory rate compared to the Company’s income tax expense as reported is as follows:

	Year Ended			Year Ended
	December 31,			December 31,
	2025			2024
Income tax benefit computed at the statutory rate	$	806,000		$	965,000
Tax effect of:
True-up and non-deductible expenses		(183,000	)		(422,000
Change in valuation allowance		(623,000	)		(543,000	)
Provision for income taxes	$	–		$	–

The Company adopted ASC 2023-09 during the year ended December 31, 2025 prospectively. A reconciliation setting forth the differences between the effective tax rates and the U.S. federal statutory tax rate is as follows:

	Year Ended December 31, 2025
	Amount			Rate
US federal statutory tax rate	$	806,000			21.0	%
Changes in valuation allowances		(623,000	)		-16.2	%
Non-taxable or non-deductible items		(183,000	)		-4.8	%
Effective income tax rate	$	–			0	%

Significant components of the Company’s deferred tax assets and liabilities after applying enacted corporate income tax rates are as follows:

	As of			As of
	December 31,			December 31,
	2025			2024
Deferred income tax assets
Net operating losses	$	4,691,000		$	4,069,000
Valuation allowance		(4,691,000	)		(4,069,000	)
Net deferred income tax assets	$	–		$	–

F-20

As of December 31, 2025, the Company currently has net operating loss carry forwards of approximately $22,340,000.

Note 10. Subsequent Events

On December 16, 2025, the Company issued 0% interest convertible notes payable to a the director nominee in exchange for $200,000. The funds were available to the Company on January 13, 2026. The convertible notes mature six months following that date of issuance and do not accrue interest. The note is convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

On January 27, 2026, the Company entered into a promissory note agreement for $80,000 with Roy Chestnutt, Company’s Director. The Company recognized debt discount of $1,612 at the issuance of the note. Pursuant to the agreement, the interest on the promissory note shall equal to 16,000 shares of restricted common stock of the Company. Both the principal balance and the shares are payable on February 1, 2026. As of February 1, 2026, the Company paid the principal balance of $80,000 and issued the 16,000 common shares for the accrued interest.

On February 2, 2026, the Company’s Chief Executive Officer advanced the Company $25,000 to be used for operating expenditures. The advance is due on demand and accrues interest at a rate of 14%. On April 10, 2026, the Company repaid $5,000 on the advance.

On February 3, 2026, the Company entered into a stock purchase agreement for the issuance of 1,388,889 common stock for a net proceed of $250,000.

Pursuant to the October 31, 2025 note and warrant purchase agreements, on February 11, 2026, the Company entered into two and amendment to the note and warrant purchase agreements where the lenders loaned an additional $200,000. Pursuant to the amended agreement, the interest on the promissory note shall equal to 125,000 shares of common stock of the Company for each note. Both the principal balance and the shares are payable on February 26, 2026. If the loans were note repaid when mature, the Company will issued an additional 125,000 shares of common stock for each note.

On March 9, 2026, the board of directors approved the issuance of 800,000 of Preferred B Stock to the Company’s Chief Executive Officer as a performance-based bonus.

On March 20, 2026, the Company entered into a stock purchase agreement for the issuance of 833,334 common stock for a net proceed of $100,000.

On March 23, 2026, the Company entered into a stock purchase agreement for the issuance of 2,083,334 common stock for a net proceed of $250,000.

On March 26, 2026, the Company entered Secured Promissory Note Agreements with two investors for their purchase of (i) 14% secured promissory notes of the Company in the aggregate original principal amount of $700,000 payable on April 17, 2026 and (ii) 5-year warrants to purchase 3,300,000 shares of the Company’s common stock at an exercise price of $0.08. The proceeds are to used to purchase the shares held by Rowland Day as part of the Stock Purchase Agreement. Should the Company default on repayment for the note in full by the maturity date, the Common shall issue to the holders a total of 8,750,000 shares of the Company’s common stock. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders.

On April 8, 2026, the Company entered into a Master Reseller Agreement for an initial term of three-years. Upon execution of the agreement, the Company received $3,000,000 as a credit balance for future service.

On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. As of April 10, 2026, the Company purchased 4,166,667 shares of the Company’s Series B-1 Preferred Stock held by Rowland at a price of $0.66 per Series B-1 Preferred share for a total cash consideration of $2,750,000.

F-21

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Evaluation of Disclosure Controls and Procedures.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management to allow timely decisions regarding required disclosure.

As required by paragraph (b) of Rules 13a-15 or 15d-15 under the Exchange Act, our management, with the participation of our chief executive officer (our principal executive officer) and our chief financial officer (our principal financial officer and principal accounting officer) evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this annual report, being December 31, 2025.

Based on this evaluation, these officers concluded that, as of December 31, 2025 these disclosure controls and procedures were not effective to ensure that the information required to be disclosed by our company in reports it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities Exchange Commission. The conclusion that our disclosure controls and procedures were not effective was due to Company’s lack of pre-planning for expenses and documentation of all transactions.

The Company has only recently become subject to the periodic reporting requirements of the Exchange Act. We must design our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. For example, our directors or executive officers could inadvertently fail to disclose a new relationship or arrangement causing us to fail to make a required related party transaction disclosure. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. The term “internal control over financial reporting” is defined as a process designed by, or under the supervision of, an issuer’s principal executive and principal financial officers, or persons performing similar functions, and effected by the issuer’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

(1)	Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the issuer; and
(2)	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the issuer.

Under the supervision of our chief executive officer, being our principal executive officer, and our chief financial officer, being our principal financial officer and principal accounting officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2025 using the criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). This evaluation included review of the documentation of controls, evaluation of the design effectiveness of controls, testing of the operating effectiveness of controls and a conclusion on this evaluation. Based on this evaluation, our management concluded our internal control over financial reporting were not effective as of December 31, 2025.

25

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a more than remote possibility that a misstatement of our company’s annual or interim financial statements could occur. In its assessment of the effectiveness of our internal control over financial reporting as of December 31, 2025, we determined that there were control deficiencies that constituted material weaknesses which are indicative of many small companies with small staff, such as:

(1) inadequate segregation of duties and effective risk assessment;

(2) insufficient written policies and procedures for documenting all transactions with vendors;

(3) insufficient written policies and procedure for the approval, identification and reporting of related-party transactions;

(4) inadequate internal control procedures over financial reporting, resulting in non-reliance on previously issued financial statements; and

(5) inadequate written policies and procedures for documenting informal agreements.

Our management is currently evaluating remediation plans for the above deficiencies. During the period covered by this annual report on Form 10-K, we have been able to remediate some of the weaknesses described above. However, we plan to take steps to enhance and improve the design of our internal control over financial reporting.

Item 9B. Other Information.

During the Company’s fourth quarter, no director or officer adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not applicable.

26

PART III

Item 10. Directors, Executive Officers and Corporate Governance

The following table sets forth certain information of our officers and directors, as of December 31, 2025.

Name	Age	Position
Executive Officers
Saul I. Leal	43	Chief Executive Officer, Director
Roy Chestnutt	66	Independent Director

Our executive officers are appointed by, and serve at the discretion of, our board of directors and each holds office until his or her successor is duly elected and qualified or until his or her earlier resignation or removal. There are no family relationships among any of our directors or executive officers.

The following are biographical summaries of the experience of our directors and executive officers:

Saul I. Leal—Chief Executive Officer and Director. Saul joined the Company in August 2022. Mr. Leal holds a degree in Systems Engineering from Military University UNEFA in Venezuela, a master’s degree in business from The Marriott School of Business, cum laude, Executive Education in Marketing from the Kellogg School of Management, and Advance Statistics Executive Education from Stanford University. Mr. Leal’s experience includes the following:

● From 2006 to 2007, Mr. Leal worked at Deloitte & Touche.

● From 2007 to 2014, Mr. Leal worked as Station Manager at BYU Broadcasting, where he developed viable businesses in more than 20 countries, built products that have been distributed to over 55 million cell phones and approximately 39 million pay TV viewers, and translated over 15,000 hours of content into multiple languages.

● From 2014 to 2021, Mr. Leal served as General Manager and Director of Global Initiatives at Deseret Management Corporation. Mr. Leal led the development of one of the largest digital publishers achieving more than 256 million social media follows and over 4 billion monthly impressions.

● In 2021, Mr. Leal founded Metalanguage, an artificial intelligence architecture using the latest NLP and LLM technology to provide pragmatic, user-centric solutions to the interpretation and behavioral industry.

● Mr. Leal has served on multiple advisory boards, including Oracle Cloud USA CAB, Ad Council, Leadership Council, and The Leonardo, Museum of Creativity & Innovation.

● During his career, Mr. Leal earned 27 nominations and 9 regional Emmys.

27

Non-Employee Directors

Roy Chestnutt—Independent Director. Mr. Chestnutt has been a member of our Board of Directors since January 2024. He is also a member of our audit committee. He is the former Executive Vice President and Chief Strategy Officer for Verizon. He brings a remarkable 30+ year track record of experience in operations, corporate strategy, business development, joint ventures, and strategic investments.

Mr. Chestnutt is currently on the Board of Directors of Telstra-Australia, a leading telecommunications and technology company, Tillman Global Holdings, and Digital Turbine. Additionally, he serves as a Senior Advisor for Alvarez and Marsal Holdings, LLC. Previously Mr. Chestnutt served as a director of Intelsat, a director of Saudi Telecom, as a Senior Advisor to Blackstone, Accenture Luminaries Board of Advisors, FTI/Delta Partners Board of Advisors and served on the Board of Directors of Global System for Mobile Communications Association (“GSMA”), which is comprised of numerous mobile carriers from around the world and over 400 companies involved in the mobile ecosystem.

Non-Employee Director Compensation

Non-Employee Director Compensation Policy

We believe that equity compensation is appropriate to attract and retain the individuals we desire to serve on our board of directors and that this approach is comparable to the policies of our peers. We further believe that it is appropriate to provide equity compensation to our non-employee directors to align their long-term interests with those of the Company and our stockholders.

Upon joining the Company in January 2024, we awarded Mr. Chestnutt options to purchase 750,000 shares vesting over a four year period and with an exercise price of $0.51.

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act requires our directors and executive officers and persons who own more than 10% of our common stock to file with the SEC initial reports of beneficial ownership and reports of changes in beneficial ownership. Officers, directors, and stockholders who own more than 10% of our Class A common stock are required by SEC regulations to furnish us with copies of all such reports.

To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, we believe that for fiscal year 2025 all required reports were filed on a timely basis under Section 16(a), other than one initial report for each of Saul Leal, Rowland Day and Thomas Hogan. We are working to remedy these delinquent filings.

28

Item 11. Executive Compensation

The following table provides details with respect to the total compensation of our NEOs during the fiscal years ended December 31, 2025 and 2024. Our NEOs are (a) each person who served as our Chief Executive Officer during 2025, (b) the next two most highly compensated executive officers serving as of December 31, 2025 whose total compensation exceeded $100,000 and (c) any person who could have been included under (b) except for the fact that such persons were not an executive officer on December 31, 2025.

Summary Compensation Table

Name and Principal Position	Fiscal Year		Salary ($)		Bonus ($)		Stock Awards ($)		Restricted Stock Awards ($)		Option Awards ($)		Non Equity Incentive Plan Compensation ($)		Nonqualified Deferred Compensation Earnings ($)		All Other Compensation ($)		Total ($)
Rowland W. Day, II (Former President, Chief Financial Officer, Secretary and Chairman of the Board)(1)		2025		240,000		-		-		-		-		-		-		-		240,000
		2024		240,000		-		-		-		-		-		-		-		240,000
Saul I. Leal (Chief Executive Officer and Director)		2025		240,000		-		-		-		-		-		-		-		240,000
		2024		240,000		-		-		-		-		-		-		-		240,000

(1) Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. On October 31, 2025, the Company entered into (i) a Confidential General Release and Settlement Agreement with Rowland W. Day II, the Company’s former President, Chief Financial Officer, Secretary, Chief Legal Officer, and a member of the Board of Directors (the “Settlement Agreement”), and (ii) a related Stock Repurchase Agreement with the Rowland W. Day II and Jaimie D. Day Family Trust under declaration dated April 13, 1990 (the “Stock Repurchase Agreement” and together with the Settlement Agreement, the “Agreements”). The Agreements were approved by the Company’s Board of Directors on November 3, 2025. In connection with his resignation, the Company made payments to Mr. Day in the amount of $917,966.43 in satisfaction of outstanding loans and reimbursable credit card balances owed to him and a payment in the amount of $408,486.01 for accrued salary. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of 4,309,710 shares of the Company’s Series B-1 Preferred Stock and 307,647 shares of common stock, at per-share prices ranging from $0.605-$0.66 for the preferred shares and $0.055-$0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. As of April 10, 2026, the Company purchased 4,166,667 shares of the Company’s Series B-1 Preferred Stock held by Rowland at a price of $0.66 per Series B-1 Preferred share for a total cash consideration of $2,750,000.

Compensation of Executive Officers

On January 1, 2025, the Company agreed to compensate Mr. Leal $20,000 per month for his service. During the years ended December 31, 2025, and 2024, the Company recognized $480,000 of salary expense. As of December 31, 2025, and 2024, the Company accrued $97,000 and $364,500 of salary expense, with accrued interest of $12,306 and $23,121, respectively.

Compensation of Directors

No compensation is paid to our directors, who are not Independent Directors.

The table below sets forth the compensation of the Company’s non-employee directors for 2025.

Name	Fees Earned or Paid in Cash ($)	Stock Awards ($)	Option Awards ($)(1)	Non-Equity Incentive Plan Compensation ($)	All Other Compensation ($)	Total ($)
Roy Chestnutt	-	-	-	-	-	-

(1) Mr. Chestnutt has options to purchase 750,000 shares of the Company’s common stock, vesting over a four-year period from January 2025.

29

Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth, as of December 31, 2025, the number of shares of common stock and preferred stock owned of record and beneficially by our executive officers, directors, and persons who beneficially own more than 5% of any class of our capital stock.

Beneficial ownership is determined based on the rules and regulations of the Commission as defined in Rule 13d-3 of the Exchange Act. A person has beneficial ownership of shares if such individual has the power to vote and/or dispose of shares. This power may be sole or shared and direct or indirect. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of common stock that are subject to RSUs, options or warrants held by that person and exercisable as of, or within 60 days of, the date of this prospectus are counted as outstanding. These shares, however, are not counted as outstanding for the purposes of computing the percentage ownership of any other person(s). Except as may be indicated in the footnotes to this table and pursuant to applicable community property laws, each person named in the table has sole voting and dispositive power with respect to the shares of common stock set forth opposite that person’s name. The inclusion of shares in the table does not, however, constitute an admission that the named stockholder is a direct or indirect beneficial owner of those shares. Unless otherwise indicated, (i) each person or entity named in the table has sole voting power and investment power (or shares that power with that person’s spouse) with respect to all shares of capital stock listed as owned by that person or entity, and (ii) the address of each person or entity named in the table is c/o OneMeta Inc. 450 South 400 East, Suite 200, Bountiful, Utah 84010.

The percentage of shares beneficially owned is computed on the basis of 38,890,943 shares of our common stock issued and outstanding as of December 31, 2025 and all of the preferred stock should be presented as common stock on an as converted basis.

Beneficial Owner	Number of Shares Beneficially Owned			Percentage of common stock Beneficially Owned
Directors and Executive Officers		49,849,610	(1)		37.28	%
Rowland W. Day, II (Former President, Chief Financial Officer, Secretary and Chairman of the Board)
Saul I. Leal (Chief Executive Officer and Director)		49,549,610	(1)		37.06	%
5% or greater stockholders
-
All current executive officers and directors as a group (4 persons)

(1) Include a total of 8,619,420 Series B-1 Convertible Preferred Stock. Each Series B-1 Convertible Preferred Stock is convertible on a 1 to 11 common share basis.

30

2023 Equity Incentive Plan

General

Our board of directors and stockholders adopted the 2023 Equity Incentive Plan as of September 1, 2023, which provides for the grant of incentive stock options and non-qualified stock options to purchase shares of our common stock and other types of awards. The general purpose of the 2023 Equity Incentive Plan is to provide a means whereby eligible employees, officers, non-employee directors and other individual service providers develop a sense of proprietorship and personal involvement in our development and financial success, and to encourage them to devote their best efforts to our business, thereby advancing our interests and the interests of our stockholders. By means of the 2023 Equity Incentive Plan, we seek to retain the services of such eligible persons and to provide incentives for such persons to exert maximum efforts for our success and the success of our subsidiaries.

Description of the 2023 Equity Incentive Plan

The following description of the principal terms of the 2023 Equity Incentive Plan is a summary and is qualified in its entirety by the full text of the 2023 Equity Incentive Plan.

Administration. In general, the 2023 Equity Incentive Plan will be administered by the Compensation Committee of the board of directors. The Compensation Committee will determine the persons to whom options to purchase shares of common stock, stock appreciation rights (or “SARs”), restricted stock units, restricted or unrestricted shares of common stock, performance shares, performance units, incentive bonus awards, other stock-based awards and other cash-based awards may be granted. The Compensation Committee may also establish rules and regulations for the administration of the 2023 Equity Incentive Plan and amendments or modifications of outstanding awards. No options, stock purchase rights or awards may be made under the 2023 Equity Incentive Plan on or after January 7, 2032 (or, the expiration date), but the 2023 Equity Incentive Plan will continue thereafter while previously granted options, SARs or other awards remain outstanding.

Eligibility. Persons eligible to receive options, SARs or other awards under the 2023 Equity Incentive Plan are those employees, officers, directors, consultants, advisors and other individual service providers of our Company and our subsidiaries who, in the opinion of the Compensation Committee, are in a position to contribute to our success, or any person who is determined by the Compensation Committee to be a prospective employee, officer, director, consultant, advisor or other individual service provider of the Company or any subsidiary. As of the date of this prospectus, we had four full-time employees, of which two are executive officers. As awards under the 2023 Equity Incentive Plan are within the discretion of the Compensation Committee, we cannot determine how many individuals in each of the categories described above will receive awards.

Shares Subject to the 2023 Equity Incentive Plan. The aggregate number of shares of common stock initially available for issuance in connection with options and other awards granted under the 2023 Equity Incentive Plan is 5,000,000. The number of shares of common stock available for issuance under the 2023 Equity Incentive Plan automatically increases on the first day of each fiscal year of the Company commencing with fiscal year 2024, and the first day of each fiscal year thereafter until the expiration date, in an amount equal to 5% percent of the total number of shares of our common stock outstanding on the last day of the immediately preceding fiscal year of the Company, unless the board of directors takes action prior thereto to provide that there will not be an increase in the share reserve for such year or that the increase in the share reserve for such year will be of a lesser number of shares of common stock than would otherwise occur.

“Incentive stock options”, or ISOs, that are intended to meet the requirements of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”) may be granted under the 2023 Equity Incentive Plan with respect to all of the shares of common stock authorized for issuance under the 2023 Equity Incentive Plan.

If any option or SAR granted under the 2023 Equity Incentive Plan terminates without having been exercised in full or if any award is forfeited, the number of shares of common stock as to which such option or award was forfeited will be available for future grants under the 2023 Equity Incentive Plan. Awards settled in cash will not count against the number of shares available for issuance under the 2023 Equity Incentive Plan.

No non-employee director may receive awards in any calendar year having an accounting value in excess of $250,000 (inclusive of any cash awards to the non-employee director for such year that are not made pursuant to the 2023 Equity Incentive Plan); provided that, in the case of a new non-employee director, such amount is increased to $350,000 for the initial year of the non-employee director’s term.

The number of shares authorized for issuance under the 2023 Equity Incentive Plan and the foregoing share limitations are subject to customary adjustments for stock splits, stock dividends or similar transactions.

31

Terms and Conditions of Options. Options granted under the 2023 Equity Incentive Plan may be either ISOs or “non-statutory stock options” that do not meet the requirements of Section 422 of the Code. The Compensation Committee will determine the exercise price of options granted under the 2023 Equity Incentive Plan. The exercise price of stock options may not be less than the fair market value per share of our common stock on the date of grant (or 110% of fair market value in the case of ISOs granted to a ten-percent stockholder).

If on the date of grant the common stock is listed on a stock exchange or is quoted on the automated quotation system of the Nasdaq Stock Market, the fair market value will generally be the closing sale price on the date of grant (or the last trading day before the date of grant if no trades occurred on the date of grant). If no such prices are available, the fair market value will be determined in good faith by the Compensation Committee based on the reasonable application of a reasonable valuation method.

No option may be exercisable for more than ten years (five years in the case of an ISO granted to a ten-percent stockholder) from the date of grant. Options granted under the 2023 Equity Incentive Plan will be exercisable at such time or times as the Compensation Committee prescribes at the time of grant. No employee may receive ISOs that first become exercisable in any calendar year in an amount exceeding $100,000. The Compensation Committee may, in its discretion, permit a holder of an option to exercise the option before it has otherwise become exercisable, in which case the shares of our common stock issued to the recipient will continue to be subject to the vesting requirements that applied to the option before exercise.

Generally, the option price may be paid in cash, by certified check, or by bank draft. The Compensation Committee may permit other methods of payment, including through delivery of shares of our common stock having a fair market value equal to the purchase price. The Compensation Committee is authorized to establish a cashless exercise program and to permit the exercise price (and/or tax withholding obligations) to be satisfied by reducing from the shares otherwise issuable upon exercise a number of shares having a fair market value equal to the exercise price.

No option may be transferred other than by will or by the laws of descent and distribution, and during a recipient’s lifetime an option may be exercised only by the recipient. However, the Compensation Committee may permit the holder of an option, SAR or other award to transfer the option, right or other award to immediate family members or a family trust for estate planning purposes. The Compensation Committee will determine the extent to which a holder of a stock option may exercise the option following termination of service with us.

Stock Appreciation Rights. The Compensation Committee may grant SARs under the 2023 Equity Incentive Plan. The Compensation Committee will determine the other terms applicable to SARs. The exercise price per share of a SAR will not be less than 100% of the fair market value of a share of our common stock on the date of grant, as determined by the Compensation Committee. The maximum term of any SAR granted under the 2023 Equity Incentive Plan is ten years from the date of grant. Generally, each SAR will entitle a participant upon exercise to an amount equal to:

● the excess of the fair market value on the exercise date of one share of our common stock over the exercise price, multiplied by

● the number of shares of common stock covered by the SAR.

Payment may be made in shares of our common stock, in cash, or partly in common stock and partly in cash, all as determined by the Compensation Committee.

Restricted Stock and Restricted Stock Units. The Compensation Committee may award restricted common stock and/or restricted stock units under the 2023 Equity Incentive Plan. Restricted stock awards consist of shares of stock that are transferred to a participant subject to restrictions that may result in forfeiture if specified conditions are not satisfied. Restricted stock units confer the right to receive shares of our common stock, cash, or a combination of shares and cash, at a future date upon or following the attainment of certain conditions specified by the Compensation Committee. The restrictions and conditions applicable to each award of restricted stock or restricted stock units may include performance-based conditions. Dividends with respect to restricted stock may be paid to the holder of the shares as and when dividends are paid to stockholders or at the time that the restricted stock vests, as determined by the Compensation Committee. Dividend equivalent amounts may be paid with respect to restricted stock units either when cash dividends are paid to stockholders or when the units vest. Unless the Compensation Committee determines otherwise, holders of restricted stock will have the right to vote the shares.

32

Performance Shares and Performance Units. The Compensation Committee may award performance shares and/or performance units under the 2023 Equity Incentive Plan. Performance shares and performance units are awards, denominated in either shares or U.S. dollars, which are earned during a specified performance period subject to the attainment of performance criteria, as established by the Compensation Committee. The Compensation Committee will determine the restrictions and conditions applicable to each award of performance shares and performance units.

Incentive Bonuses. The Compensation Committee may grant incentive bonus awards under the 2023 Equity Incentive Plan from time to time. The terms of incentive bonus awards will be set forth in award agreements. Each award agreement will have such terms and conditions as the Compensation Committee determines, including performance goals and amount of payment based on achievement of such goals. Incentive bonus awards are payable in cash and/or shares of our common stock.

Other Stock-Based and Cash-Based Awards. The Compensation Committee may award other types of equity-based or cash-based awards under the 2023 Equity Incentive Plan, including the grant or offer for sale of shares of our common stock that do not have vesting requirements and the right to receive one or more cash payments subject to satisfaction of such conditions as the Compensation Committee may impose.

Effect of Certain Corporate Transactions. The Compensation Committee may, at the time of the grant of an award provide for the effect of a change in control (as defined in the 2023 Equity Incentive Plan) on any award, including (i) accelerating or extending the time periods for exercising, vesting in, or realizing gain from any award, (ii) eliminating or modifying the performance or other conditions of an award, or (iii) providing for the cash settlement of an award for an equivalent cash value, as determined by the Compensation Committee. The Compensation Committee may, in its discretion and without the need for the consent of any recipient of an award, also take one or more of the following actions contingent upon the occurrence of a change in control: (a) cause any or all outstanding options and SARs to become immediately exercisable, in whole or in part; (b) cause any other awards to become non-forfeitable, in whole or in part; (c) cancel any option or SAR in exchange for a substitute option; (d) cancel any award of restricted stock, restricted stock units, performance shares or performance units in exchange for a similar award of the capital stock of any successor corporation; (e) cancel or terminate any award for cash and/or other substitute consideration in exchange for an amount of cash and/or property equal to the amount, if any, that would have been attained upon the exercise of such award or realization of the participant’s rights as of the date of the occurrence of the change in control, but if the change in control consideration with respect to any option or SAR does not exceed its exercise price, the option or SAR may be canceled without payment of any consideration; or (f) make such other modifications, adjustments or amendments to outstanding awards as the Compensation Committee deems necessary or appropriate.

Amendment, Termination. The board of directors may at any time amend the 2023 Equity Incentive Plan for the purpose of satisfying the requirements of the Code, or other applicable law or regulation or for any other legal purpose, provided that, without the consent of our stockholders, the board of directors may not (a) increase the number of shares of common stock available under the 2023 Equity Incentive Plan, (b) change the group of individuals eligible to receive options, SARs and/or other awards, or (c) extend the term of the 2023 Equity Incentive Plan.

Tax Withholding

As and when appropriate, we shall have the right to require each optionee purchasing shares of common stock and each grantee receiving an award of shares of common stock under the 2023 Equity Incentive Plan to pay any federal, state, or local taxes required by law to be withheld.

The table below sets forth certain information regarding our OneMeta Inc. 2023 Equity Compensation Plan as of December 31, 2025.

	Equity Compensation Plan Information
Plan category	(a) Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants, and Rights			(b) Weighted Average Exercise Price of Outstanding Options, Warrants, and Rights		(c) Number of Securities Remaining Available for Future Issuance under Equity Compensation Plan (Excluding Securities Referenced in Column (a))
Equity compensation plans approved by security holders(1):		5,000,000	(1)	$	0.44		3,370,000
Equity compensation plans not approved by security holders:		N/A			N/A		N/A
Total		5,000,000		$	0.44		3,370,000

(1) To automatically be increased on the first day of each fiscal year beginning with 2024, in an amount equal to lesser of (i) five percent (5%) of the outstanding shares of all classes of the Company’s Common Stock (on a fully diluted basis, but rounded to the nearest 1,000 share increment) as of the last day of the immediately preceding Fiscal Year or (ii) such number of Shares determined by the Board (the “Annual Increase”). Notwithstanding the foregoing and, subject to adjustment as provided in Section 4.3 of the Plan, the maximum number of shares of Common Stock that may be issued upon the exercise of Incentive Stock Options will equal the aggregate number of shares Common Stock stated in Section 4.1(a), and shall be increased on the first day of each Fiscal Year beginning with the Company’s Fiscal Year beginning in 2024 until (and including) the Company’s Fiscal Year beginning in 2033, by the Annual Increase for such Fiscal Year.

33

Item 13. Certain Relationships and Related Transactions, and Director Independence

Expense paid on the Company’s behalf

During the years ended December 31, 2025 and 2024, Mr. Day, a significant shareholder and former President and CFO, paid $345,984 and $341,108 of expenses on the Company’s behalf. The Company repaid $416,332 and $275,097 during the years ended December 31, 2025 and 2024, respectively. The advances accrued interest at the rate of 14%. As of December 31, 2025 and December 31, 2024, the balance owed to Mr. Day, with accrued interest, was $0 and $70,348, respectively.

Accrued salary and interest

As of December 31, 2025, the accrued related party salary and accrued interest expense was $97,000 and $12,307, respectively. As of December 31, 2024, the accrued related party salary and accrued interest expense was $364,500 and $23,121, respectively.

Senior secured notes payable

On May 10, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $225,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 10, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the remaining principal balance of $139,516 and the accrued interest of $27,171.

On June 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $216,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) December 12, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $216,000 and the accrued interest of $36,731.

On August 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) February 12, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $80,000 and the accrued interest of $13,409.

On August 27, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $5,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on October 31, 2024. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $5,000 and the accrued interest of $809.

34

On September 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $23,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) March 26, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $23,000 and the accrued interest of $3,458.

On October 14, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 13, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $80,000 and the accrued interest of $11,476.

On January 28, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $6,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on February 28, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $6,000 and the accrued interest of $71.

On March 21, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $3,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on April 21, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $3,000 and the accrued interest of $36.

On May 13, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $36,500 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on June 12, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $36,500 and the accrued interest of $420.

On June 25, 2025, Rowland Day paid $4,345 of debt origination fees related to loans made by Day on behalf of the Company. The balance due accrued interest at the rate of 14% per annum. The balance is payable on demand. During the year ended December 31, 2025, the Company repaid the balance of $4,345 and the accrued interest of $204.

On July 3, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $8,000 with Saul Leal (the “Lender”). The note will accrue interest at the rate of 14% per annum and matures on January 3, 2026. During the year ended December 31, 2025, the Company repaid the principal balance of $8,000 and the accrued interest of $120.

On July 10, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $104,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. In the event of a default, the Company will accrued interest at a rate of 16%. Under the July 10, 2025 secured promissory note agreement, on July 30, 2025 and August 30, 2025, the Company borrowed an additional $75,000 and $30,000, respectively. During the year ended December 31, 2025, the Company repaid the principal balance of $104,000 and the accrued interest of $7,439.

35

On November 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $14,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on January 31, 2025. During the year ended December 31, 2024, the Company repaid $14,000 of the secured promissory note principal.

For all of the secured promissory notes payable with the Lender, to secure the prompt and complete payment of all secured obligations, for value received and pursuant to the notes, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

As of December 31, 2025 and 2024, the related party senior secured promissory notes payable principal balance was $0 and $543,515, respectively, with accrued interest of $0 and $43,853, respectively.

Separation Agreement

Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. In connection with his resignation, the Company made payments to Mr. Day in the amount of $917,966.43 in satisfaction of outstanding loans and reimbursable credit card balances owed to him and a payment in the amount of $408,486.01 for accrued salary. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of 4,309,710 shares of the Company’s Series B-1 Preferred Stock and 307,647 shares of common stock, at per-share prices ranging from $0.605-$0.66 for the preferred shares and $0.055-$0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. As of April 10, 2026, the Company purchased 4,166,667 shares of the Company’s Series B-1 Preferred Stock held by Rowland at a price of $0.66 per Series B-1 Preferred share for a total cash consideration of $2,750,000.

Convertible notes payable

During the year ended December 31, 2025, the Company issued 0% interest convertible notes payable to a director, a director nominee and two relatives of the director nominee in exchange for $250,000. The convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

The Company calculated imputed interest of $30,359 on these zero percent convertible notes using an interest rate of 14% and recorded to additional paid-in-capital. The Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates of the convertible notes. As of December 31, 2025, the convertible notes payable principal balance was $250,000.

The convertible notes matured and became convertible during the year ended December 31, 2025. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of December 31, 2025. As of December 31, 2025, the matured convertible notes would potentially be converted into 1,299,934 common shares.

Director Independence

We are not currently a “listed company” under SEC rules and are therefore not required to have a Board comprised of a majority of independent directors or separate committees comprised of independent directors. We currently have two independent directors as the term “independent” is defined by the rules of the Nasdaq Stock Market.

Item 14. Principal Accountant Fees and Services.

The following table sets forth fees billed to us for principal accountant fees and services for years ended December 31, 2025 and 2024.

	Year Ended December 31, 2025		Year Ended December 31, 2024
Total Audit and Audit-Related Fees	$	75,750	$	63,425

36

PART IV

Item 15. Exhibits and Financial Statement Schedules.

(a) Exhibits

The following exhibits are filed with this Report on Form 10-K:

		Incorporated by Reference			Filed or Furnished
Exhibit No.	Exhibit Description	Form	Date Filed	Number	Herewith
3.1	Articles of Incorporation, as currently in effect	Form 10	9/19/2023	3.1
3.2	Bylaws as currently in effect	Form 10	9/19/23	3.2
31.1	Certification of CEO and CFO Pursuant to Exchange Act Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X
32.1	Certification of CEO and CFO Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002				XX
24	Power of Attorney*
101.INS	Inline XBRL Instance Document				X
101.SCH	Inline XBRL Instance Schema				X
101.CAL	Inline XBRL Instance Calculation Linkbase				X
101.DEF	Inline XBRL Instance Definition Linkbase				X
101.LAB	Inline XBRL Instance Label Linkbase				X
101.PRE	Inline XBRL Instance Presentation Linkbase				X
104	The Cover Page Interactive Data File, formatted in Inline XBRL (included in Exhibit 101).				X

*Previously filed.

Item 16. Form 10-K Summary.

None.

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Date: May 1, 2026

ONEMETA INC.
By:	/s/ Saul Leal
	Saul Leal
	Chief Executive Officer and Director (Principal Executive and Financial Officer)

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature	Title	Date
/s/ SAUL LEAL	Chief Executive Officer, Director	May 1, 2026
Saul Leal	(Principal Executive Officer and Financial Officer)
*	Director	May 1, 2026
Roy Chestnutt

*By:	/s/ Saul Leal
	Saul Leal
	Attorney-in-Fact

38

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS PURSUANT TO

RULE 13A-14(A) OR RULE 15D-14(A),

AS ADOPTED PURSUANT TO

RULE 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Saul Leal, certify that:

1.	I have reviewed this annual report on Form 10-K for the year ended December 31, 2025 of OneMeta Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to me by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	/s/ Saul Leal
	Saul Leal
	Chief Executive Officer
	(Principal Executive and Financial Officer)
Dated: May 1, 2026

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of OneMeta Inc. (the “Company”) on Form 10-K for the period ended December 31, 2025 (the “Report”) I, Saul Leal, Chief Executive Officer of the Company, certify, pursuant to 18 USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 1, 2026
	/s/ Saul Leal
Name:	Saul Leal
Title:	Chief Executive Officer (Principal Executive and Financial Officer)

This certification accompanies the foregoing Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Apr. 15, 2026	Jun. 30, 2025
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	OneMeta, Inc. is filing this Amendment No. 1 on Form 10-K/A, or this Amendment No. 1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, or the Original 10-K, originally filed with the U.S. Securities and Exchange Commission, or SEC, on April 15, 2026, or Original Filing Date, solely for the purpose of updating the patents and trademarks list of the Company. The information previously included patents that were not owned by Company as of December 31, 2025. This Amendment No. 1 amends and restates the list of intellectual properties of patents and trademarks that are owned by the Company as of December 31, 2025. Except as described above, no other changes have been made to the Original 10-K. The Original 10-K continues to speak as of the date of the Original 10-K, and we have not updated the disclosures contained therein to reflect any events that have occurred as of a date subsequent to the date of the Original 10-K. Accordingly, this Amendment No. 1 should be read in conjunction with the Original 10-K. Defined terms used, but not defined, herein have the meanings ascribed to them in the Original 10-K.
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2025
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--12-31
Entity File Number	000-56565
Entity Registrant Name	ONEMETA INC.
Entity Central Index Key	0001388295
Entity Tax Identification Number	20-5150818
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	450 South 400 East
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Bountiful
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84010
City Area Code	(702)
Local Phone Number	550-0122
Title of 12(b) Security	None.
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 12
Entity Common Stock, Shares Outstanding		38,890,943
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Firm ID	2738
Auditor Opinion [Text Block]	We have audited the accompanying balance sheets of OneMeta, Inc. (the Company) as of December 31, 2025 and 2024, and the related statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the years in the two-year period ended December 31, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America.
Auditor Name	M&K CPAS, PLLC
Auditor Location	The Woodlands, TX

XML

Balance Sheets - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash	$ 4,584	$ 215,816
Accounts receivable, net	22,508	5,000
Prepaid and other current assets	94,845	94,031
Total current assets	121,937	314,847
Noncurrent Assets:
Property and equipment, net	1,843
Total noncurrent assets	1,843
Total assets	123,780	314,847
Current liabilities:
Accounts payable	926,889	586,305
Accrued expenses	133,845	18,025
Accrued expenses, related party	97,000	501,822
Convertible notes payable	940,000	650,000
Convertible notes payable, related party	250,000
Promissory notes payable, net	380,321
Deferred revenue	316,196	700,000
Total current liabilities	3,044,251	2,999,667
Noncurrent Liabilities:
Convertible notes payable, net of current portion and discount	1,387,612
Total noncurrent liabilities	1,387,612
Total liabilities	4,431,863	2,999,667
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, value
Common stock, $0.001 par value, 500,000,000 shares authorized, 38,890,943 and 37,790,943 shares issued and outstanding, respectively	38,891	37,791
Common stock liability	527,889
Additional paid in capital	38,480,044	36,792,679
Accumulated deficit	(43,355,771)	(39,516,154)
Total stockholders’ equity (deficit)	(4,308,083)	(2,684,820)
Total liabilities and stockholders’ equity (deficit)	123,780	314,847
Series A Preferred Stock [Member]
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, value	2	2
Series B-1 Convertible Preferred Stock [Member]
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, value	862	862
Related Party [Member]
Current liabilities:
Convertible notes payable	250,000
Senior secured promissory notes, related party		$ 543,515

XML

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2025	Dec. 31, 2024
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, share issued	38,890,943	37,790,943
Common stock, shares outstanding	38,890,943	37,790,943
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	2,068	2,068
Preferred stock, shares outstanding	2,068	2,068
Series B-1 Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	8,619,420	8,619,420
Preferred stock, shares issued	8,619,420	8,619,420
Preferred stock, shares outstanding	8,619,420	8,619,420

XML

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Income Statement [Abstract]
Revenue	$ 1,505,866	$ 31,304
Cost of revenue	208,590
Gross profit	1,297,276	31,304
Operating expenses:
Research and development	1,178,595	896,899
General and administrative	2,888,343	2,937,425
Advertising and marketing	25,760	92,688
Legal and professional	687,066	625,957
Total operating expenses	4,779,764	4,552,969
Loss from operations	(3,482,488)	(4,521,665)
Other expense:
Interest expense	(357,129)	(73,890)
Total other expense	(357,129)	(73,890)
Net loss	(3,839,617)	(4,595,555)
Deemed dividend
Common stock dividend		(1,011,803)
Net loss available to common shareholders	$ (3,839,617)	$ (5,607,358)
Net loss per common share:
Basic	$ (0.10)	$ (0.17)
Diluted	$ (0.10)	$ (0.17)
Weighted average common shares outstanding:
Basic	38,612,313	33,883,019
Diluted	38,612,313	33,883,019

XML

Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B-1 Convertible Preferred Stock [Member]	Common Stock [Member]	Common Stock Liability [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2023	$ 2	$ 862	$ 32,996		$ 33,992,707	$ (33,908,796)	$ 117,771
Balance, shares at Dec. 31, 2023	2,068	8,619,420	32,995,460
Common shares issued for cash			$ 969		724,631		$ 725,600
Common shares issued for cash, shares			969,500				969,500
Stock based compensation			$ 1,500		1,055,791		$ 1,057,291
Stock based compensation, shares			1,500,000
Deemed dividend			$ 2,326		1,009,477	(1,011,803)
Deemed dividend, shares			2,325,983
Contributed capital					4,448		4,448
Imputed interest					5,625		5,625
Net loss						(4,595,555)	(4,595,555)
Common shares issued for service							652,500
Balance at Dec. 31, 2024	$ 2	$ 862	$ 37,791		36,792,679	(39,516,154)	(2,684,820)
Balance, shares at Dec. 31, 2024	2,068	8,619,420	37,790,943
Common shares issued for cash			$ 1,000		474,000		$ 475,000
Common shares issued for cash, shares			1,000,000				300,000
Stock based compensation					392,585		$ 392,585
Imputed interest					149,399		149,399
Net loss						(3,839,617)	(3,839,617)
Common shares issued for service			$ 100		22,900		23,000
Common shares issued for service, shares			100,000
Relative fair value of warrants issued with convertible debt					648,481		648,481
Common shares liability				527,889			527,889
Balance at Dec. 31, 2025	$ 2	$ 862	$ 38,891	$ 527,889	$ 38,480,044	$ (43,355,771)	$ (4,308,083)
Balance, shares at Dec. 31, 2025	2,068	8,619,420	38,890,943

XML

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,839,617)	$ (4,595,555)
Adjustment to reconcile net loss to cash used in operating activities:
Imputed interest	149,399	5,625
Stock based compensation	415,585	1,057,291
Common stock liability	527,889
Amortization expense	108
Depreciation expense	58,414
Net change in:
Accounts receivable	(17,508)	1,935
Prepaid and other current assets	(814)	(87,211)
Accounts payable	686,568	388,769
Accrued expenses	115,820	18,025
Accrued expenses, related party	(750,806)	(100,123)
Deferred revenue	(383,804)	700,000
CASH FLOWS USED IN OPERATING ACTIVITIES	(3,038,766)	(2,611,244)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(1,951)
CASH FLOWS USED IN INVESTING ACTIVITIES	(1,951)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of related party note		(221,990)
Proceeds from senior secured promissory notes, related party	266,935	643,000
Payments of senior secured notes payable, related party	(810,450)	(99,485)
Proceeds from convertible notes	2,250,000	650,000
Proceeds from convertible notes, related party	290,000
Proceeds from senior secured promissory notes	370,000
Repayment of senior secured promissory notes	(12,000)
Proceeds from related party advances		72,000
Payment of related party advances		(72,000)
Proceeds from issuance of common shares	475,000	725,600
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	2,829,485	1,697,125
NET CHANGE IN CASH	(211,232)	(914,119)
Cash, beginning of period	215,816	1,129,935
Cash, end of period	4,584	215,816
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid on interest expense	101,345	42,526
Cash paid for income taxes
NON-CASH TRANSACTIONS
Expenses paid on the Company’s behalf	345,984	325,381
Deemed dividend		1,011,803
Relative fair value of warrants issued with convertible debt	648,481
Contributed capital		$ 4,448

XML

Pay vs Performance Disclosure - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (3,839,617)	$ (4,595,555)

XML

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2025
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Cybersecurity Risk Management and Strategy Disclosure

12 Months Ended

Dec. 31, 2025

Cybersecurity Risk Management, Strategy, and Governance [Abstract]

Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]

The Company’s Cybersecurity System includes administrative, technical, and physical safeguards and is designed to provide an appropriate level of protection to maintain the confidentiality, integrity and availability of the Company’s and its customers’ information. This includes protecting against known and evolving threats to the security of the Company’s systems and information, and against unauthorized access, compromise, or loss of data. The Cybersecurity System is managed centrally, so the same security controls, policies and procedures are implemented across the organization. The Company maintains cybersecurity policies including an Acceptable Use Policy that all system users sign to acknowledge that they understand their security responsibilities. All system users receive security awareness training which includes phishing attack simulation testing.

Cybersecurity Risk Management Processes Integrated [Flag]

true

Cybersecurity Risk Management Third Party Engaged [Flag]

true

Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]

false

Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]

The Company does not maintain cyber insurance coverage at this time. During the last three years, the Company has not experienced a material security breach and, as a result, the Company has not incurred any material expenses from such a breach. Furthermore, during such time, the Company has not been penalized or paid any amount under any information security breach settlement.

Cybersecurity Risk Board of Directors Oversight [Text Block]

Governance

The Company has established controls and procedures to escalate enterprise-level issues, including cybersecurity matters, to the appropriate management levels within its organization and to its Board of Directors, or members or committees thereof, as appropriate. The Company’s Board of Directors is responsible for enterprise risk management, including its approach to managing cybersecurity risk, and has delegated oversight responsibility of information security risks to its Audit Committee. Under the Company’s framework, cybersecurity issues are analyzed by subject matter experts for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact. Matters determined to present potential material impacts to the Company’s financial results, operations, and/or reputation are immediately reported by management to the Company’s Board of Directors or its Audit Committee, as appropriate, in accordance with its escalation framework.

In addition, the Company has established procedures to ensure that management responsible for overseeing the effectiveness of disclosure controls is informed in a timely manner of known cybersecurity risks and incidents that may materially impact the Company’s operations and that timely public disclosure is made as appropriate. The Company’s Cybersecurity System is led by the Chief Executive Officer (“CEO”) in collaboration with other third-party cybersecurity service providers which in turn assist in monitoring our exposure from significant information technology suppliers, significant software as a service providers and major vendors with access to our information technology systems. Further, team members who support our cybersecurity program have relevant educational and industry experience through various roles involving information technology, security, auditing, compliance, systems and programming. The Company does not maintain cyber insurance coverage at this time. During the last three years, the Company has not experienced a material security breach and, as a result, the Company has not incurred any material expenses from such a breach. Furthermore, during such time, the Company has not been penalized or paid any amount under any information security breach settlement.

 

Cybersecurity Risk Management Positions or Committees Responsible [Flag]

true

Cybersecurity Risk Management Positions or Committees Responsible [Text Block]

The Company’s Board of Directors is responsible for enterprise risk management, including its approach to managing cybersecurity risk, and has delegated oversight responsibility of information security risks to its Audit Committee. Under the Company’s framework, cybersecurity issues are analyzed by subject matter experts for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact.

XML

Basis of Presentation

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Basis of Presentation

Note 1. Basis of Presentation

The accompanying audited financial statements of OneMeta Inc. (“we”, “our”, “OneMeta” or the “Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America and the rules of the Securities and Exchange Commission (“SEC”). The Company’s fiscal year end is December 31.

OneMeta was originally incorporated as Promotions on Wheels Holdings, Inc., a Nevada corporation, on July 3, 2006. On December 26, 2008, the name of the Company was changed to Blindspot Alert, Inc. On September 11, 2009, the Company’s name was changed to WebSafety, Inc. On March 23, 2021, the Company’s name was changed to VeriDetx Corp. On June 8, 2021, the Company’s name was changed to WebSafety, Inc. On July 10, 2022, the Company’s name was changed to OneMeta AI. On June 20, 2023, the Company’s name was changed to OneMeta Inc.

XML

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

Use of Estimates

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of stock-based compensation, fair value measurement and long-term customer contracts.

Cash and Cash Equivalents

Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable

Accounts receivables are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, past experience, review of customer profiles and the aging of receivable balances. As of December 31, 2025 and 2024, there was $1,160 and $1,160 of allowance for credit losses, respectively.

Property and Equipment

Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows:

	Estimated
Category	Useful Lives
Computer Equipment	3 years

Intangible Assets, and Long-Lived Assets

The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of a long-lived asset is measured by comparison of the carrying amount to the expected future undiscounted cash flows that the asset is expected to generate. Any impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value.

Related Parties

The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

Fair Value of Financial Instruments

The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates.

Revenue Recognition

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

● Identification of the contract with a customer

● Identification of the performance obligations in the contract

● Determination of the transaction price

● Allocation of the transaction price to the performance obligations in the contract

● Recognition of revenue when, or as, the Company satisfies a performance obligation

Subscription and license

We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software.

We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service.

Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient.

Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed.

OEM solution

The Company provides Over-the-phone, consecutive AI Translation Service (“VerbumCall SDK”) that uses WebSocket connections to provide an AI service designed to facilitate effortless communication across languages within the platforms. This product leverages advanced AI capabilities to provide consecutive audio translation, ensuring that both patrons and agents experience conversations without the need for additional steps or complicated setups.

The Company has multiple performance obligations in the customer contract with inContact. The Company is to generate revenue through the following sources: sale of OEM Solution software and professional services, which consist of implementation, configuration, custom development, optimization, training and technical support services of the OEM Solution.

VerbumAgentis

On March 31, 2025, the Company entered into a reseller and distribution agreement to provide software development kit (SDK) to the reseller to use and/or resell to their customers. The Company will provide the reseller with a VerbumAgentis communication platform and an encryption key to install on their computer system and servers. In return, the reseller is to pay an initial one-time paid-up fee of $500,000.

VerbumAgentis is a standalone communication platform with core capabilities such as chat-based interaction, transcription, and multilingual simultaneous interpretation for voice-to-voice customer interactions. It includes real-time bidirectional communication and integrations. While live translation leverages underlying language models (SDK), the core platform delivers independent value even without SDK execution for each interaction.

VerbumAgentis is installed on client’s servers that they control. The Company is to deliver and install the VerbumAgentis platform on the customers’ server and provide translation services on an as requested basis by the end customers. The customer benefits from the VerbumAgentis platform as a standalone system once installed on their infrastructure. Further, the translation services and other per usage items outlined in the contract are obligations that arise when those services are initiated by the customer.

Disaggregation of revenues

The Company disaggregates revenue between subscription and license revenue and training and education revenue.

	For the Years Ended
	December 31, 2025		December 31, 2024
Subscription, license and software revenue	$	617,430	$	27,804
Professional Services		868,881		3,500
OEM Solution		19,555		-
Total Revenue	$	1,505,866	$	31,304

Deferred Revenue

Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. On October 8, 2024, the Company entered into an OEM Agreement to provide OEM Solutions hosting consisting of over-the-phone consecutive AI language translation solutions. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. The Company identified three separate performance obligations within the contract. The performance obligations are OEM Solution service, professional services and technical support. The OEM Solution revenue is recognized based on a per-minute rate while the professional services and technical support revenue is recognized based on a per hour rate. The Company expects the $700,000 credit to be used mainly by OEM Solution and professional services. The Company recognized $448,804 of the credit during the year ended December 31, 2025. As of December 31, 2025, the Company expects to recognize all the unsatisfied performance obligations as revenue in the following five months.

During the year ended December 31, 2025, the Company recognized additional $65,000 of deferred revenue on new sales contracts. As of December 31, 2025 and 2024, the deferred revenue balance was $316,196 and $700,000, respectively.

Stock-Based Compensation

All stock-based awards to employees and non-employee contractors, including any grants of stock and stock options, are measured at fair value at the grant date and recognized over the relevant vesting period in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. Stock based awards to non-employees are recognized as a selling, general and administrative expense over the period of performance. Such awards are measured at fair value at the date of grant. In addition, for awards that vest immediately, the awards are measured at fair value and recognized in full at the grant date.

Basic and Diluted Loss Per Share

Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined by using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2025, the Company’s potentially dilutive shares, which were not included in the calculation of net loss per share, included warrants to purchase 6,350,000 common shares, options to purchase 5,465,000 common shares, conversion of Series B-1 shares to purchase 94,813,620 common shares, conversion of Series A shares to purchase 2,585 common shares, the conversion of the convertible notes to 31,838,135 common shares and common stock liability to issue 2,228,000 common shares. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations for the years ended December 31, 2025 and 2024, reflected in the accompanying statement of operations.

Segments Reporting

The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company using information about combined net income from operations. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.

Recent Accounting Pronouncements

Income Taxes

In December 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning January 1, 2025 on a prospective basis, with retrospective application permitted for all prior periods presented. We adopted ASU No. 2023-09 during the year ended December 31, 2025, which had no material impact on the Company’s financial statements.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires specified information about certain costs and expenses be disclosed in the notes to the financial statements, including the expense caption on the face of the income statement in which they are disclosed, in addition to a qualitative description of remaining amounts not separately disaggregated. Entities will also be required to disclose their definition of “selling expenses” and the total amount in each annual period. The standard is effective for the Company for annual periods beginning January 1, 2027 and for interim periods beginning January 1, 2028, with updates applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures.

Credit Losses

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides updates related to CECL guidance for certain short-term receivables. The ASU is effective for fiscal years beginning after December 15, 2025. The Company is currently evaluating the impact of this guidance on its disclosures.

XML

Going Concern

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

Note 3. Going Concern

These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of December 31, 2025, the Company had not yet achieved profitable operations and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The Company is actively seeking funding through debt and equity offerings. Management cannot be certain that such events or a combination thereof can be achieved.

XML

Related Party Transactions

12 Months Ended

Dec. 31, 2025

Related Party Transactions [Abstract]

Related Party Transactions

Note 4. Related Party Transactions

Expense paid on the Company’s behalf

During the years ended December 31, 2025 and 2024, Mr. Day, a significant shareholder and former President and CFO, paid $345,984 and $341,108 of expenses on the Company’s behalf. The Company repaid $416,332 and $275,097 during the years ended December 31, 2025 and 2024, respectively. The advances accrued interest at the rate of 14%. As of December 31, 2025 and December 31, 2024, the balance owed to Mr. Day, with accrued interest, was $0 and $70,348, respectively.

Accrued salary and interest

As of December 31, 2025, the accrued related party salary and accrued interest expense was $97,000 and $12,307, respectively. As of December 31, 2024, the accrued related party salary and accrued interest expense was $364,500 and $23,121, respectively.

Senior secured notes payable

On May 10, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $225,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 10, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the remaining principal balance of $139,516 and the accrued interest of $27,171.

On June 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $216,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) December 12, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date). If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $216,000 and the accrued interest of $36,731.

On August 12, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) February 12, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $80,000 and the accrued interest of $13,409.

On August 27, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $5,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on October 31, 2024. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $5,000 and the accrued interest of $809.

On September 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $23,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) March 26, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $23,000 and the accrued interest of $3,458.

On October 14, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $80,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 13, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date) . If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years. In April 2025, the note maturity was extended to July 31, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $80,000 and the accrued interest of $11,476.

On January 28, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $6,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on February 28, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $6,000 and the accrued interest of $71.

On March 21, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $3,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on April 21, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $3,000 and the accrued interest of $36.

On May 13, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $36,500 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on June 12, 2025. During the year ended December 31, 2025, the Company repaid the principal balance of $36,500 and the accrued interest of $420.

On June 25, 2025, Rowland Day paid $4,345 of debt origination fees related to loans made by Day on behalf of the Company. The balance due accrued interest at the rate of 14% per annum. The balance is payable on demand. During the year ended December 31, 2025, the Company repaid the balance of $4,345 and the accrued interest of $204.

On July 3, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $8,000 with Saul Leal (the “Lender”). The note will accrue interest at the rate of 14% per annum and matures on January 3, 2026. During the year ended December 31, 2025, the Company repaid the principal balance of $8,000 and the accrued interest of $120.

On July 10, 2025, the Company (the “Grantor”) entered into a secured promissory note payable for $104,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. In the event of a default, the Company will accrued interest at a rate of 16%. Under the July 10, 2025 secured promissory note agreement, on July 30, 2025 and August 30, 2025, the Company borrowed an additional $75,000 and $30,000, respectively. During the year ended December 31, 2025, the Company repaid the principal balance of $104,000 and the accrued interest of $7,439.

On November 26, 2024, the Company (the “Grantor”) entered into a secured promissory note payable for $14,000 with Rowland Day (the “Lender”). The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum. The note is payable on demand. If the Lender does not demand payment, the note matures on January 31, 2025. During the year ended December 31, 2024, the Company repaid $14,000 of the secured promissory note principal.

For all of the secured promissory notes payable with the Lender, to secure the prompt and complete payment of all secured obligations, for value received and pursuant to the notes, the Grantor hereby grants, assigns and transfers to the Lender a security interest in and to all of the Grantor’s assets. At the time any Collateral becomes subject to a security interest of the Lender hereunder, unless the Lender shall otherwise consent, the Grantor shall be deemed to have represented and warranted that (a) the Grantor is the lawful owner of such Collateral or has the power to transfer the Collateral and have the right and authority to subject the same to the security interest of the Lender.

As of December 31, 2025 and 2024, the related party senior secured promissory notes payable principal balance was $0 and $543,515, respectively, with accrued interest of $0 and $43,853, respectively.

Settlement Agreement

Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. In connection with his resignation, the Company made payments to Mr. Day in the amount of $917,966.43 in satisfaction of outstanding loans and reimbursable credit card balances owed to him and a payment in the amount of $408,486.01 for accrued salary. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of 4,309,710 shares of the Company’s Series B-1 Preferred Stock and 307,647 shares of common stock, at per-share prices ranging from $0.605-$0.66 for the preferred shares and $0.055-$0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. If the Company does not complete the stock repurchase by the stated deadline, the parties may pursue non-financial remedies available under the Stock Repurchase Agreement. As of December 31, 2025, the Company determined that the probability of the option to purchase the shares was improbable, as such, no accrual for the purchase of the shares was recognized as of December 31, 2025.

Convertible notes payable

During the year ended December 31, 2025, the Company issued 0% interest convertible notes payable to a director, a director nominee and two relative of a the director nominee in exchange for $250,000. The convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

The Company calculated imputed interest of $30,359 on these zero percent convertible notes using an interest rate of 14% and recorded to additional paid-in-capital. The Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates of the convertible notes. As of December 31, 2025, the convertible notes payable principal balance was $250,000.

The convertible notes matured and became convertible during the year ended December 31, 2025. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of December 31, 2025. As of December 31, 2025, the matured convertible notes would potentially be converted into 1,299,934 common shares.

	For the Years Ended
	December 25, 2025			December 25, 2024
Convertible notes payable, relate party	$	250,000		$	-
Total convertible notes payable, relate party		250,000			-
Less: current portion		(250,000	)		-
Long term convertible notes payable, relate party, net of current	$	-		$	-

XML

Convertible Notes Payable

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Convertible Notes Payable

Note 5. Convertible Notes Payable

In December 2024, the Company issued convertible notes payable to three investors in exchange for $650,000. During the year ended December 31, 2025, the Company issued 0% interest convertible notes payable to three investors in exchange for $190,000. The convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date. The Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates.

The Company calculated imputed interest of $119,040 on these zero percent convertible notes using an interest rate of 14% and recorded to additional paid-in-capital. As of December 31, 2025 and December 31, 2024, the convertible notes payable principal balance was $940,000 and $650,000, respectively.

All convertible notes matured and became convertible during the year ended December 31, 2025. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of December 31, 2025. As of December 31, 2025, the matured convertible notes would potentially be converted into 5,538,201 common shares.

On November 3, 2025, the Company entered into a Convertible Notes Agreement and a Warrant Purchase Agreements (the “Purchase Agreements”), dated as of October 31, 2025, with two investors (the “Holders”) for their purchase of (i) 14% convertible secured promissory notes of the Company in the aggregate original principal amount of $2,000,000 payable on October 31, 2028 (the “Notes”) with a fixed conversion price of $0.08 and (ii) 5-year warrants to purchase 6,000,000 shares of the Company’s common stock at an exercise price of $0.08. The proceeds are to used to repay all amounts outstanding under those certain 14% secured promissory notes and credit card balances to the former President of the Company in the amounts of $917,966 and $408,486, respectively. The remainder of the proceeds were used for working capital and general corporate purposes. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders.

The warrants had a relative fair value of $648,481, which was recorded as a discount on the note. The Company recognized amortization on the debt discount of $36,093 during the year ended December 31, 2025. As of December 31, 2025, the principal balance of the notes was $2,000,000 with an unamortized debt discount of $612,389.

	For the Years Ended
	December 25, 2025			December 25, 2024
Convertible notes payable	$	2,327,612		$	650,000
Total convertible notes payable		2,327,612			650,000
Less: current portion		(940,000	)		(650,000	)
Long term convertible notes payable, net of current	$	1,387,612		$	-

XML

Promissory Notes

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Promissory Notes

Note 6. Promissory Notes

On September 11, 2025, the Company entered into a Promissory Note for a principal amount of $353,050 with the Company receiving cash proceeds of $300,000. The Company recognized debt discount of $53,050 at the issuance of the notes. The note matures on August 30, 2026, and bears a one-time interest of 12% or $42,366. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date.

The Company recognized amortization on the debt discount of $17,683 during the year ended December 31, 2025. As of December 31, 2025, the principal balance of the note was $353,050 with an unamortized debt discount of $35,367.

On October 13, 2025, the Company entered into a Promissory Note for a principal amount of $88,550 with the Company receiving cash proceeds of $70,000. The Company recognized debt discount of $18,550 at the issuance of the notes. The note matures on August 15, 2026 and bears a one-time interest of 15% or $13,282. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date.

The Company repaid $12,000 of the principal balance and recognized amortization on the debt discount of $4,638 during the year ended December 31, 2025. As of December 31, 2025, the principal balance of the note was $76,550 with an unamortized debt discount of $13,913.

	For the Years Ended
	December 25, 2025			December 25, 2024
Promissory notes payable, net	$	380,321		$	-
Total Promissory notes payable, net		380,321			-
Less: current portion		(380,321	)		-
Long term Promissory notes payable, net of current	$	-		$	-

As of December 31, 2025, the Company had unamortized debt discount of $49,279.

XML

Equity

12 Months Ended

Dec. 31, 2025

Equity [Abstract]

Equity

Note 7. Equity

The Company is currently authorized to issue up to 500,000,000 shares of common stock with a par value of $0.001. In addition, The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors.

On May 1, 2023, the Company amended their articles of incorporation to increase the authorized B-1 preferred shares to 8,619,420 shares.

Common Stock

2025

On April 1, 2025, the Company issued 1,000,000 common shares at $0.50 per share for a net proceed of $475,000. The Company paid $25,000 as a finder fee to a consultant related to the issuance.

On April 17, 2025, the Company issued 100,000 common shares for service performed. The grant-date fair value of these shares was $23,000, calculated using the market price of $0.23 of the common stock on the date of grant. The awards are immediately vested, and the value of the issuance was recorded as stock-based compensation.

2024

During the year ended December 31, 2024, the Company issued 969,500 shares of common stock for cash and collected $725,600.

On November 25, 2024, the Company issued 1,500,000 shares of common stock to a consultant for service that were valued at $652,500.

On November 25, 2024, the Board approved the issuance of additional 2,325,983 shares of common stock to shareholders. The shares were issued to shareholders who previously entered into subscription agreements with the Company. This issuance was recorded as a deemed dividend and valued at $1,011,803.

Preferred Stock

Under our Articles of Incorporation, we are authorized to issue up to 2,068 shares of Series A Preferred Stock and up to 8,619,420 of Series B-1 Preferred Stock, each with par value of $0.001. The Series B-1 Preferred Stock is comprised solely of Series B-1 Preferred Stock.

Series A Preferred Stock

The Series A Preferred Stock has liquidation and dividend preferences. Each share of Series A has voting rights equal to the number of shares of common stock the Series A is convertible to and is convertible on a 1 to 1.25 common share basis. As of December 31, 2025 and December 31, 2024 there are 2,068 shares of Series A-1 issued and outstanding.

Series B-1 Preferred Stock

The Series B -1 Preferred Stock (“Series B-1”) has liquidation and dividend preferences. Each share of Series B-1 Preferred Stock has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock that the series of preferred shares are convertible into. Each share is convertible on a 1 to 11 common share basis. Our Articles of Incorporation include covenants requiring 51% of the outstanding votes of the series of stock to amend or repeal any incorporation documents that would alter the rights or preferences of the Series B-1 Preferred Stock, alter the authorized number of shares of the series, create or issue any classes of preferred stock senior to the Series B-1 Preferred Stock, amend the company’s bylaws, or enter into a transaction that would result in a change in control. On September 30, 2023, the Company amended its Articles of Incorporation to remove the redemption right of the Series B-1 Preferred Stock. As of December 31, 2025 and 2024, there are 8,619,420 shares of Series B-1 issued and outstanding.

Common Stock Liability

During the year ended December 31, 2025, the Company granted the issuance of 28,000 common shares to three consultants for services rendered in prior years. The shares had a fair value of $17,360, which was recorded as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On December 1, 2024, the Company granted the issuance of 300,000 restricted common shares to an advisor. The restricted common shares vest in twelve months equal instalments. The restricted common shares had a fair value of $141,000, of which was recognized as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the 300,000 restricted common shares were fully vested. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On August 1, 2025, the Company entered into a consultant agreement where the consultant will receive 7,000 common shares on a monthly basis beginning on the effective date of the agreement. On December 15,2025, the Company entered into an amendment to the consultant agreement to increase the number of monthly common shares to 14,000 common shares per month beginning on January 1, 2026. As of December 31, 2025, the Company granted the issuance of 35,000 common shares to the consultant. The shares had a fair value of $8,197, which was recorded as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On August 1, 2025, the Company entered into a consultant agreement where the consultant will receive 7,000 common shares on a monthly basis beginning on the effective date of the agreement. As of December 31, 2025, the Company granted the issuance of 35,000 common shares to the consultant. The shares had a fair value of $8,197, which was recorded as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On October 1, 2025, the Company granted the issuance of 120,000 restricted common shares to an advisor. The restricted common shares vest in twelve months equal instalments. The restricted common shares had a fair value of $32,280. The Company recognized $8,070 as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, 30,000 restricted common shares were vested. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

On November 10, 2025, the Company entered into a service agreement where the Company will grant the issuance of 40,000 restricted common shares to the advisor on or before January 18, 2026. The Company granted the issuance of the restricted common shares on December 12, 2025. The restricted common shares were granted with a six month restriction period. The restricted common shares had a fair value of $9,196. The Company recognized $3,065 as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, 0 restricted common shares were vested.

On December 12, 2025, the Company granted the issuance of 1,800,000 common shares to two employees. The shares had a fair value of $342,000, which was recorded as stock-based compensation during the year ended December 31, 2025. As of December 31, 2025, the common shares were not physically issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity.

As of December 31, 2025, the total common stock liability was 2,228,000 shares of common stock.

Stock Warrants

During the year ended December 31, 2025, the Company issued 6,000,000 common stock warrants in conjunction with convertible secured promissory notes agreements. The warrants had a relative fair value of $648,481, which was recorded as a discount on the note. The relative fair value of the warrants was estimated using a black-scholes model with the following assumptions:

	Year Ended
	December 31, 2025
Fair value of common stock on measurement date		$0.16 per share
Risk free interest rate (1)		3.71	%
Volatility (2)		307.04	%
Dividend yield (3)		0	%
Expected term (in years)		5 years

(1)	The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
(2)	The trading volatility was determined by calculating the volatility of the Company’s peer group.
(3)	The Company does not expect to pay a dividend in the foreseeable future.

The following table summarizes the stock warrant activity for the years ended December 31, 2025 and 2024:

	Warrants		Weighted-Average Exercise Price Per Share
Outstanding, December 31, 2023		350,000	$	1.29
Granted		–		–
Exercised		–		–
Forfeited		–		–
Expired		–		–
Outstanding, December 31, 2024		350,000		1.29
Granted		6,000,000		0.08
Exercised		–		–
Forfeited		–		–
Expired		–		–
Outstanding, December 31, 2025		6,350,000	$	0.15

As of December 31, 2025, the outstanding and exercisable warrants have a weighted average remaining term of 4.70 with intrinsic value of $966,000.

Stock Options

2025

On December 12, 2025, the board of directors approved the issuance of 1,050,000 option to employees, a director and an advisors. The options issued have a five-year term at an exercise price of $0.19. The options issued to the employees vest immediately on the date of issuance. The options issued to the director and the advisor vest in 12 months instalments beginning on the date of issuance. The total fair value of these option grants at issuance was $131,135. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.19, Exercise price $0.19, Term 2.5-3.0 years, Volatility 99.34%-117.91% and Discount rate 3.73%.

2024

On January 24, 2024, the board of directors approved the issuance of 750,000 options to a director. The options have a ten-year term at an exercise price of $0.51 and vest in 4 equal annual instalments beginning one year from the issuance date. The total fair value of these option grants at issuance was $368,386. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 6.25 years, Volatility 162.68% and Discount rate 4.14%.

On August 5, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The options vest as follows: (i) 50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options. Participant’s sales objectives for the following calendar year will be set by November 15 of the prior year. The total fair value of these option grants at issuance was $43,894. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.51, Exercise price $0.51, Term 3.75 and 5 years, Volatility 120.76% and 167.38% and Discount rate 3.62%.

On August 19, 2024, the board of directors approved the issuance of 100,000 options to an employee. The options have a five-year term at an exercise price of $0.51. The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028. The total fair value of these option grants at issuance was $52,021. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.57, Exercise price $0.57, Term 3.75 years, Volatility 117.27% and Discount rate 3.75%.

On October 29, 2024, the board of directors approved the issuance of 1,200,000 options to an employee. The options expire on March 28, 2029 and have an exercise price of $0.75. 75,000 Options are fully vested and 525,000 Options will become vested and exercisable with respect to 37,500 shares on the last day of each calendar quarter beginning December 31, 2024, and ending on September 30, 2028, until 525,000 Option Shares are 100% vested. For a period of four years beginning October 1, 2024, ending September 30, 2025; October 1, 2025, ending September 30, 2026; October 1, 2026 ending September 30, 2027; and October 1, 2027 ending September 30, 2028, 150,000 Option Shares will vest (subject to meeting certain total new bookings) on September 30 of each year, beginning September 30, 2025. Vesting for each 12-month term is contingent upon Participant exceeding a minimum amount of total new bookings as determined by the Company’s board of directors or their designee. For the first term ending on September 30, 2025, Participant must exceed $5 million of total new bookings for the first vesting of 150,000 Option Shares. The total fair value of these option grants at issuance was $387,206. The Company valued the stock options using the Black-Scholes model with the following key assumptions: Stock price $0.43, Exercise price $0.75, Term 4.21 and 4.41 years, Volatility 120.02% and 122.74 and Discount rate 4.38%.

On November 26, 2024, the Company amended the October 29, 2024 option issuance to change the exercise price to $0.41 per commons stock share and to extend the expiration of the options to October 1, 2029. The Company calculated the incremental fair value based on the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified. The total incremental fair value of the modified awards was $67,171.

The following table summarizes the stock option activity for the years ended December 31, 2025 and 2024:

	Options			Weighted-Average Exercise Price Per Share
Outstanding, December 31, 2023		3,645,000		$	0.43
Granted		2,170,000			0.46
Exercised		–			–
Forfeited		(1,400,000	)		0.33
Expired		–			–
Outstanding, December 31, 2024		4,415,000			0.46
Granted		1,050,000			0.19
Exercised		–			–
Forfeited		–			–
Expired		–			–
Outstanding, December 31, 2025		5,465,000		$	0.41
Exercisable, December 31, 2025		912,744		$	0.40

During the year ended December 31, 2025, the Company recognized $392,585 of expense related to outstanding stock options. During the year ended December 31, 2024, the Company recognized $404,791 of expense related to outstanding stock options. As of December 31, 2025, the un-recognized stock compensation was $665,593. As of December 31, 2025, the outstanding and exercisable options have a weighted average remaining term of 3.37.

XML

Commitments and Obligations

12 Months Ended

Dec. 31, 2025

Commitments and Contingencies Disclosure [Abstract]

Commitments and Obligations

Note 8: Commitments and Obligations

In December 2024, The Company entered into employment agreements with Mr. Leal and Mr. Day, each of which will become effective as of the effective date of the registration statement on Form S-1 in connection with the Company’s planned public offering of its shares. Pursuant to the employment agreements, Mr. Day has agreed to serve as President, Chief Financial Officer, Secretary, Chief Legal Officer and Chairman of the Board of the Company and Mr. Leal has agreed to serve as Chief Executive Officer and as a Director for five years from the effective date in consideration for an annualized salary of $300,000, payable in regular instalments in accordance with the usual payment practices of the Company. The employment agreements contemplate annual bonus awards based on the achievement of performance objectives and targets established annually by the Board of Directors and possible additional bonuses for services and results achieved by Mr. Day and Mr. Leal.

Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. On October 31, 2025, the Company entered into (i) a Confidential General Release and Settlement Agreement with Rowland W. Day II, the Company’s former President, Chief Financial Officer, Secretary, Chief Legal Officer, and a member of the Board of Directors (the “Settlement Agreement”), and (ii) a related Stock Repurchase Agreement with the Rowland W. Day II and Jaimie D. Day Family Trust under declaration dated April 13, 1990 (the “Stock Repurchase Agreement” and together with the Settlement Agreement, the “Agreements”). The Agreements were approved by the Company’s Board of Directors on November 3, 2025. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of 4,309,710 shares of the Company’s Series B-1 Preferred Stock and 307,647 shares of common stock, at per-share prices ranging from $0.605-$0.66 for the preferred shares and $0.055-$0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. If the Company does not complete the stock repurchase by the stated deadline, the parties may pursue remedies available under the Stock Repurchase Agreement.

On July 22, 2024, the Company entered into an Independent Software Vendor Program Agreement (the “Agreement”) with Five9, Inc. (“Five9”), a Delaware corporation. Five9 is a leading provider of intelligent cloud software and applications for contact centers. Pursuant to the Agreement, Five9 granted the Company a non-exclusive, worldwide, royalty-free, non-sublicensable and non-transferable license to access the Five9 developer account with the purpose of integrating the Company’s products and services and becoming an accredited vendor under Five9’s ISV program. The Company has agreed to pay a non-refundable ISV Program participation fee to Five9 for the initial one-year term of the Agreement and for each one-year renewal term thereafter. Further, each party to the Agreement may receive referral fees from the other party for the referral of prospective customers.

One August 22, 2024, the Company entered into a Genesys AppFoundery ISV Partner Agreement with Genesys Cloud Services, Inc. (“Genesys”), a California corporation. Genesys manages the Genesys AppFoundry, a marketplace of solutions that offers Genesys customers a curated selection of integrations and applications. The agreement governs the Company’s non-exclusive participation as an AppFoundry ISV Partner in the Genesys AppFoundry Program. The Company has agreed to pay a non-refundable revenue share to Genesys during the term of the Agreement based on a percentage of the revenue invoiced by the Company or Genesys in connection with the sale of the Company’s software through the AppFoundry marketplace. The agreement may be terminated by either party without cause upon ninety (90) days written notice to the other party.

On October 8, 2024, the Company entered into an OEM Agreement (the “Agreement”) with inContact, Inc. (“inContact”), a Delaware corporation. inContact is an affiliate of NICE Ltd., a company incorporated in Israel, whose shares are traded on the Tel Aviv Stock Exchange and whose American Depositary Shares are traded on the Nasdaq Global Select Market. NICE is one of the largest customer service companies in the world. Pursuant to the Agreement, inContact will distribute and sell the Company’s OEM solutions, consisting of over-the-phone consecutive AI language translation solutions to customers and inContact will pay fees to the Company based on usage of the Company’s OEM solutions. The agreement has an initial term of three years and will automatically renew for additional periods of one year. Additionally, the Company will continue to provide support to NICE for a period of five years following termination or expiration of the agreement. The agreement also has an exclusivity period of eighteen months. During the exclusivity period, NICE shall not develop or make its own native over-the-phone consecutive AI language translation solution, nor shall NICE OEM a competitive over-the-phone consecutive AI language translation solution, where such solution is embedded within the NICE Product. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. As of December 31, 2025, the Company recognized $448,804 of the credit balance as revenue and expects to recognize all the unsatisfied performance obligations as revenue in the next five months.

XML

Income Tax

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Income Tax

Note 9. Income Tax

The Company is subject to United States federal income taxes at an approximate rate of 21%. The reconciliation of the provision for income taxes at the United States federal statutory rate compared to the Company’s income tax expense as reported is as follows:

	Year Ended			Year Ended
	December 31,			December 31,
	2025			2024
Income tax benefit computed at the statutory rate	$	806,000		$	965,000
Tax effect of:
True-up and non-deductible expenses		(183,000	)		(422,000
Change in valuation allowance		(623,000	)		(543,000	)
Provision for income taxes	$	–		$	–

The Company adopted ASC 2023-09 during the year ended December 31, 2025 prospectively. A reconciliation setting forth the differences between the effective tax rates and the U.S. federal statutory tax rate is as follows:

	Year Ended December 31, 2025
	Amount			Rate
US federal statutory tax rate	$	806,000			21.0	%
Changes in valuation allowances		(623,000	)		-16.2	%
Non-taxable or non-deductible items		(183,000	)		-4.8	%
Effective income tax rate	$	–			0	%

Significant components of the Company’s deferred tax assets and liabilities after applying enacted corporate income tax rates are as follows:

	As of			As of
	December 31,			December 31,
	2025			2024
Deferred income tax assets
Net operating losses	$	4,691,000		$	4,069,000
Valuation allowance		(4,691,000	)		(4,069,000	)
Net deferred income tax assets	$	–		$	–

As of December 31, 2025, the Company currently has net operating loss carry forwards of approximately $22,340,000.

XML

Subsequent Events

12 Months Ended

Dec. 31, 2025

Subsequent Events [Abstract]

Subsequent Events

Note 10. Subsequent Events

On December 16, 2025, the Company issued 0% interest convertible notes payable to a the director nominee in exchange for $200,000. The funds were available to the Company on January 13, 2026. The convertible notes mature six months following that date of issuance and do not accrue interest. The note is convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

On January 27, 2026, the Company entered into a promissory note agreement for $80,000 with Roy Chestnutt, Company’s Director. The Company recognized debt discount of $1,612 at the issuance of the note. Pursuant to the agreement, the interest on the promissory note shall equal to 16,000 shares of restricted common stock of the Company. Both the principal balance and the shares are payable on February 1, 2026. As of February 1, 2026, the Company paid the principal balance of $80,000 and issued the 16,000 common shares for the accrued interest.

On February 2, 2026, the Company’s Chief Executive Officer advanced the Company $25,000 to be used for operating expenditures. The advance is due on demand and accrues interest at a rate of 14%. On April 10, 2026, the Company repaid $5,000 on the advance.

On February 3, 2026, the Company entered into a stock purchase agreement for the issuance of 1,388,889 common stock for a net proceed of $250,000.

Pursuant to the October 31, 2025 note and warrant purchase agreements, on February 11, 2026, the Company entered into two and amendment to the note and warrant purchase agreements where the lenders loaned an additional $200,000. Pursuant to the amended agreement, the interest on the promissory note shall equal to 125,000 shares of common stock of the Company for each note. Both the principal balance and the shares are payable on February 26, 2026. If the loans were note repaid when mature, the Company will issued an additional 125,000 shares of common stock for each note.

On March 9, 2026, the board of directors approved the issuance of 800,000 of Preferred B Stock to the Company’s Chief Executive Officer as a performance-based bonus.

On March 20, 2026, the Company entered into a stock purchase agreement for the issuance of 833,334 common stock for a net proceed of $100,000.

On March 23, 2026, the Company entered into a stock purchase agreement for the issuance of 2,083,334 common stock for a net proceed of $250,000.

On March 26, 2026, the Company entered Secured Promissory Note Agreements with two investors for their purchase of (i) 14% secured promissory notes of the Company in the aggregate original principal amount of $700,000 payable on April 17, 2026 and (ii) 5-year warrants to purchase 3,300,000 shares of the Company’s common stock at an exercise price of $0.08. The proceeds are to used to purchase the shares held by Rowland Day as part of the Stock Purchase Agreement. Should the Company default on repayment for the note in full by the maturity date, the Common shall issue to the holders a total of 8,750,000 shares of the Company’s common stock. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders.

On April 8, 2026, the Company entered into a Master Reseller Agreement for an initial term of three-years. Upon execution of the agreement, the Company received $3,000,000 as a credit balance for future service.

On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. As of April 10, 2026, the Company purchased 4,166,667 shares of the Company’s Series B-1 Preferred Stock held by Rowland at a price of $0.66 per Series B-1 Preferred share for a total cash consideration of $2,750,000.

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of stock-based compensation, fair value measurement and long-term customer contracts.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable

Accounts Receivable

Accounts receivables are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, past experience, review of customer profiles and the aging of receivable balances. As of December 31, 2025 and 2024, there was $1,160 and $1,160 of allowance for credit losses, respectively.

Property and Equipment

Property and Equipment

Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows:

	Estimated
Category	Useful Lives
Computer Equipment	3 years

Intangible Assets, and Long-Lived Assets

Intangible Assets, and Long-Lived Assets

The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of a long-lived asset is measured by comparison of the carrying amount to the expected future undiscounted cash flows that the asset is expected to generate. Any impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value.

Related Parties

Related Parties

The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates.

Revenue Recognition

Revenue Recognition

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

● Identification of the contract with a customer

● Identification of the performance obligations in the contract

● Determination of the transaction price

● Allocation of the transaction price to the performance obligations in the contract

● Recognition of revenue when, or as, the Company satisfies a performance obligation

Subscription and license

We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software.

We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service.

Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient.

Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed.

OEM solution

The Company provides Over-the-phone, consecutive AI Translation Service (“VerbumCall SDK”) that uses WebSocket connections to provide an AI service designed to facilitate effortless communication across languages within the platforms. This product leverages advanced AI capabilities to provide consecutive audio translation, ensuring that both patrons and agents experience conversations without the need for additional steps or complicated setups.

The Company has multiple performance obligations in the customer contract with inContact. The Company is to generate revenue through the following sources: sale of OEM Solution software and professional services, which consist of implementation, configuration, custom development, optimization, training and technical support services of the OEM Solution.

VerbumAgentis

On March 31, 2025, the Company entered into a reseller and distribution agreement to provide software development kit (SDK) to the reseller to use and/or resell to their customers. The Company will provide the reseller with a VerbumAgentis communication platform and an encryption key to install on their computer system and servers. In return, the reseller is to pay an initial one-time paid-up fee of $500,000.

VerbumAgentis is a standalone communication platform with core capabilities such as chat-based interaction, transcription, and multilingual simultaneous interpretation for voice-to-voice customer interactions. It includes real-time bidirectional communication and integrations. While live translation leverages underlying language models (SDK), the core platform delivers independent value even without SDK execution for each interaction.

VerbumAgentis is installed on client’s servers that they control. The Company is to deliver and install the VerbumAgentis platform on the customers’ server and provide translation services on an as requested basis by the end customers. The customer benefits from the VerbumAgentis platform as a standalone system once installed on their infrastructure. Further, the translation services and other per usage items outlined in the contract are obligations that arise when those services are initiated by the customer.

Disaggregation of revenues

The Company disaggregates revenue between subscription and license revenue and training and education revenue.

	For the Years Ended
	December 31, 2025		December 31, 2024
Subscription, license and software revenue	$	617,430	$	27,804
Professional Services		868,881		3,500
OEM Solution		19,555		-
Total Revenue	$	1,505,866	$	31,304

Deferred Revenue

Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. On October 8, 2024, the Company entered into an OEM Agreement to provide OEM Solutions hosting consisting of over-the-phone consecutive AI language translation solutions. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. The Company identified three separate performance obligations within the contract. The performance obligations are OEM Solution service, professional services and technical support. The OEM Solution revenue is recognized based on a per-minute rate while the professional services and technical support revenue is recognized based on a per hour rate. The Company expects the $700,000 credit to be used mainly by OEM Solution and professional services. The Company recognized $448,804 of the credit during the year ended December 31, 2025. As of December 31, 2025, the Company expects to recognize all the unsatisfied performance obligations as revenue in the following five months.

During the year ended December 31, 2025, the Company recognized additional $65,000 of deferred revenue on new sales contracts. As of December 31, 2025 and 2024, the deferred revenue balance was $316,196 and $700,000, respectively.

Stock-Based Compensation

Stock-Based Compensation

All stock-based awards to employees and non-employee contractors, including any grants of stock and stock options, are measured at fair value at the grant date and recognized over the relevant vesting period in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. Stock based awards to non-employees are recognized as a selling, general and administrative expense over the period of performance. Such awards are measured at fair value at the date of grant. In addition, for awards that vest immediately, the awards are measured at fair value and recognized in full at the grant date.

Basic and Diluted Loss Per Share

Basic and Diluted Loss Per Share

Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined by using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2025, the Company’s potentially dilutive shares, which were not included in the calculation of net loss per share, included warrants to purchase 6,350,000 common shares, options to purchase 5,465,000 common shares, conversion of Series B-1 shares to purchase 94,813,620 common shares, conversion of Series A shares to purchase 2,585 common shares, the conversion of the convertible notes to 31,838,135 common shares and common stock liability to issue 2,228,000 common shares. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations for the years ended December 31, 2025 and 2024, reflected in the accompanying statement of operations.

Segments Reporting

Segments Reporting

The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company using information about combined net income from operations. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Income Taxes

In December 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning January 1, 2025 on a prospective basis, with retrospective application permitted for all prior periods presented. We adopted ASU No. 2023-09 during the year ended December 31, 2025, which had no material impact on the Company’s financial statements.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires specified information about certain costs and expenses be disclosed in the notes to the financial statements, including the expense caption on the face of the income statement in which they are disclosed, in addition to a qualitative description of remaining amounts not separately disaggregated. Entities will also be required to disclose their definition of “selling expenses” and the total amount in each annual period. The standard is effective for the Company for annual periods beginning January 1, 2027 and for interim periods beginning January 1, 2028, with updates applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures.

Credit Losses

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides updates related to CECL guidance for certain short-term receivables. The ASU is effective for fiscal years beginning after December 15, 2025. The Company is currently evaluating the impact of this guidance on its disclosures.

XML

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Schedule of Property and Equipment

	Estimated
Category	Useful Lives
Computer Equipment	3 years

Schedule of Disaggregation of Revenue

The Company disaggregates revenue between subscription and license revenue and training and education revenue.

	For the Years Ended
	December 31, 2025		December 31, 2024
Subscription, license and software revenue	$	617,430	$	27,804
Professional Services		868,881		3,500
OEM Solution		19,555		-
Total Revenue	$	1,505,866	$	31,304

XML

Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2025

Related Party Transactions [Abstract]

Schedule of Convertible Notes Payable Related Party

	For the Years Ended
	December 25, 2025			December 25, 2024
Convertible notes payable, relate party	$	250,000		$	-
Total convertible notes payable, relate party		250,000			-
Less: current portion		(250,000	)		-
Long term convertible notes payable, relate party, net of current	$	-		$	-

XML

Convertible Notes Payable (Tables)

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Schedule of Convertible Notes Payable

	For the Years Ended
	December 25, 2025			December 25, 2024
Convertible notes payable	$	2,327,612		$	650,000
Total convertible notes payable		2,327,612			650,000
Less: current portion		(940,000	)		(650,000	)
Long term convertible notes payable, net of current	$	1,387,612		$	-

XML

Promissory Notes (Tables)

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Schedule of Promissory Notes Payable Related Party

	For the Years Ended
	December 25, 2025			December 25, 2024
Promissory notes payable, net	$	380,321		$	-
Total Promissory notes payable, net		380,321			-
Less: current portion		(380,321	)		-
Long term Promissory notes payable, net of current	$	-		$	-

XML

Equity (Tables)

12 Months Ended

Dec. 31, 2025

Equity [Abstract]

Schedule of Fair Value of Warrants Was Estimated Using a Black-Scholes Model

	Year Ended
	December 31, 2025
Fair value of common stock on measurement date		$0.16 per share
Risk free interest rate (1)		3.71	%
Volatility (2)		307.04	%
Dividend yield (3)		0	%
Expected term (in years)		5 years

(1)	The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.
(2)	The trading volatility was determined by calculating the volatility of the Company’s peer group.
(3)	The Company does not expect to pay a dividend in the foreseeable future.

Schedule of Warrant Outstanding

The following table summarizes the stock warrant activity for the years ended December 31, 2025 and 2024:

	Warrants		Weighted-Average Exercise Price Per Share
Outstanding, December 31, 2023		350,000	$	1.29
Granted		–		–
Exercised		–		–
Forfeited		–		–
Expired		–		–
Outstanding, December 31, 2024		350,000		1.29
Granted		6,000,000		0.08
Exercised		–		–
Forfeited		–		–
Expired		–		–
Outstanding, December 31, 2025		6,350,000	$	0.15

Schedule of Stock Options

The following table summarizes the stock option activity for the years ended December 31, 2025 and 2024:

	Options			Weighted-Average Exercise Price Per Share
Outstanding, December 31, 2023		3,645,000		$	0.43
Granted		2,170,000			0.46
Exercised		–			–
Forfeited		(1,400,000	)		0.33
Expired		–			–
Outstanding, December 31, 2024		4,415,000			0.46
Granted		1,050,000			0.19
Exercised		–			–
Forfeited		–			–
Expired		–			–
Outstanding, December 31, 2025		5,465,000		$	0.41
Exercisable, December 31, 2025		912,744		$	0.40

XML

Income Tax (Tables)

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of Income Tax Rate Reconciliation

	Year Ended			Year Ended
	December 31,			December 31,
	2025			2024
Income tax benefit computed at the statutory rate	$	806,000		$	965,000
Tax effect of:
True-up and non-deductible expenses		(183,000	)		(422,000
Change in valuation allowance		(623,000	)		(543,000	)
Provision for income taxes	$	–		$	–

The Company adopted ASC 2023-09 during the year ended December 31, 2025 prospectively. A reconciliation setting forth the differences between the effective tax rates and the U.S. federal statutory tax rate is as follows:

	Year Ended December 31, 2025
	Amount			Rate
US federal statutory tax rate	$	806,000			21.0	%
Changes in valuation allowances		(623,000	)		-16.2	%
Non-taxable or non-deductible items		(183,000	)		-4.8	%
Effective income tax rate	$	–			0	%

Schedule of Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred tax assets and liabilities after applying enacted corporate income tax rates are as follows:

	As of			As of
	December 31,			December 31,
	2025			2024
Deferred income tax assets
Net operating losses	$	4,691,000		$	4,069,000
Valuation allowance		(4,691,000	)		(4,069,000	)
Net deferred income tax assets	$	–		$	–

XML

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024	Oct. 08, 2024	Dec. 31, 2023
Allowance for credit loss		$ 1,160	$ 1,160
Fee income	$ 500,000
Deferred revenue		316,196	$ 700,000
Revenue recognized		448,804
Deferred revenue recognized		$ 65,000
Series B-1 Convertible Preferred Stock [Member]
Conversion shares		94,813,620
Series A Preferred Stock [Member]
Conversion shares		2,585
Share-Based Payment Arrangement, Option [Member]
Options outstanding		5,465,000
Warrant [Member]
Warrants outstanding		6,350,000	350,000		350,000
Common Stock [Member]
Conversion shares		31,838,135
Common stock liability		2,228,000
OEM Agreement [Member]
Deferred revenue				$ 700,000
Deferred revenue expected to be used				$ 700,000

XML

Schedule of Property and Equipment (Details)	Dec. 31, 2025
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years

XML

Schedule of Disaggregation of Revenue (Details) - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Product Information [Line Items]
Total Revenue	$ 1,505,866	$ 31,304
Subscription And License And Software Revenue [Member]
Product Information [Line Items]
Total Revenue	617,430	27,804
Professional Services [Member]
Product Information [Line Items]
Total Revenue	868,881	3,500
OEM Solution [Member]
Product Information [Line Items]
Total Revenue	$ 19,555

XML

Related Party Transactions (Details Narrative) - USD ($)																					1 Months Ended	12 Months Ended
	Apr. 10, 2026	Mar. 26, 2026	Oct. 31, 2025	Oct. 13, 2025	Sep. 11, 2025	Jul. 10, 2025	Jul. 03, 2025	May 13, 2025	Apr. 17, 2025	Apr. 01, 2025	Mar. 21, 2025	Jan. 28, 2025	Nov. 26, 2024	Oct. 14, 2024	Sep. 26, 2024	Aug. 27, 2024	Aug. 12, 2024	Jun. 12, 2024	May 10, 2024	Jan. 01, 2024	Apr. 30, 2025	Dec. 31, 2025	Dec. 31, 2024	Dec. 16, 2025	Aug. 30, 2025	Jul. 30, 2025	Jul. 25, 2025
Interest rate				15.00%	12.00%
Debt maturity date				Aug. 15, 2026	Aug. 30, 2026
Additional borrowed																									$ 30,000	$ 75,000
Stock issued during the period, shares									100,000	1,000,000										300,000		300,000	969,500
Share price										$ 0.50
Payment of related party																							$ 72,000
Proceeds from convertible notes																						$ 2,250,000	650,000
Interest rate																						14.00%
Convertible note payable related party																						$ 940,000	$ 650,000
Common stock capital shares reserved for future issuance																						1,299,934
Convertible Notes Payable [Member]
Interest rate																								0.00%
Proceeds from convertible notes																						$ 250,000
Convertible price, description																						(x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date
Common Stock [Member]
Stock issued during the period, shares																						1,000,000	969,500
Common stock capital shares reserved for future issuance																						5,538,201
Senior Secured Promissory Notes Payable [Member]
Interest rate																						0.00%
accrued interest expense																						$ 0	$ 43,853
Notes payable principal balance																						0	543,515
Debt instrumental Repaid																						139,516
Rowland Day [Member]
Balance owed																						$ 0	70,348
Accrued salaries			$ 408,486.01
Debt face amount			$ 917,966.43
Rowland Day [Member] | Subsequent Event [Member]
Payment of related party	$ 100,000	$ 100,000
Rowland Day [Member] | Common Stock [Member]
Stock issued during the period, shares			307,647
Rowland Day [Member] | Series B Preferred Stock [Member]
Stock issued during the period, shares			4,309,710
Rowland Day [Member] | Series B Preferred Stock [Member] | Minimum [Member]
Share price			$ 0.605
Rowland Day [Member] | Series B Preferred Stock [Member] | Maximum [Member]
Share price			0.66
Rowland Day [Member] | Common Stock [Member] | Minimum [Member]
Share price			0.055
Rowland Day [Member] | Common Stock [Member] | Maximum [Member]
Share price			$ 0.06
Rowland Day [Member] | Senior Secured Promissory Notes Payable [Member]
Interest rate						14.00%		14.00%			14.00%	14.00%	14.00%	14.00%	14.00%	14.00%	14.00%	14.00%	14.00%			14.00%					14.00%
Notes payable principal balance						$ 104,000		$ 36,500			$ 3,000	$ 6,000	$ 14,000	$ 80,000	$ 23,000	$ 5,000	$ 80,000	$ 216,000	$ 225,000				14,000				$ 4,345
Debt default description						The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum		The note is payable on demand. If the Lender does not demand payment, the note matures on June 12, 2025			The note is payable on demand. If the Lender does not demand payment, the note matures on April 21, 2025	The note is payable on demand. If the Lender does not demand payment, the note matures on February 28, 2025	The note is secured by the assets of the Company and will accrue interest at the rate of 14% per annum	The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 13, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date)	The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) March 26, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date)	The note is payable on demand. If the Lender does not demand payment, the note matures on October 31, 2024	The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) February 12, 2025, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date)	The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) December 12, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date)	The note is payable on demand. If the Lender does not demand payment, the note matures the earlier of; (i) November 10, 2024, (ii) the closing of a minimum of $500,000 in a subsequent financing of either debt or equity; (iii) a subsequent registration statement with minimum proceeds of one million dollars ($1,000,000) is received by the Company; and /or (iv) a change in control transaction occurs in which the collective ownership of Saul Leal and Holder is reduced to less than fifty percent (50%) or Holder’s ownership is reduced to less than thirty-five percent (35%) (any such date, or transaction shall be the maturity date)
Debt default description														If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years	If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years		If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years	If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years	If any Event of Default occurs and continues for a period that exceeds ten (10) days, Holder may by written election, elect to either (i) declare the Note immediately due and payable, or (ii) receive 1,000,000 warrants with an exercise price of $0.01 per share which shall have a term of 5 years
Warrants receivable														1,000,000	1,000,000		1,000,000	1,000,000	1,000,000
Exercise price														$ 0.01	$ 0.01		$ 0.01	$ 0.01	$ 0.01
Warrants term														5 years	5 years		5 years	5 years	5 years
Debt maturity date																					Jul. 31, 2025
Interest rate increase						16.00%
Impute interest																						$ 30,359
Rowland Day [Member] | Senior Secured Promissory Notes Payable One [Member]
Debt instrumental Repaid																						216,000
Accrued salaries																						36,731
Rowland Day [Member] | Senior Secured Promissory Notes Payable Two [Member]
Debt instrumental Repaid																						80,000
Accrued salaries																						13,409
Rowland Day [Member] | Senior Secured Promissory Notes Payable Three [Member]
Debt instrumental Repaid																						5,000
Accrued salaries																						809
Rowland Day [Member] | Senior Secured Promissory Notes Payable Four [Member]
Debt instrumental Repaid																						23,000
Accrued salaries																						3,458
Rowland Day [Member] | Senior Secured Promissory Notes Payable Five [Member]
Debt maturity date																					Jul. 31, 2025
Debt instrumental Repaid																						80,000
Accrued salaries																						11,476
Rowland Day [Member] | Senior Secured Promissory Notes One Payable [Member]
Notes payable principal balance																						6,000
Accrued salaries																						71
Rowland Day [Member] | Senior Secured Promissory Notes Two Payable [Member]
Notes payable principal balance																						3,000
Accrued salaries																						36
Rowland Day [Member] | Senior Secured Promissory Notes Three Payable [Member]
Notes payable principal balance																						36,500
Accrued salaries																						420
Rowland Day [Member] | Senior Secured Promissory Notes Four Payable [Member]
Notes payable principal balance																						4,345
Accrued salaries																						204
Rowland Day [Member] | Senior Secured Promissory Notes Five Payable [Member]
Notes payable principal balance																						104,000
Accrued salaries																						7,439
Related Party [Member]
Accrued salary																						97,000	364,500
accrued interest expense																						12,307	23,121
Accrued salaries																						27,171
Convertible note payable related party																						250,000
Saul Leal [Member] | Senior Secured Promissory Notes Payable [Member]
Interest rate							14.00%
Notes payable principal balance							$ 8,000
Debt default description							The note will accrue interest at the rate of 14% per annum and matures on January 3, 2026
Saul Leal [Member] | Senior Secured Promissory Notes Five Payable [Member]
Notes payable principal balance																						8,000
Accrued salaries																						120
Chief Financial Officer [Member]
Expenses paid on the company's behalf																						345,984	341,108
Repayments of expenses to related party																						$ 416,332	$ 275,097

XML

Schedule of Convertible Notes Payable Related Party (Details) - USD ($)	Dec. 31, 2025	Dec. 25, 2025	Dec. 31, 2024	Dec. 25, 2024
Related Party Transactions [Abstract]
Convertible notes payable, relate party	$ 250,000	$ 250,000
Total convertible notes payable, relate party		250,000
Less: current portion		(250,000)
Long term convertible notes payable, relate party, net of current

XML

Schedule of Convertible Notes Payable (Details) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Debt Disclosure [Abstract]
Total convertible notes payable	$ 2,327,612	$ 650,000
Less: current portion	(940,000)	(650,000)
Long term convertible notes payable, net of current	$ 1,387,612

XML

Convertible Notes Payable (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
	Oct. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024	Dec. 16, 2025	Oct. 13, 2025	Sep. 11, 2025
Short-Term Debt [Line Items]
Proceeds from convertible notes			$ 2,250,000	$ 650,000
Interest rate						15.00%	12.00%
Adjustment to additional paid in capital other			$ 119,040
Interest rate			14.00%
Convertible notes payable		$ 650,000	$ 940,000	$ 650,000
Common stock capital shares reserved for future issuance			1,299,934
Debt instrumental original amount	$ 2,000,000
debt discount	$ 648,481		$ 612,389			$ 18,550	$ 53,050
debt discount			$ 36,093
Purchase Agreements [Member]
Short-Term Debt [Line Items]
Interest rate	14.00%
Debt instrumental original amount	$ 2,000,000
debt exercise price	$ 0.08
Warrants Term	5 years
Debt converted instumental , shares	6,000,000
Purchase Agreements [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Debt amount	$ 917,966
Purchase Agreements [Member] | Minimum [Member]
Short-Term Debt [Line Items]
Debt amount	$ 408,486
Common Stock [Member]
Short-Term Debt [Line Items]
Common stock capital shares reserved for future issuance			5,538,201
Senior Secured Promissory Notes Payable [Member]
Short-Term Debt [Line Items]
Interest rate			0.00%
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Proceeds from convertible notes			$ 250,000
Interest rate					0.00%
Convertible price, description			(x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date
Convertible Notes Payable One [Member]
Short-Term Debt [Line Items]
Proceeds from convertible notes			$ 190,000
Three Investors [Member] | Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Proceeds from convertible notes		$ 650,000
Convertible price, description			(x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date

XML

Schedule of Promissory Notes Payable Related Party (Details) - USD ($)	Dec. 31, 2025	Dec. 25, 2025	Dec. 31, 2024	Dec. 25, 2024
Short-Term Debt [Line Items]
Promissory notes payable, net	$ 380,321
Promissory Note [Member]
Short-Term Debt [Line Items]
Promissory notes payable, net		$ 380,321
Total Promissory notes payable, net		380,321
Less: current portion		(380,321)
Long term Promissory notes payable, net of current

XML

Promissory Notes (Details Narrative) - USD ($)				12 Months Ended
	Oct. 13, 2025	Sep. 11, 2025	Apr. 01, 2025	Dec. 31, 2025	Dec. 31, 2024	Oct. 31, 2025
Short-Term Debt [Line Items]
Principal amount	$ 88,550	$ 353,050
Cash proceeds	70,000	300,000	$ 475,000	$ 475,000	$ 725,600
Debt discount	$ 18,550	$ 53,050		612,389		$ 648,481
Maturity date	Aug. 15, 2026	Aug. 30, 2026
One-time interest percentage	15.00%	12.00%
One-time interest	$ 13,282	$ 42,366
Interest percentage	22.00%	22.00%
Debt description	Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date	Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date
Amortization of debt discount				17,683
Unamortized debt discount				35,367
Promissory Note Agreement [Member]
Short-Term Debt [Line Items]
Principal balance				353,050
Promissory Note [Member]
Short-Term Debt [Line Items]
Principal amount				12,000
Amortization of debt discount				4,638
Principal balance				76,550
Unamortized debt discount				13,913
Unamortized debt discount				$ 49,279

XML

Schedule of Fair Value of Warrants Was Estimated Using a Black-Scholes Model (Details) - Warrant [Member]	Dec. 31, 2025
Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants and rights outstanding measurement input	0.16
Measurement Input, Risk Free Interest Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants and rights outstanding measurement input	3.71	[1]
Measurement Input, Price Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants and rights outstanding measurement input	307.04	[2]
Measurement Input, Expected Dividend Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants and rights outstanding measurement input	0	[3]
Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants and rights outstanding measurement input	5

[1] The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.

[2] The trading volatility was determined by calculating the volatility of the Company’s peer group.

[3] The Company does not expect to pay a dividend in the foreseeable future.

XML

Schedule of Warrant Outstanding (Details) - $ / shares		12 Months Ended
	Apr. 17, 2025	Dec. 31, 2025	Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]
Weighted average exercise price per share, granted	$ 0.23
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants outstanding, beginning balance		350,000	350,000
Weighted average exercise price per share, beginning balance		$ 1.29	$ 1.29
Warrants outstanding, granted		6,000,000
Weighted average exercise price per share, granted		$ 0.08
Warrants outstanding, exercised
Weighted average exercise price per share, exercised
Warrants outstanding, forfeited
Weighted average exercise price per share, forfeited
Warrants outstanding, expired
Weighted average exercise price per share, expired
Warrants outstanding, ending balance		6,350,000	350,000
Weighted average exercise price per share, ending balance		$ 0.15	$ 1.29

XML

Schedule of Stock Options (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding, Balance	4,415,000	3,645,000
Weighted average exercise price, Balance	$ 0.46	$ 0.43
Options outstanding, Granted	1,050,000	2,170,000
Weighted average exercise price, Granted	$ 0.19	$ 0.46
Options outstanding, Exercised
Weighted average exercise price, Exercised
Options outstanding, Forfeited		(1,400,000)
Weighted average exercise price, Forfeited		$ 0.33
Options outstanding, Expired
Weighted average exercise price, Expired
Options outstanding, Balance	5,465,000	4,415,000
Weighted average exercise price, Balance	$ 0.41	$ 0.46
Options exercisable, Balance	912,744
Weighted average exercisable, Balance	$ 0.40

XML

Equity (Details Narrative) - USD ($)																	12 Months Ended
	Dec. 15, 2025	Dec. 12, 2025	Nov. 10, 2025	Oct. 13, 2025	Oct. 01, 2025	Sep. 11, 2025	Aug. 01, 2025	Apr. 17, 2025	Apr. 01, 2025	Nov. 26, 2024	Nov. 25, 2024	Oct. 29, 2024	Aug. 19, 2024	Aug. 05, 2024	Jan. 24, 2024	Jan. 01, 2024	Dec. 31, 2025	Dec. 31, 2024	May 01, 2023
Class of Stock [Line Items]
Common stock, shares authorized																	500,000,000	500,000,000
Common stock, par value																	$ 0.001	$ 0.001
Preferred stock, shares authorized																	50,000,000	50,000,000
Preferred stock, par value																	$ 0.001	$ 0.001
Issuance of common shares								100,000	1,000,000							300,000	300,000	969,500
Stock price									$ 0.50
Common stock issued, value				$ 70,000		$ 300,000			$ 475,000								$ 475,000	$ 725,600
Finder fee									$ 25,000
Grant date fair value								$ 23,000
Grant date fair value per share								$ 0.23
Common shares issued for services, shares											1,500,000
Common shares issued for services, value																	23,000	652,500
Additional shares issued for prior year, shares											2,325,983
Deemed dividend											$ 1,011,803							1,011,803
Stock based compensation																	$ 415,585	$ 1,057,291
Restricted common shares of fair value																$ 141,000
Common stock liability																	2,228,000
Warrant issued																	6,000,000
Fair value of warrants																	$ 648,481
Share-Based Payment Arrangement, Option [Member]
Class of Stock [Line Items]
Stock options, issuance																	1,050,000	2,170,000
Options exercise price																	$ 0.19	$ 0.46
Share-Based Payment Arrangement, Expense																	$ 392,585	$ 404,791
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount																	$ 665,593
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term																	3 years 4 months 13 days
Share-Based Payment Arrangement, Option [Member] | Employee Stock [Member]
Class of Stock [Line Items]
Stock price												$ 0.43	$ 0.57	$ 0.51
Stock options, issuance												1,200,000	100,000	100,000
Options term														5 years
Options exercise price												$ 0.75	$ 0.51	$ 0.51
Option grants issuance												$ 387,206	$ 52,021	$ 43,894
Exercise price										$ 0.41		$ 0.75	$ 0.57	$ 0.51
Term													3 years 9 months
Volatility													117.27%
Discount rate												4.38%	3.75%	3.62%
Stock options vested description												75,000 Options are fully vested and 525,000 Options will become vested and exercisable with respect to 37,500 shares on the last day of each calendar quarter beginning December 31, 2024, and ending on September 30, 2028, until 525,000 Option Shares are 100% vested. For a period of four years beginning October 1, 2024, ending September 30, 2025; October 1, 2025, ending September 30, 2026; October 1, 2026 ending September 30, 2027; and October 1, 2027 ending September 30, 2028, 150,000 Option Shares will vest (subject to meeting certain total new bookings) on September 30 of each year, beginning September 30, 2025.	The Option will become vested and exercisable with respect to 7,500 shares on December 31, 2024, and 7,500 shares at the end of each calendar quarter for years 2025, 2026, 2027 and ending on September 30, 2028.	(i) 50,000 options will become vested and exercisable with respect to 3,125 shares on December 31, 2024, and 3,125 shares at the end of each calendar quarter for years 2025, 2026, 2027, and ending on September 30, 2028, until the 50,000 Options are 100% vested (ii) 12,500 Options will vest over four years on an annual basis when the Participant exceeds annual sales objectives established by the Company for years 2025, 2026, 2027, and 2028, for a total of 50,000 Options.
Options expire date										Oct. 01, 2029		Mar. 28, 2029
Stock options vesting value												$ 5,000,000
Stock options vesting shares												150,000
Incremental fair value										$ 67,171
Share-Based Payment Arrangement, Option [Member] | Minimum [Member] | Employee Stock [Member]
Class of Stock [Line Items]
Term												4 years 2 months 15 days		3 years 9 months
Volatility												120.02%		120.76%
Share-Based Payment Arrangement, Option [Member] | Maximum [Member] | Employee Stock [Member]
Class of Stock [Line Items]
Term												4 years 4 months 28 days		5 years
Volatility												122.74%		167.38%
Warrant [Member]
Class of Stock [Line Items]
Grant date fair value per share																	$ 0.08
Weighted average remaining term, exercisable																	4 years 8 months 12 days
Intrinsic value, exercisable																	$ 966,000
Consultant Agreement [Member]
Class of Stock [Line Items]
Issuance of common shares	14,000						7,000										35,000
Stock based compensation																	$ 8,197
Service Agreement [Member]
Class of Stock [Line Items]
Stock based compensation			$ 3,065
Restricted common shares			40,000
Restricted common shares fair value			$ 9,196
Restricted common shares vested																	0
Three Consultants [Member]
Class of Stock [Line Items]
Issuance of common shares																	28,000
Stock based compensation																	$ 17,360
Advisor [Member]
Class of Stock [Line Items]
Stock based compensation					$ 8,070
Restricted common shares					120,000
Restricted common shares fair value					$ 32,280
Restricted common shares vested																	30,000
Two Employees [Member]
Class of Stock [Line Items]
Issuance of common shares		1,800,000
Stock based compensation		$ 342,000
Director [Member] | Share-Based Payment Arrangement, Option [Member]
Class of Stock [Line Items]
Stock price		$ 0.19													$ 0.51
Stock options, issuance		1,050,000													750,000
Options term		5 years													10 years
Options exercise price		$ 0.19													$ 0.51
Option grants issuance		$ 131,135													$ 368,386
Exercise price		$ 0.19													$ 0.51
Term															6 years 3 months
Volatility															162.68%
Discount rate		3.73%													4.14%
Director [Member] | Share-Based Payment Arrangement, Option [Member] | Minimum [Member]
Class of Stock [Line Items]
Term		2 years 6 months
Volatility		99.34%
Director [Member] | Share-Based Payment Arrangement, Option [Member] | Maximum [Member]
Class of Stock [Line Items]
Term		3 years
Volatility		117.91%
Series B One Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized																			8,619,420
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized																	5,000,000	5,000,000
Preferred stock, par value																	$ 0.001	$ 0.001
Preferred stock, shares issued																	2,068	2,068
Preferred stock, conversion terms																	Each share of Series A has voting rights equal to the number of shares of common stock the Series A is convertible to and is convertible on a 1 to 1.25 common share basis.
Preferred stock, shares outstanding																	2,068	2,068
Series B-1 Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized																	8,619,420	8,619,420
Preferred stock, par value																	$ 0.001	$ 0.001
Preferred stock, shares issued																	8,619,420	8,619,420
Preferred stock, conversion terms																	Each share is convertible on a 1 to 11 common share basis.
Preferred stock, shares outstanding																	8,619,420	8,619,420
Preferred stock, voting rights																	Each share of Series B-1 Preferred Stock has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock that the series of preferred shares are convertible into
Outstanding votes percent																	51.00%

XML

Commitments and Obligations (Details Narrative) - USD ($)					12 Months Ended
	Apr. 10, 2026	Mar. 26, 2026	Oct. 31, 2025	Oct. 08, 2024	Dec. 31, 2025	Dec. 31, 2024
Loss Contingencies [Line Items]
Payment of related party						$ 72,000
Revenue recognized					$ 448,804
OEM Agreement [Member]
Loss Contingencies [Line Items]
Fees received				$ 700,000
Rowland Day [Member]
Loss Contingencies [Line Items]
Salaries payable			$ 408,486.01
Rowland Day [Member] | Subsequent Event [Member]
Loss Contingencies [Line Items]
Payment of related party	$ 100,000	$ 100,000
Chief Executive Officer and Director [Member]
Loss Contingencies [Line Items]
Salaries payable						$ 300,000
Mr. Day [Member] | Common Stock [Member]
Loss Contingencies [Line Items]
Payments to satisfaction of outstanding loans			307,647
Mr. Day [Member] | Common Stock [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Share price			$ 0.055
Mr. Day [Member] | Common Stock [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Share price			$ 0.06
Mr. Day [Member] | Series B-1 Convertible Preferred Stock [Member]
Loss Contingencies [Line Items]
Payments to satisfaction of outstanding loans			4,309,710
Mr. Day [Member] | Series B-1 Convertible Preferred Stock [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Share price			$ 0.605
Mr. Day [Member] | Series B-1 Convertible Preferred Stock [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Share price			$ 0.66

XML

Schedule of Income Tax Rate Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Income Tax Disclosure [Abstract]
US federal statutory tax rate	$ 806,000	$ 965,000
Non-taxable or non-deductible items	(183,000)	(422,000)
Changes in valuation allowances	(623,000)	(543,000)
Effective income tax rate
US Federal Statutory Tax Rate, percentage	21.00%
Changes in Valuation Allowances, percentage	(16.20%)
Nontaxable or Nondeductible Items, percentage	(4.80%)
Effective income tax rate, percentage	0.00%

XML

Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Net operating losses	$ 4,691,000	$ 4,069,000
Valuation allowance	(4,691,000)	(4,069,000)
Net deferred income tax assets

XML

Income Tax (Details Narrative)	Dec. 31, 2025 USD ($)
Income Tax Disclosure [Abstract]
Operating loss carryforward	$ 22,340,000

XML

Subsequent Events (Details Narrative) - USD ($)																		12 Months Ended
	Apr. 10, 2026	Mar. 26, 2026	Mar. 23, 2026	Mar. 20, 2026	Mar. 09, 2026	Feb. 11, 2026	Feb. 03, 2026	Feb. 02, 2026	Jan. 27, 2026	Dec. 16, 2025	Oct. 31, 2025	Oct. 13, 2025	Sep. 11, 2025	Apr. 17, 2025	Apr. 01, 2025	Nov. 25, 2024	Jan. 01, 2024	Dec. 31, 2025	Dec. 31, 2024	Apr. 17, 2026
Subsequent Event [Line Items]
Interest rate												15.00%	12.00%
Convertible note payable																		$ 2,327,612	$ 650,000
Debt instrument, Description												Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date	Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date
Debt discount																		17,683
Issuance of common stock																		$ 475,000	$ 725,600
Common shares issued for cash, shares														100,000	1,000,000		300,000	300,000	969,500
Operating expenditures																		$ 4,779,764	$ 4,552,969
Proceeds from issuance of common shares												$ 70,000	$ 300,000		$ 475,000			475,000	725,600
Number of shares issued for future service																1,500,000
Payment of related party																			$ 72,000
Rowland Day [Member]
Subsequent Event [Line Items]
Principal amount											$ 917,966.43
Series B Preferred Stock [Member] | Rowland Day [Member]
Subsequent Event [Line Items]
Common shares issued for cash, shares											4,309,710
Subsequent Event [Member] | Rowland Day [Member]
Subsequent Event [Line Items]
Payment of related party	$ 100,000	$ 100,000
Subsequent Event [Member] | Chief Executive Officer [Member]
Subsequent Event [Line Items]
Interest rate								14.00%
Operating expenditures								$ 25,000
Advance amount	$ 5,000
Subsequent Event [Member] | Chief Executive Officer [Member] | Series B Preferred Stock [Member]
Subsequent Event [Line Items]
Common shares issued for cash, shares					800,000
Promissory Note Agreement [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Promissory note									$ 80,000
Debt discount									$ 1,612
Restricted common stock									16,000
Issuance of common stock									$ 80,000
Common shares issued for cash, shares									16,000
Stock Purchase Agreement [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Common shares issued for cash, shares			2,083,334	833,334			1,388,889
Proceeds from issuance of common shares			$ 250,000	$ 100,000			$ 250,000
Two Notes Payable Agreement [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Common shares issued for cash, shares						125,000
Notes Payable						$ 200,000
Stock issued during period shares additional new issues						125,000
Secured Promissory Note Agreements [Member] | Subsequent Event [Member] | Two Investors [Member]
Subsequent Event [Line Items]
Interest rate				14.00%
Common shares issued for cash, shares		8,750,000
Principal amount																				$ 700,000
Warrants term		5 years
Warrants to purchase common stock																				3,300,000
Exercise price																				$ 0.08
Number of shares issued for future service		3,000,000
Stock Repurchase Agreement [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Purchase of shares	4,166,667
Price per share	$ 0.66
Consideration received on transaction	$ 2,750,000
Convertible Notes Payable [Member]
Subsequent Event [Line Items]
Interest rate										0.00%
Convertible note payable										$ 2,000
Debt instrument, Description										(i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.